|
G |
Folh1 |
folate hydrolase 1 |
affects binding multiple interactions |
ISO |
isospaglumic acid binds to FOLH1 protein [2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [isospaglumic acid binds to FOLH1 protein] |
CTD |
PMID:24508213 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
|
G |
A1bg |
alpha-1-B glycoprotein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of A1BG mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 7:92,493,934...92,498,460
Ensembl chr 7:92,494,372...92,498,097
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased methylation of ABCA1 promoter] |
CTD |
PMID:31150806 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abca5 |
ATP binding cassette subfamily A member 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA5 mRNA] |
CTD |
PMID:31004932 |
|
NCBI chr10:95,240,159...95,309,195
Ensembl chr10:95,240,154...95,308,976
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO EXP |
Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]; Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mRNA]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of ABCB1 mRNA] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of ABCB1]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased activity of ABCB1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of and results in increased activity of ABCB1 protein] |
CTD |
PMID:10636889 PMID:18474546 PMID:22914566 PMID:23867903 PMID:25824409 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mRNA]; Acetylcysteine inhibits the reaction [formononetin results in decreased expression of ABCC1 mRNA]; Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC1 protein]; Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]; Buthionine Sulfoximine analog inhibits the reaction [Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]] |
CTD |
PMID:11820781 PMID:15473893 PMID:22914566 PMID:23867903 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mRNA]; Acetylcysteine inhibits the reaction [formononetin results in decreased expression of ABCC2 mRNA] Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein] |
CTD |
PMID:22914566 PMID:23867903 PMID:34303734 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC3 protein] |
CTD |
PMID:11820781 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of ABCG1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of ABL1 protein] |
CTD |
PMID:16481037 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions affects response to substance |
EXP ISO |
[Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Cadmium results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [chlorpyrifos-methyl results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Dimethoate results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased activity of ACHE protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of ACHE protein] ACHE protein affects the susceptibility to Acetylcysteine Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of ACHE mRNA alternative form]; Acetylcysteine inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:20399762 PMID:20688495 PMID:26769589 PMID:27087133 PMID:27163631 PMID:28499986 PMID:29253600 PMID:30639957 PMID:31173782 PMID:34425170 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acp3 |
acid phosphatase 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACP3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSM5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of ACTA2 mRNA] Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 PMID:21134390 PMID:32659284 PMID:33131013 PMID:35622622 PMID:36493885 More...
|
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ADAM33 mRNA] |
CTD |
PMID:29753051 |
|
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Ethanol results in increased expression of ADH1 mRNA] |
CTD |
PMID:20705415 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Palmitates results in decreased expression of ADIPOQ mRNA]; Acetylcysteine inhibits the reaction [Palmitates results in decreased expression of ADIPOQ protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ protein]] |
CTD |
PMID:17471172 PMID:21912612 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOR2 protein]] |
CTD |
PMID:21912612 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein] Acetylcysteine inhibits the reaction [AGT protein modified form results in increased abundance of Reactive Oxygen Species] |
CTD |
PMID:15849355 PMID:30703374 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of AGTR1 mRNA] |
CTD |
PMID:23603059 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression multiple interactions |
ISO |
Acetylcysteine results in increased expression of AHR protein Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of and affects the localization of AHR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of AHR protein]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1A enhancer]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1B enhancer] |
CTD |
PMID:18022818 PMID:21569840 PMID:31551408 PMID:35123993 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of AIF1 protein]] |
CTD |
PMID:36762617 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride affects the localization of AIFM1 protein] Acetylcysteine inhibits the reaction [bisphenol A affects the localization of AIFM1 protein] Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of AIFM1 protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone affects the localization of AIFM1 protein] |
CTD |
PMID:18034189 PMID:18412143 PMID:18506790 PMID:18951928 PMID:19679660 PMID:21741372 PMID:27189055 PMID:31518672 More...
|
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of AIMP1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of AKR1C3 protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AKR1C3 mRNA] |
CTD |
PMID:18829485 PMID:21787718 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased activity of and results in increased phosphorylation of AKT1 protein]; [Acetylcysteine co-treated with Hydrogen Peroxide] results in increased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of and affects the localization of AKT1 protein]; Acetylcysteine inhibits the reaction [arsenic trichloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [butein results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E affects the phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [cyadox results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Daunorubicin results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [divinyl sulfone analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Morpholines analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [morusin results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [N-arachidonoylalanine results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [oenothein B results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Oligopeptides analog results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Patulin results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [synaptamide results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [tubocapsenolide A results in increased degradation of AKT1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of AKT1 protein]; Acetylcysteine results in increased activity of and results in increased phosphorylation of AKT1 protein Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Zinc results in increased phosphorylation of AKT1 protein] Acetylcysteine inhibits the reaction [cadmium acetate results in decreased expression of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of AKT1 mRNA] |
CTD |
PMID:12168106 PMID:12614848 PMID:16137721 PMID:16731823 PMID:18442981 PMID:21055460 PMID:21195169 PMID:21787718 PMID:22427991 PMID:22867088 PMID:23000059 PMID:23159718 PMID:23948867 PMID:24299490 PMID:24449419 PMID:24489685 PMID:24582688 PMID:24875536 PMID:24933620 PMID:25199686 PMID:25471227 PMID:25939952 PMID:25944616 PMID:26514923 PMID:26804764 PMID:26942697 PMID:27106530 PMID:27117918 PMID:27411387 PMID:27658547 PMID:28087840 PMID:28600122 PMID:29604266 PMID:30265530 PMID:30452899 PMID:30797898 PMID:30871965 PMID:31068539 PMID:31157476 PMID:32305283 PMID:32745510 PMID:33035517 PMID:34963561 PMID:35130734 PMID:36810933 PMID:37148176 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
EXP |
Acetylcysteine promotes the reaction [Zinc Sulfate inhibits the reaction [sodium arsenite results in decreased activity of ALAD protein]] |
CTD |
PMID:16959597 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
multiple interactions affects binding |
EXP |
Acetylcysteine inhibits the reaction [Acetaminophen results in decreased expression of ALB protein]; Acetylcysteine inhibits the reaction [ALB protein modified form results in decreased expression of MFN2 protein]; Acetylcysteine inhibits the reaction [ALB protein modified form results in increased abundance of Hydrogen Peroxide]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Acetylcysteine inhibits the reaction [Mustard Gas results in increased expression of ALB protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]] N-acetyl-L-cysteine binds Alb protein in serum |
CTD RGD |
PMID:11428623 PMID:20804811 PMID:24485406 PMID:27997345 PMID:12458670 |
RGD:1625447 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Nitroglycerin results in decreased activity of ALDH2 protein] |
CTD |
PMID:17585900 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Alk |
ALK receptor tyrosine kinase |
multiple interactions |
ISO |
Acetylcysteine affects the phosphorylation of and affects the activity of ALK protein mutant form |
CTD |
PMID:19503098 |
|
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
|
|
G |
Alkbh5 |
alkB homolog 5, RNA demethylase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ALKBH5 mRNA] Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of ALKBH5 mRNA] |
CTD |
PMID:31004932 PMID:34425375 |
|
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of ALPL mRNA] |
CTD |
PMID:34547296 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AMACR mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Ang |
angiogenin |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of ANG protein] |
CTD |
PMID:26138014 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases secretion |
ISO |
Acetylcysteine results in decreased secretion of ANGPT1 protein |
CTD |
PMID:19622383 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd29 |
ankyrin repeat domain 29 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANKRD29 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr18:3,436,301...3,494,292
Ensembl chr18:3,436,303...3,494,296
|
|
G |
Anxa5 |
annexin A5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ANXA5 protein]; Acetylcysteine inhibits the reaction [Tin Fluorides results in increased expression of ANXA5 protein] |
CTD |
PMID:22093110 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Methotrexate results in increased activity of AOC1 protein] |
CTD |
PMID:20885979 |
|
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of APAF1 mRNA]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein] Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of APAF1 protein] |
CTD |
PMID:15877105 PMID:19477266 PMID:35396826 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of APEX1 protein] Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of APEX1 mRNA] |
CTD |
PMID:12231548 PMID:17938202 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apex2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA] Acetylcysteine results in decreased expression of APEX2 mRNA |
CTD |
PMID:26332274 |
|
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
|
|
G |
Aph1b |
aph-1 homolog B, gamma secretase subunit |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of APH1B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:67,429,198...67,454,735
Ensembl chr 8:67,429,198...67,450,243
|
|
G |
Apoe |
apolipoprotein E |
increases expression multiple interactions |
EXP |
Acetylcysteine results in increased expression of APOE mRNA Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of APOE mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of APOE mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of APOE mRNA] |
CTD |
PMID:33188856 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [APP protein affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of NLRP3 protein] |
CTD |
PMID:12684028 PMID:28004443 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp2 |
aquaporin 2 |
increases expression |
EXP |
Acetylcysteine results in increased expression of AQP2 protein |
CTD |
PMID:23183129 |
|
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the activity of AR protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of AR mRNA]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of AR protein] |
CTD |
PMID:16928829 PMID:18829485 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arl13a |
ADP ribosylation factor like GTPase 13A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARL13A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr X:97,380,370...97,406,704
Ensembl chr X:97,380,390...97,406,702
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Curcumin results in increased degradation of ARNT protein] |
CTD |
PMID:16880289 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Art4 |
ADP-ribosyltransferase 4 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of ART4 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASNS mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Astl |
astacin like metalloendopeptidase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASTL mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:114,563,135...114,580,295
Ensembl chr 3:114,563,135...114,578,868
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of ATF2 protein] Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:19654923 PMID:22288910 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf3 |
activating transcription factor 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of ATF3 protein] |
CTD |
PMID:25531190 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions decreases expression increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased expression of ATF4 protein] [Acetylcysteine co-treated with Trichloroethylene] results in increased expression of ATF4 mRNA; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ATF4 protein] Acetylcysteine results in decreased expression of ATF4 protein Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of ATF4 protein]; Acetylcysteine promotes the reaction [perfluorooctanoic acid results in increased expression of ATF4 mRNA] Acetylcysteine results in increased expression of ATF4 protein |
CTD |
PMID:15788408 PMID:19722195 PMID:21266191 PMID:24291486 PMID:25451595 PMID:25568320 PMID:27484784 PMID:27634458 PMID:27816613 PMID:28754437 PMID:31330229 PMID:32506763 PMID:32578922 PMID:36396003 PMID:37072049 PMID:37300854 More...
|
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine results in increased metabolism of and results in increased activity of ATF6 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein] Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein] |
CTD |
PMID:18077580 PMID:19722195 PMID:21198628 PMID:21911445 PMID:24291486 PMID:25451595 PMID:31330229 PMID:34520753 PMID:37148176 PMID:37692514 More...
|
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg10 |
autophagy related 10 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG10 mRNA] |
CTD |
PMID:24614525 |
|
NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
|
|
G |
Atg12 |
autophagy related 12 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG12 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [Vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]] Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG12 mRNA] |
CTD |
PMID:20543569 PMID:24614525 PMID:29307831 PMID:30205151 PMID:33146789 PMID:34439521 More...
|
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg14 |
autophagy related 14 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA] |
CTD |
PMID:34439521 |
|
NCBI chr15:20,795,750...20,827,113
Ensembl chr15:20,795,750...20,827,113
|
|
G |
Atg16l1 |
autophagy related 16-like 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG16L1 protein] |
CTD |
PMID:30205151 |
|
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
|
|
G |
Atg16l2 |
autophagy related 16-like 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG16L2 mRNA] |
CTD |
PMID:33146789 |
|
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
|
|
G |
Atg4a |
autophagy related 4A, cysteine peptidase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of ATG4A protein] |
CTD |
PMID:29179951 |
|
NCBI chr X:104,665,345...104,765,271
Ensembl chr X:104,665,345...104,765,268
|
|
G |
Atg4c |
autophagy related 4C, cysteine peptidase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of ATG4C mRNA] |
CTD |
PMID:34425375 |
|
NCBI chr 5:113,867,218...113,935,534
Ensembl chr 5:113,867,092...113,934,830
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG5 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of ATG5 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]] Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] |
CTD |
PMID:20543569 PMID:24614525 PMID:28600122 PMID:29307831 PMID:30205151 PMID:33146789 PMID:33462182 More...
|
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA] |
CTD |
PMID:29247770 PMID:29307831 PMID:30205151 PMID:31319114 PMID:33462182 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions increases phosphorylation |
ISO EXP |
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATM protein]; Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased expression of ATM protein modified form]; Acetylcysteine inhibits the reaction [ATM protein promotes the reaction [Doxorubicin results in increased activity of TP53 protein]]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased phosphorylation of ATM protein]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK1 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK2 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein]]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of TP53 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of ATM protein]; Acetylcysteine inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of ATM protein]; Acetylcysteine inhibits the reaction [usnic acid results in increased phosphorylation of ATM protein] Acetylcysteine affects the reaction [yttrium chloride affects the expression of ATM protein] Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of ATM protein] Acetylcysteine results in increased phosphorylation of ATM protein |
CTD |
PMID:15489221 PMID:23274516 PMID:24792323 PMID:26451628 PMID:31168028 PMID:31715134 PMID:32142722 PMID:35088107 More...
|
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATOX1 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP1A1 protein] |
CTD |
PMID:10506578 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression multiple interactions |
ISO EXP |
Acetylcysteine results in increased expression of ATP2A2 mRNA Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATP2A2 mRNA] Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] |
CTD |
PMID:10625299 PMID:16084531 PMID:17005195 PMID:36315628 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP5F1A mRNA] |
CTD |
PMID:36493885 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA] |
CTD |
PMID:29307831 PMID:31319114 |
|
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA] |
CTD |
PMID:22129741 PMID:30742845 |
|
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
|
|
G |
Atr |
ATR serine/threonine kinase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATR protein] |
CTD |
PMID:26451628 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Atxn1 |
ataxin 1 |
affects localization multiple interactions |
ISO |
Acetylcysteine affects the localization of ATXN1 protein mutant form Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of ATXN1 protein mutant form]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form] |
CTD |
PMID:12893416 |
|
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
|
|
G |
Aurkb |
aurora kinase B |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of AURKB protein] |
CTD |
PMID:28343997 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
B2m |
beta-2 microglobulin |
decreases response to substance multiple interactions |
ISO |
Acetylcysteine results in decreased susceptibility to B2M protein modified form Acetylcysteine inhibits the reaction [B2M protein modified form results in increased abundance of Reactive Oxygen Species] |
CTD |
PMID:21864514 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
B3galt5 |
Beta-1,3-galactosyltransferase 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GALT5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
|
|
G |
B3gnt9 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GNT9 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr19:33,129,740...33,134,048
Ensembl chr19:33,128,142...33,132,344
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of BACH1 protein] |
CTD |
PMID:19350554 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAD protein]; Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BAD protein] Acetylcysteine results in increased expression of BAD mRNA |
CTD |
PMID:21310227 PMID:22245127 PMID:26332274 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of BAG3 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of BAK1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of BAK1 protein] Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAK1] Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of BAK1 mRNA]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAK1 mRNA] |
CTD |
PMID:21533816 PMID:21549813 PMID:22085843 PMID:23339468 PMID:28296042 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Barx2 |
BARX homeobox 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BARX2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased activity of BAX protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased expression of BAX protein]]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased expression of BAX protein]] N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases expression of BAX protein in the stomach) Acetylcysteine affects the reaction [lead acetate results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of BAX protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased expression of BAX mRNA] Acetylcysteine results in increased expression of BAX mRNA Acetylcysteine results in decreased expression of BAX protein 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in decreased expression of BAX protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased localization of BAX protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of BAX protein]; Acetylcysteine inhibits the reaction [chromium tripicolinate results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of and results in increased activity of BAX protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenbendazole analog results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenbendazole results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [gingerol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [glabridin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Malathion results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of BAX mRNA]; Acetylcysteine inhibits the reaction [perfosfamide affects the folding of BAX protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of BAX]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Propofol results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]]; Acetylcysteine inhibits the reaction [surfactin peptide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BAX protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [tomentosin results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased expression of BAX protein] Acetylcysteine results in increased expression of BAX protein |
CTD RGD |
PMID:11166918 PMID:11341981 PMID:15496615 PMID:15735709 PMID:16169029 PMID:17237268 PMID:17542780 PMID:17574045 PMID:18034189 PMID:18412143 PMID:18547707 PMID:19376147 PMID:19954742 PMID:20674558 PMID:20981856 PMID:21310227 PMID:21533816 PMID:21549813 PMID:21616140 PMID:22085843 PMID:22245127 PMID:22704995 PMID:23711929 PMID:24036456 PMID:25034532 PMID:25845326 PMID:26332274 PMID:26512966 PMID:26772155 PMID:26797587 PMID:26804764 PMID:27189055 PMID:27816613 PMID:28804952 PMID:29087013 PMID:29248572 PMID:29945211 PMID:30104959 PMID:30769050 PMID:30797898 PMID:30917517 PMID:31173782 PMID:31313457 PMID:31368586 PMID:32402895 PMID:32527420 PMID:32540572 PMID:33031904 PMID:33485121 PMID:33797725 PMID:33971260 PMID:34547296 PMID:35430258 PMID:35569513 PMID:36029289 PMID:36070022 PMID:37084995 PMID:37148176 PMID:37308051 PMID:29408335 More...
|
RGD:127284846 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of BBC3 mRNA] Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of BBC3 protein] |
CTD |
PMID:24291486 PMID:32540572 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcas1 |
brain enriched myelin associated protein 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCAS1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:159,136,077...159,219,072
Ensembl chr 3:159,136,083...159,219,106
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Streptozocin results in increased activity of BCHE protein] Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased activity of BCHE protein]; Acetylcysteine inhibits the reaction [chlorpyrifos-methyl results in decreased activity of BCHE protein] |
CTD |
PMID:27087133 PMID:34425170 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions decreases response to substance |
ISO EXP |
Acetylcysteine results in decreased expression of BCL2 protein N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases expression of BCL2 protein in the stomach) Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of BCL2 protein] 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]; [saikosaponin D co-treated with Acetylcysteine] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [glabridin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Malathion results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [nickel acetate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [salvin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BCL2 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in decreased expression of BCL2 protein] Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of BCL2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in decreased expression of BCL2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]] BCL2 results in decreased susceptibility to Acetylcysteine |
CTD RGD |
PMID:11341981 PMID:17041759 PMID:17395010 PMID:17542780 PMID:18077580 PMID:18412143 PMID:19082730 PMID:19679660 PMID:19954742 PMID:20674558 PMID:21310227 PMID:21549813 PMID:21600978 PMID:21616140 PMID:22085843 PMID:22245127 PMID:22578287 PMID:22704995 PMID:22976841 PMID:23711929 PMID:24036456 PMID:24909818 PMID:25034532 PMID:25845326 PMID:26079211 PMID:26772155 PMID:27816613 PMID:28804952 PMID:28918123 PMID:29248572 PMID:30104959 PMID:30769050 PMID:30796935 PMID:30797898 PMID:30917517 PMID:31157476 PMID:31173782 PMID:31368586 PMID:31563593 PMID:31900833 PMID:32402895 PMID:32527420 PMID:33002460 PMID:33485121 PMID:34303041 PMID:34547296 PMID:34599545 PMID:36029289 PMID:37084995 PMID:37209937 PMID:37308051 PMID:29408335 More...
|
RGD:127284846 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein] Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2L1 protein] Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [fucoxanthin results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [nickel acetate results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of BCL2L1 protein] |
CTD |
PMID:18281123 PMID:18483861 PMID:20594983 PMID:21310227 PMID:22085843 PMID:22245127 PMID:23711929 PMID:30917517 PMID:31313457 PMID:31900833 PMID:37308051 More...
|
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein] |
CTD |
PMID:15173094 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6 |
BCL6, transcription repressor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of BDKRB1 mRNA] |
CTD |
PMID:22264228 |
|
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of BDNF protein] |
CTD |
PMID:16553631 PMID:26138014 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [brazilin results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased expression of and results in increased phosphorylation of BECN1 protein]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [pyrovalerone analog results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of BECN1 mRNA]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Vorinostat results in increased expression of BECN1 protein] Acetylcysteine inhibits the reaction [4-nonylphenol results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of BECN1 protein] Acetylcysteine inhibits the reaction [[Air Pollutants, Occupational results in increased abundance of Particulate Matter] which results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [[CASP2 protein affects the susceptibility to Rotenone] which results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of BECN1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Trichloroethylene results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of BECN1 protein] |
CTD |
PMID:20543569 PMID:21216964 PMID:24614525 PMID:26588882 PMID:26804764 PMID:27106530 PMID:27208422 PMID:28025121 PMID:28063998 PMID:28578026 PMID:28600122 PMID:29923297 PMID:31563593 PMID:32687844 PMID:33146789 PMID:34439521 PMID:36739042 PMID:36849104 More...
|
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BGLAP mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BGLAP protein] |
CTD |
PMID:34547296 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO EXP |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [sanguinarine results in increased cleavage of BID protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of BID protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of BID protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BID protein] Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BID protein] |
CTD |
PMID:16169029 PMID:17574045 PMID:21310227 PMID:23660334 PMID:23711929 PMID:25034532 PMID:25845326 PMID:30408460 More...
|
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bik |
BCL2-interacting killer |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of BIK protein] |
CTD |
PMID:31313457 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC2 protein] |
CTD |
PMID:19679660 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of BIRC3 protein] |
CTD |
PMID:19679660 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein] |
CTD |
PMID:21741372 PMID:23711929 PMID:25034532 PMID:31837377 PMID:34599545 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmp5 |
bone morphogenetic protein 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
multiple interactions |
EXP |
[Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of BMP7 mRNA |
CTD |
PMID:21051528 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of BNIP3 protein]; Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] |
CTD |
PMID:19442826 PMID:36739042 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of BNIP3L protein] |
CTD |
PMID:34861471 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of BPGM mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of BTG1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
|
|
G |
C3 |
complement C3 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased activity of C3 protein modified form]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of C3 protein] |
CTD |
PMID:20946910 PMID:32924446 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5 |
complement C5 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of C5 protein] |
CTD |
PMID:32924446 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Capn1 |
calpain 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of CAPN1 protein] |
CTD |
PMID:25451595 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn2 |
calpain 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of CAPN2 protein] |
CTD |
PMID:25451595 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Casp1 |
caspase 1 |
multiple interactions increases cleavage |
ISO EXP |
[Acetylcysteine co-treated with Cobalt] results in decreased expression of CASP1 protein; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of CASP1 mRNA]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased cleavage of CASP1 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of and results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [Cobalt results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [Ethanol results in increased expression of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of and results in increased cleavage of CASP1 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of CASP1 protein modified form]; Acetylcysteine inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP1 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]] Acetylcysteine results in increased cleavage of CASP1 protein Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of CASP1 protein] Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of CASP1 mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide inhibits the reaction [anthrax toxin results in increased cleavage of CASP1 protein]]; Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein] |
CTD |
PMID:23940760 PMID:24337744 PMID:24885895 PMID:25929180 PMID:26079697 PMID:26086368 PMID:26435000 PMID:26809137 PMID:26901245 PMID:27783111 PMID:28004443 PMID:28814068 PMID:30205151 PMID:30878009 PMID:30977640 PMID:32805375 PMID:34217685 PMID:34238121 PMID:34510229 PMID:34791735 PMID:35190838 PMID:36055550 PMID:36347317 PMID:36354081 PMID:36646296 PMID:37300869 PMID:37393521 PMID:37692514 More...
|
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of and results in increased activity of CASP12 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP12 protein]] Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP12 protein] Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of CASP12 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP12 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP12 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP12 protein] |
CTD |
PMID:18077580 PMID:21145380 PMID:21616140 PMID:25451595 PMID:28296042 PMID:31330229 PMID:37300854 More...
|
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp14 |
caspase 14 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CASP14 protein] |
CTD |
PMID:16137721 |
|
NCBI chr 7:10,929,759...10,932,591
Ensembl chr 7:10,926,725...10,933,405
|
|
G |
Casp2 |
caspase 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP2 protein] Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP2 protein] Acetylcysteine inhibits the reaction [[CASP2 protein affects the susceptibility to Rotenone] which results in increased expression of BECN1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased cleavage of CASP2 protein] |
CTD |
PMID:15158148 PMID:17041759 PMID:21216964 PMID:30408460 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions increases activity increases expression decreases activity |
ISO EXP |
Acetylcysteine results in increased cleavage of CASP3 protein N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid increases cleavage of CASP3 protein in stomach] N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP3 protein in the stomach) Acetylcysteine results in increased activity of CASP3 protein [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [4-nonylphenol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [arsenite results in decreased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Carmustine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Estradiol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP3]; Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Lead results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [menadione epoxide results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Pilocarpine results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Propranolol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of CASP3 protein modified form] [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone analog results in decreased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [6-iodo-5-hydroxy-eicosatrienoic acid, delta-lactone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [8-bromo-7-methoxychrysin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Naphthalimides co-treated with Spermidine] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [[Pentachlorophenol co-treated with copper-1,10-phenanthroline] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Vitamin K 2 co-treated with Arsenic Trioxide] results in increased expression of CASP3]; Acetylcysteine inhibits the reaction [ABBV-744 results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [aristolochic acid I results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [butein results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [chelerythrine results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [chromium tripicolinate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [crocin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [dimethoxycurcumin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Eosine I Bluish results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Etoposide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [fenpyroximate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [fucoxanthin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [ganoderic acid analog results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [glabridin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [isoliensinine results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [manumycin results in increased activity of CASP3]; Acetylcysteine inhibits the reaction [menadione epoxide results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Paraquat results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [platycodin D results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Prodigiosin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [pyrovalerone analog results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Reactive Oxygen Species results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Soot analog results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [sulforaphane promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [surfactin peptide results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased cleavage of CASP3 protein]; Acetylcysteine promotes the reaction [brazilin results in increased activity of CASP3 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP3 protein]; Acetylcysteine promotes the reaction [sinularin results in increased cleavage of CASP3 protein]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased cleavage of CASP3 protein]; Oxygen deficiency affects the reaction [Acetylcysteine results in increased activity of CASP3 protein] Acetylcysteine results in increased expression of CASP3 protein modified form Acetylcysteine results in decreased activity of CASP3 protein [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]; Acetylcysteine affects the reaction [nonylphenol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of and results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [mancozeb results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP3 mRNA]; Acetylcysteine inhibits the reaction [nitrofen results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [POMC protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of CASP3 protein modified form]; Acetylcysteine inhibits the reaction [Simvastatin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [T-2 Toxin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Acetylcysteine results in increased expression of CASP3 protein modified form] |
CTD RGD |
PMID:11969376 PMID:12168106 PMID:12750841 PMID:12754411 PMID:14660655 PMID:15050407 PMID:15158148 PMID:15375156 PMID:15496615 PMID:15545282 PMID:15582350 PMID:15683462 PMID:15816534 PMID:16014620 PMID:16169029 PMID:16282376 PMID:17041759 PMID:17136323 PMID:17309078 PMID:17332930 PMID:17468103 PMID:17542780 PMID:17574045 PMID:17888894 PMID:18077580 PMID:18281123 PMID:18483861 PMID:18547707 PMID:18703135 PMID:18791325 PMID:18804340 PMID:19014919 PMID:19082730 PMID:19376147 PMID:19409983 PMID:19477266 PMID:19523979 PMID:19536524 PMID:19722195 PMID:19771260 PMID:19837105 PMID:19840221 PMID:20100472 PMID:20114059 PMID:20362650 PMID:20594983 PMID:20632440 PMID:20674558 PMID:20883752 PMID:20946910 PMID:20981856 PMID:21145380 PMID:21166495 PMID:21221209 PMID:21242791 PMID:21300145 PMID:21310227 PMID:21349322 PMID:21418039 PMID:21453688 PMID:21533816 PMID:21549813 PMID:21565247 PMID:21600974 PMID:21616140 PMID:21741372 PMID:21804221 PMID:21843585 PMID:21998720 PMID:22002103 PMID:22085843 PMID:22260869 PMID:22440610 PMID:22578287 PMID:22710416 PMID:22714038 PMID:22824136 PMID:22909951 PMID:22922937 PMID:23088786 PMID:23405080 PMID:23677851 PMID:23711929 PMID:23836369 PMID:23867903 PMID:24036456 PMID:24157283 PMID:24273890 PMID:24291486 PMID:24299490 PMID:24412703 PMID:24614525 PMID:24634002 PMID:24908156 PMID:24998639 PMID:25034532 PMID:25341683 PMID:25568320 PMID:25845326 PMID:25891866 PMID:25940438 PMID:25947082 PMID:26079211 PMID:26124276 PMID:26219228 PMID:26282491 PMID:26549478 PMID:26588882 PMID:26630137 PMID:26772155 PMID:26804764 PMID:27106530 PMID:27417252 PMID:27484784 PMID:27539140 PMID:28025121 PMID:28063998 PMID:28219700 PMID:28237877 PMID:28296042 PMID:28548367 PMID:28578026 PMID:28778520 PMID:28804952 PMID:28918123 PMID:28993239 PMID:29087013 PMID:29108775 PMID:29111403 PMID:29248572 PMID:29432840 PMID:29454061 PMID:29484840 PMID:29774349 PMID:29944906 PMID:29945211 PMID:30037311 PMID:30236763 PMID:30240709 PMID:30259999 PMID:30590774 PMID:30633982 PMID:30641872 PMID:30769050 PMID:30796935 PMID:30871965 PMID:30917517 PMID:31077745 PMID:31157476 PMID:31173782 PMID:31229567 PMID:31313457 PMID:31330229 PMID:31381934 PMID:31408635 PMID:31433961 PMID:32506763 PMID:32540572 PMID:32662599 PMID:32708634 PMID:32924446 PMID:33031904 PMID:33485121 PMID:33592258 PMID:33797725 PMID:33961949 PMID:34303041 PMID:34547296 PMID:34627931 PMID:34816377 PMID:34850538 PMID:34861471 PMID:34897981 PMID:35085590 PMID:35123993 PMID:35130734 PMID:35396826 PMID:35430258 PMID:35622622 PMID:35738838 PMID:35810264 PMID:36029289 PMID:36070022 PMID:36252918 PMID:36493885 PMID:36933581 PMID:37084995 PMID:37146930 PMID:37308051 PMID:37487865 PMID:37499777 PMID:37769529 PMID:32106377 PMID:29408335 More...
|
RGD:127284886, RGD:127284846 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CASP4 mRNA] Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP4 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP4 protein] Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP4 mRNA] |
CTD |
PMID:16137721 PMID:19477266 PMID:22922937 PMID:25341683 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP6 protein] Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP6 protein] Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP6 protein]; Acetylcysteine inhibits the reaction [surfactin peptide results in increased cleavage of and results in increased activity of CASP6 protein] |
CTD |
PMID:15158148 PMID:19954742 PMID:24157283 PMID:37146930 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP7 mRNA] Acetylcysteine results in decreased expression of CASP7 protein modified form Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [fucoxanthin results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP7 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP7 protein] Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein] |
CTD |
PMID:17136323 PMID:19771260 PMID:20594983 PMID:21145380 PMID:21549813 PMID:21843585 PMID:22085843 PMID:22260869 PMID:22909951 PMID:23405080 PMID:24157283 PMID:24998639 PMID:25824409 PMID:27106530 PMID:27539140 PMID:28087840 PMID:28161410 PMID:29800641 PMID:30408460 PMID:30917517 PMID:31313457 PMID:31330229 PMID:31433961 PMID:34627931 PMID:36252918 PMID:37146930 More...
|
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO EXP |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of CASP8 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of CASP8 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of CASP8 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of CASP8 protein]]; Acetylcysteine inhibits the reaction [cannabidiol hydroxyquinone results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Simvastatin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [T-2 Toxin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP8 protein] N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP8 protein in the stomach) [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased activity of CASP8 protein]; [Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased expression of CASP8 protein]; Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP8 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP8 protein] Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP8 mRNA]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP8 protein]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased activity of and results in increased cleavage of CASP8 protein] |
CTD RGD |
PMID:16169029 PMID:17574045 PMID:18791325 PMID:19014919 PMID:19477266 PMID:20184945 PMID:20576514 PMID:20674558 PMID:20883752 PMID:20946910 PMID:21310227 PMID:22578287 PMID:23711929 PMID:23867903 PMID:24614525 PMID:25034532 PMID:25845326 PMID:27313093 PMID:27484784 PMID:28087840 PMID:28219700 PMID:28548367 PMID:28918123 PMID:29432840 PMID:30917517 PMID:32506763 PMID:32662599 PMID:35833596 PMID:29408335 More...
|
RGD:127284846 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [monomethylarsonous acid results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]]; Acetylcysteine inhibits the reaction [T-2 Toxin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP9 protein] N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid increases cleavage of CASP9 protein in stomach] N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP9 protein in the stomach) Acetylcysteine results in increased expression of CASP9 protein; Acetylcysteine results in increased expression of CASP9 protein modified form Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [CASP9 protein binds to CYCS protein]]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; [saikosaponin D co-treated with Acetylcysteine] results in decreased expression of CASP9 protein; Acetylcysteine affects the reaction [SOD2 protein affects the activity of CASP9 protein]; Acetylcysteine inhibits the reaction [10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP9 mRNA]; Acetylcysteine inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [oenothein B results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [Soot analog results in increased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP9 protein modified form]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP9 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] |
CTD RGD |
PMID:15158148 PMID:15496615 PMID:16169029 PMID:17309078 PMID:17574045 PMID:18336854 PMID:18483861 PMID:18594523 PMID:18629305 PMID:18791325 PMID:19082730 PMID:19477266 PMID:19771260 PMID:20576514 PMID:20848084 PMID:21145380 PMID:21166495 PMID:21310227 PMID:21418039 PMID:21549813 PMID:21616140 PMID:22002103 PMID:22085843 PMID:22578287 PMID:22714038 PMID:23088786 PMID:23405080 PMID:23711929 PMID:23867903 PMID:24157283 PMID:24614525 PMID:24634002 PMID:25845326 PMID:25940438 PMID:26282491 PMID:27313093 PMID:27539140 PMID:28296042 PMID:28548367 PMID:28804952 PMID:28918123 PMID:29108775 PMID:29432840 PMID:29945211 PMID:29962303 PMID:30240709 PMID:30408460 PMID:30452899 PMID:30769050 PMID:30917517 PMID:31313457 PMID:31330229 PMID:31433961 PMID:32662599 PMID:34627931 PMID:35396826 PMID:37084995 PMID:37209937 PMID:32106377 PMID:29408335 More...
|
RGD:127284886, RGD:127284846 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity increases expression |
EXP ISO |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Carmustine results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [chlorpyrifos-methyl results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Dichlorvos results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Diclofenac results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Dimethoate results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Dimethylnitrosamine results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Malathion results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of CAT protein]; Acetylcysteine inhibits the reaction [Zinc results in decreased expression of CAT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Particulate Matter results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CAT protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [ceric oxide results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Chlorine results in increased expression of CAT protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos affects the activity of CAT protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Malathion results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [mancozeb results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Propofol results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Smoke analog results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of CAT mRNA]; CAT protein inhibits the reaction [Acetylcysteine results in increased abundance of Hydrogen Peroxide] Acetylcysteine results in decreased activity of CAT protein Acetylcysteine results in increased expression of CAT protein Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in decreased expression of CAT protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [mancozeb results in decreased activity of CAT protein]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased activity of CAT protein] |
CTD |
PMID:7491977 PMID:16169029 PMID:19840221 PMID:19853593 PMID:20332008 PMID:21114986 PMID:21131394 PMID:22416658 PMID:22427991 PMID:23416263 PMID:24299490 PMID:24485406 PMID:24577230 PMID:24810974 PMID:26079211 PMID:26257840 PMID:26769589 PMID:27235710 PMID:27246665 PMID:28012895 PMID:28013216 PMID:28108387 PMID:28535741 PMID:28804952 PMID:29143438 PMID:30037311 PMID:30423402 PMID:30769050 PMID:30951941 PMID:30998386 PMID:31157476 PMID:32023790 PMID:32402895 PMID:34425170 PMID:34547296 PMID:34767868 PMID:34856488 PMID:35065218 PMID:35430258 PMID:37458150 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of CAV1 Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein]; Acetylcysteine inhibits the reaction [Rosiglitazone results in increased expression of CAV1]; Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein; Hydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein] |
CTD |
PMID:18507034 PMID:21148404 PMID:35349355 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cbs |
cystathionine beta synthase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Rotenone results in decreased expression of CBS protein] |
CTD |
PMID:25086357 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCL11 mRNA Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CCL11 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL11 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL11 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of CCL11 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of CCL11 protein] |
CTD |
PMID:12576300 PMID:22129741 PMID:26138014 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL17 protein] |
CTD |
PMID:26138014 |
|
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of CCL2 protein]; Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CCL2 mRNA] Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Palmitates results in increased secretion of CCL2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CCL2 protein]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL2 mRNA]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CCL2 protein]] Acetylcysteine affects the reaction [Doxorubicin results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]] |
CTD |
PMID:10541287 PMID:11124598 PMID:15139008 PMID:17529908 PMID:18303122 PMID:19158351 PMID:22700867 PMID:26332274 PMID:26683377 PMID:28555929 PMID:33146789 PMID:35065218 PMID:35123994 More...
|
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of CCL20 mRNA |
CTD |
PMID:22385246 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CCL22 mRNA] |
CTD |
PMID:19350554 |
|
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CCL24 protein] |
CTD |
PMID:26138014 |
|
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions decreases secretion |
ISO |
[Acetylcysteine co-treated with Particulate Matter] results in increased secretion of CCL3 protein; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CCL3 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL3 mRNA]; Acetylcysteine promotes the reaction [Polymyxin B inhibits the reaction [Particulate Matter results in increased secretion of CCL3 protein]]; Acetylcysteine promotes the reaction [Polymyxin B results in decreased secretion of CCL3 protein]; MYD88 protein affects the reaction [[Acetylcysteine co-treated with Particulate Matter] results in increased secretion of CCL3 protein]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CCL3 mRNA]]; Polymyxin B promotes the reaction [Acetylcysteine results in decreased secretion of CCL3 protein] |
CTD |
PMID:21765237 PMID:28555929 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL5 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CCL5 mRNA] |
CTD |
PMID:10495789 PMID:11167962 PMID:26138014 PMID:33146789 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased expression of CCN1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased expression of CCN1 protein]; Cycloheximide inhibits the reaction [Acetylcysteine results in increased expression of CCN1 protein] Acetylcysteine results in increased expression of CCN1 mRNA; Acetylcysteine results in increased expression of CCN1 protein |
CTD |
PMID:21055460 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Streptozocin results in increased expression of CCN2 protein] |
CTD |
PMID:17270171 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna1 |
cyclin A1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CCNA1 protein] |
CTD |
PMID:20654705 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CCNA2 protein] Acetylcysteine inhibits the reaction [alpha-terthienylmethanol results in increased expression of CCNA2 protein] |
CTD |
PMID:24909818 PMID:28506552 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CCNB1 protein]; Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CCNB1 protein] Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CCNB1 protein]; Acetylcysteine inhibits the reaction [sinularin results in decreased phosphorylation of CCNB1 protein] |
CTD |
PMID:24909818 PMID:25633853 PMID:28548367 PMID:29128613 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [[Vorinostat co-treated with Butyrates] results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of CCND1 protein]; Acetylcysteine inhibits the reaction [Estradiol results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [Hydrocarbons, Chlorinated analog results in increased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of CCND1 protein] Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of CCND1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CCND1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CCND1 protein] Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in decreased expression of CCND1 protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of CCND1 protein] |
CTD |
PMID:15173093 PMID:15897899 PMID:17602960 PMID:18563748 PMID:19409983 PMID:21600978 PMID:23948867 PMID:24355586 PMID:24909818 PMID:24968063 PMID:26332274 PMID:28321046 PMID:31433961 PMID:33485121 PMID:34627931 More...
|
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of CCND2 protein]; Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CCND2 mRNA] Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND2 protein] Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA] |
CTD |
PMID:19615393 PMID:26332274 PMID:33485121 PMID:34627931 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [thymoquinone results in decreased expression of CCND3 protein] |
CTD |
PMID:34627931 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of CCNE1 mRNA] Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CCNE1 protein] |
CTD |
PMID:15945272 PMID:24909818 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCNE2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cd14 |
CD14 molecule |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Iron deficiency results in increased expression of CD14 protein] |
CTD |
PMID:20368581 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CD36 mRNA] Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 mRNA]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 protein] Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 mRNA]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of CD36 protein]; CD36 mRNA promotes the reaction [Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased uptake of malondialdehyde-low density lipoprotein, human]] |
CTD |
PMID:22824115 PMID:26187465 PMID:33007364 PMID:35622622 PMID:36534932 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40lg |
CD40 ligand |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CD40LG mRNA] Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of TP53 protein] |
CTD |
PMID:19477266 PMID:27634759 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
Acetylcysteine affects the reaction [Dinitrochlorobenzene affects the expression of CD86 protein]; Acetylcysteine inhibits the reaction [1,10-phenanthroline results in increased expression of CD86 mRNA]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CD86 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein] |
CTD |
PMID:19033392 PMID:19641517 PMID:20417223 PMID:20457211 PMID:30842373 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CDC25C protein modified form] |
CTD |
PMID:25633853 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CDH1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH1 protein]; Acetylcysteine inhibits the reaction [DDT results in decreased expression of CDH1 mRNA]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [nickel chloride results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [nickel chloride results in increased methylation of CDH1 promoter]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of CDH1 protein] Acetylcysteine results in increased expression of CDH1 protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [SHC1 protein results in decreased expression of CDH1 protein] |
CTD |
PMID:18791180 PMID:22648416 PMID:24820114 PMID:28284859 PMID:32659284 PMID:32687844 PMID:32687961 PMID:34687772 More...
|
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh11 |
cadherin 11 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDH11 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh13 |
cadherin 13 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of CDH13 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein] Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CDH2 mRNA]; Acetylcysteine inhibits the reaction [DDT results in increased expression of CDH2 mRNA] |
CTD |
PMID:23876460 PMID:24820114 PMID:28284859 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh5 |
cadherin 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in decreased expression of CDH5 protein] |
CTD |
PMID:33131013 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CDK1 protein] Acetylcysteine inhibits the reaction [sinularin results in decreased phosphorylation of CDK1 protein] |
CTD |
PMID:25633853 PMID:28548367 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CDK4 mRNA] Acetylcysteine inhibits the reaction [tubocapsenolide A results in increased degradation of CDK4 protein] |
CTD |
PMID:18442981 PMID:19615393 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CDK7 mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions decreases expression increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [camphorquinone results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of CDKN1A]; Acetylcysteine inhibits the reaction [diaziquone results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [ethylenimine quinone results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1A enhancer]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN1A mRNA]] Acetylcysteine results in decreased expression of CDKN1A mRNA Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [dihydrolipoic acid results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN1A protein]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of CDKN1A protein] [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDKN1A mRNA; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CDKN1A protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1A protein] |
CTD |
PMID:8943236 PMID:9343371 PMID:12208374 PMID:15496615 PMID:15978937 PMID:17602960 PMID:18022818 PMID:19409983 PMID:21462292 PMID:21565247 PMID:22129741 PMID:22183962 PMID:22927544 PMID:24792323 PMID:26332274 PMID:26658076 PMID:30555576 PMID:32473187 PMID:33961949 PMID:35303175 PMID:36493885 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression multiple interactions |
EXP ISO |
Acetylcysteine results in increased expression of CDKN1B protein Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein]; Acetylcysteine inhibits the reaction [tomentosin results in increased expression of CDKN1B protein]; Acetylcysteine promotes the reaction [AHR protein binds to CDKN1B enhancer] Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] |
CTD |
PMID:17602960 PMID:18022818 PMID:30917517 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [DNMT1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [EZH2 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [KDM2A protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [TET1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CDKN2A protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN2A mRNA]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN2A mRNA]] Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CDKN2A protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN2A mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CDKN2A protein] |
CTD |
PMID:31551408 PMID:32473187 PMID:35303175 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CEBPA protein] |
CTD |
PMID:27117918 PMID:35622622 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] |
CTD |
PMID:21220312 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA]] |
CTD |
PMID:29945211 |
|
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of CFLAR protein]; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] |
CTD |
PMID:25034532 PMID:25619640 PMID:34599545 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Ozone results in decreased expression of CFTR mRNA]; Acetylcysteine inhibits the reaction [Ozone results in decreased expression of CFTR protein] |
CTD |
PMID:19061877 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chat |
choline O-acetyltransferase |
increases expression multiple interactions |
EXP |
Acetylcysteine results in increased expression of CHAT protein [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein] |
CTD |
PMID:25891525 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CHEK1 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK1 protein]] Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of CHEK1 protein modified form] |
CTD |
PMID:15489221 PMID:25633853 PMID:33971260 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased expression of CHEK2 protein modified form]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased phosphorylation of CHEK2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of CHEK2 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased phosphorylation of CHEK2 protein]; Acetylcysteine inhibits the reaction [usnic acid results in increased expression of CHEK2 protein] Acetylcysteine results in increased expression of CHEK2 protein |
CTD |
PMID:15489221 PMID:23274516 PMID:24792323 PMID:24933654 PMID:31715134 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chka |
choline kinase alpha |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHKA mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHRM2 mRNA Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM2 mRNA] |
CTD |
PMID:22129741 PMID:29253600 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM3 mRNA] |
CTD |
PMID:29253600 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM4 mRNA] |
CTD |
PMID:29253600 |
|
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
decreases activity |
ISO |
Acetylcysteine results in decreased activity of CHUK protein |
CTD |
PMID:17395010 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CISH mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Ckb |
creatine kinase B |
multiple interactions |
EXP |
[Deferoxamine co-treated with Acetylcysteine] inhibits the reaction [Acetaminophen results in decreased activity of CKB protein]; [Deferoxamine co-treated with Acetylcysteine] inhibits the reaction [Carbon Tetrachloride results in decreased activity of CKB protein] |
CTD |
PMID:19688255 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions decreases secretion |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CKM mRNA] Acetylcysteine results in decreased secretion of CKM protein |
CTD |
PMID:9689591 PMID:21912612 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Cldn1 |
claudin 1 |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLDN1 mRNA; Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 protein] Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN1 mRNA] Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of CLDN1 protein] |
CTD |
PMID:22129741 PMID:28115242 PMID:29235125 PMID:32687961 PMID:33485121 PMID:34906888 More...
|
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 mRNA]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of CLDN4 mRNA] |
CTD |
PMID:23816505 PMID:33485121 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldn5 |
claudin 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of and affects the localization of CLDN5 protein]; Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of CLDN5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] |
CTD |
PMID:28115242 PMID:34391839 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Clec9a |
C-type lectin domain containing 9A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLEC9A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:162,859,742...162,875,742
Ensembl chr 4:162,860,308...162,875,352
|
|
G |
Clk1 |
CDC-like kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of CLK1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
|
|
G |
Clu |
clusterin |
multiple interactions |
ISO |
Acetylcysteine promotes the reaction [Chlorine results in increased expression of CLU protein] |
CTD |
PMID:35065218 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cma1 |
chymase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CMA1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
|
|
G |
Cntf |
ciliary neurotrophic factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CNTF protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]] |
CTD |
PMID:16896058 PMID:26138014 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of COL18A1 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of COL18A1 protein] |
CTD |
PMID:13679210 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression multiple interactions |
ISO EXP |
Acetylcysteine results in decreased expression of COL1A1 mRNA Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of COL1A1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of COL1A1 protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of COL1A1 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of COL1A1 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of COL1A1 protein] Acetylcysteine results in decreased expression of COL1A1 mRNA; Acetylcysteine results in decreased expression of COL1A1 protein |
CTD |
PMID:11710721 PMID:17602960 PMID:32659284 PMID:34547296 PMID:36493885 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of COL1A2 mRNA |
CTD |
PMID:11710721 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of COL4A1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of COLQ mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of COPG1 mRNA] |
CTD |
PMID:34425375 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of COX4I1 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of COX4I1 mRNA] |
CTD |
PMID:35403558 PMID:36493885 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cpe |
carboxypeptidase E |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of CPE mRNA |
CTD |
PMID:16084531 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cplx1 |
complexin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPLX1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:1,184,677...1,216,392
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Dietary Fats] results in increased expression of CPT1A mRNA |
CTD |
PMID:21051528 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of CRADD mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G |
Crat |
carnitine O-acetyltransferase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of and results in increased activity of CREB1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of CREB1 protein] Acetylcysteine inhibits the reaction [4-biphenylamine results in increased expression of CREB1 protein] |
CTD |
PMID:18375950 PMID:32433928 PMID:36813253 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crem |
cAMP responsive element modulator |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CREM mRNA] |
CTD |
PMID:25381014 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CRY1 mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cryab |
crystallin, alpha B |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [arsenite results in increased expression of CRYAB protein] |
CTD |
PMID:15175009 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Cryga |
crystallin, gamma A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRYGA mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 9:66,482,176...66,484,638
Ensembl chr 9:66,482,176...66,509,896
|
|
G |
Cs |
citrate synthase |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of CS mRNA] Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of CS protein]] Acetylcysteine promotes the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] |
CTD |
PMID:21775390 PMID:27385396 PMID:36762617 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CSF1 mRNA] |
CTD |
PMID:35123994 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
[Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA; [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased secretion of CSF2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] |
CTD |
PMID:10645887 PMID:19460412 PMID:26138014 PMID:29753051 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3r |
colony stimulating factor 3 receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA]] |
CTD |
PMID:29945211 |
|
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
|
|
G |
Cst3 |
cystatin C |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CST3 protein] |
CTD |
PMID:35020164 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [GSK3B protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of and results in increased activity of CTNNB1 protein]; Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in increased cleavage of CTNNB1 protein]; Acetylcysteine inhibits the reaction [quinocetone results in decreased expression of CTNNB1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CTNNB1 protein] |
CTD |
PMID:16282376 PMID:19436114 PMID:24961358 PMID:24968063 PMID:28321046 PMID:28343033 PMID:33131013 More...
|
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctrc |
chymotrypsin C |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CTRC mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:154,147,314...154,156,540
Ensembl chr 5:154,147,316...154,156,528
|
|
G |
Ctrl |
chymotrypsin-like |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [plumbagin results in decreased activity of CTRL protein] |
CTD |
PMID:31276663 |
|
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CTSB mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CTSB mRNA] |
CTD |
PMID:29307831 PMID:31319114 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA] |
CTD |
PMID:35550146 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
[Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Ctsl |
cathepsin L |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Berberine results in decreased cleavage of CTSL protein] |
CTD |
PMID:36070022 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression multiple interactions |
ISO EXP |
Acetylcysteine results in decreased expression of CXCL1 protein Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CXCL1 protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein] |
CTD |
PMID:17395010 PMID:18257742 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CXCL12 protein] Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of CXCL12 mRNA] |
CTD |
PMID:26138014 PMID:35123994 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of CXCL2 mRNA]; Acetylcysteine inhibits the reaction [Vanadates results in increased expression of CXCL2 mRNA] Acetylcysteine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CXCL2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CXCL2 protein] |
CTD |
PMID:10718115 PMID:16919916 PMID:19350554 PMID:21507677 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of CXCL1 protein Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]] |
CTD |
PMID:17395010 PMID:24316229 PMID:28555929 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CXCL6 protein] |
CTD |
PMID:26138014 |
|
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBA protein] |
CTD |
PMID:21195169 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of CYBB protein] |
CTD |
PMID:21195169 PMID:29087013 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [dimethoxycurcumin affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [sodium arsenite affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [surfactin peptide affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein] Acetylcysteine results in decreased expression of CYCS protein Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [CASP9 protein binds to CYCS protein]]; Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CYCS mRNA] Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of CYCS mRNA]; Acetylcysteine inhibits the reaction [Methylmercury Compounds affects the localization of CYCS protein] |
CTD |
PMID:18483861 PMID:19536524 PMID:19954742 PMID:21145380 PMID:21221209 PMID:21549813 PMID:22085843 PMID:23711929 PMID:24634002 PMID:28296042 PMID:29248572 PMID:34547296 PMID:35123993 PMID:35396826 PMID:37084995 More...
|
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyct |
cytochrome c, testis |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Estradiol results in increased expression of CYCT protein] |
CTD |
PMID:15545282 |
|
NCBI chr 3:61,290,090...61,297,158
Ensembl chr 3:60,913,562...61,297,158
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of CYP11A1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP11A1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP11A1 protein] |
CTD |
PMID:26769589 PMID:29567110 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of CYP11B1 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of CYP11B1 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of CYP11B1 mRNA] |
CTD |
PMID:25617244 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of CYP11B2 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of CYP11B2 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of CYP11B2 mRNA] |
CTD |
PMID:25617244 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of CYP17A1 protein] |
CTD |
PMID:29567110 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO EXP |
[Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] which results in decreased expression of NQO1 mRNA; Acetylcysteine affects the reaction [Curcumin affects the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]]; Acetylcysteine inhibits the reaction [1-(4-chlorophenyl)-benzo-2,5-quinone results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYP1A1 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of CYP1A1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA] Acetylcysteine results in increased expression of CYP1A1 protein [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of CYP1A1 mRNA; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of CYP1A1 mRNA] [Acetylcysteine co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein]; Acetylcysteine affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Acetylcysteine affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased activity of CYP1A1 protein]; Acetylcysteine inhibits the reaction [beta-Naphthoflavone results in decreased activity of CYP1A1 protein]; Acetylcysteine inhibits the reaction [chromium trioxide results in increased expression of CYP1A1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA]; Acetylcysteine promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of CYP1A1 protein] |
CTD |
PMID:15044633 PMID:15621696 PMID:16274885 PMID:19033395 PMID:20801209 PMID:21094198 PMID:21703343 PMID:22129741 PMID:25668756 PMID:26535918 PMID:27041069 PMID:29753051 PMID:29975444 PMID:30639957 PMID:30793600 PMID:34171359 PMID:35123993 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP ISO |
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein]; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CYP1A2 mRNA] [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite |
CTD |
PMID:21424224 PMID:22129741 PMID:23159886 PMID:27989148 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO EXP |
Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA] Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:21703343 PMID:22129741 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26c1 |
cytochrome P450, family 26, subfamily C, polypeptide 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP26C1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:235,458,961...235,468,433
Ensembl chr 1:235,459,356...235,466,842
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
Acetylcysteine promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] |
CTD |
PMID:11353799 PMID:14722249 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions |
ISO |
[CYP2C19 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite |
CTD |
PMID:27989148 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP ISO |
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein]; Acetylcysteine inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of and results in increased activity of CYP2E1 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Maneb results in increased expression of and results in increased activity of CYP2E1 protein]; Acetylcysteine inhibits the reaction [Maneb results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP2E1 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CYP2E1 mRNA]; Acetylcysteine promotes the reaction [Acrylonitrile results in increased expression of CYP2E1 mRNA] Acetylcysteine inhibits the reaction [Ethanol results in increased expression of CYP2E1 mRNA] Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 protein] |
CTD |
PMID:21424224 PMID:23159886 PMID:26332274 PMID:30423402 PMID:35713687 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP3A4 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite; Acetylcysteine inhibits the reaction [[CYP3A4 protein co-treated with neferine] results in decreased abundance of Glutathione] |
CTD |
PMID:25451576 PMID:27989148 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA; Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] |
CTD |
PMID:19647067 PMID:22129741 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Dapk1 |
death associated protein kinase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] |
CTD |
PMID:19477266 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Ddhd1 |
DDHD domain containing 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DDHD1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression decreases expression multiple interactions |
ISO EXP |
Acetylcysteine results in increased expression of DDIT3 mRNA; Acetylcysteine results in increased expression of DDIT3 protein Acetylcysteine results in decreased expression of DDIT3 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of DDIT3 protein] 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [(4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DDIT3]; Acetylcysteine inhibits the reaction [CSC-3436 results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [discretamine results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [ilimaquinone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [plumbagin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Quercetin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [raspberry ketone results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [rhododendrol results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tanshinone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Ursolic Acid results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased expression of DDIT3 protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]] Acetylcysteine inhibits the reaction [[bisphenol A co-treated with Dietary Fats co-treated with Cholesterol co-treated with Cholic Acid] results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Brefeldin A results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Thapsigargin results in increased expression of DDIT3 protein]; Acetylcysteine promotes the reaction [perfluorooctanoic acid results in increased expression of DDIT3 mRNA] |
CTD |
PMID:16084531 PMID:17171638 PMID:18077580 PMID:18384088 PMID:19722195 PMID:20493918 PMID:21145380 PMID:21198628 PMID:21266191 PMID:21533816 PMID:21616140 PMID:23339468 PMID:24157283 PMID:24291486 PMID:24394546 PMID:24612139 PMID:24802810 PMID:24930757 PMID:25341683 PMID:25451595 PMID:25568320 PMID:25817893 PMID:25950987 PMID:26203587 PMID:26772155 PMID:26867644 PMID:27484784 PMID:27511942 PMID:27634458 PMID:27658547 PMID:27784618 PMID:27816613 PMID:28296042 PMID:28754437 PMID:29111403 PMID:30502353 PMID:30508555 PMID:31276663 PMID:31330229 PMID:32506763 PMID:32578922 PMID:32590070 PMID:34599545 PMID:35622622 PMID:36252918 PMID:37072049 PMID:37300854 PMID:37487865 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [withaferin A results in increased expression of DDIT4 protein] |
CTD |
PMID:21266191 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Defb105a |
defensin beta 105A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB12 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:70,136,218...70,138,645
Ensembl chr16:70,725,701...70,728,143 Ensembl chr16:70,725,701...70,728,143
|
|
G |
Defb18 |
defensin beta 18 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB18 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:20,852,230...20,853,247
Ensembl chr 9:20,852,300...20,853,211
|
|
G |
Defb49 |
defensin beta 49 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB49 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 9:20,832,686...20,837,352
Ensembl chr 9:20,832,686...20,837,352
|
|
G |
Defb5 |
defensin beta 5 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of DEFB4A mRNA |
CTD |
PMID:22385246 |
|
NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of DGAT2 mRNA]; Acetylcysteine inhibits the reaction [Valproic Acid results in increased expression of DGAT2 protein] |
CTD |
PMID:33007364 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhfr |
dihydrofolate reductase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of DHFR mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dhh |
desert hedgehog signaling molecule |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DHH mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]] |
CTD |
PMID:18420745 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Sodium Selenite] promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]] |
CTD |
PMID:18420745 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DKK1 mRNA] |
CTD |
PMID:28321046 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of DLG4 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of DLG4 protein] |
CTD |
PMID:27624276 PMID:28153600 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DMRT1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dnah3 |
dynein, axonemal, heavy chain 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:174,305,929...174,479,490
Ensembl chr 1:174,306,644...174,479,474
|
|
G |
Dnai1 |
dynein, axonemal, intermediate chain 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DNAI1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB4 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression |
ISO |
Acetylcysteine results in increased expression of DNAJB9 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 affects the reaction [DNM1L protein binds to DNM1L protein binds to DNM1L protein binds to DNM1L protein]]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of DNM1L protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of DNM1L protein] Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of and results in increased phosphorylation of DNM1L protein] Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate affects the localization of DNM1L protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the phosphorylation of DNM1L protein] |
CTD |
PMID:20307494 PMID:30641872 PMID:31408635 PMID:37084995 PMID:37499777 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
[Acetylcysteine co-treated with Hydrogen Peroxide] results in increased expression of DNMT1 mRNA; [Acetylcysteine co-treated with Hydrogen Peroxide] results in increased methylation of DNMT1 promoter; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [DNMT1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of DNMT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of DNMT1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of DNMT1 protein] |
CTD |
PMID:29854080 PMID:31150806 PMID:31551408 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of DNMT3B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of DNMT3B protein] |
CTD |
PMID:26942697 PMID:31551408 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dsp |
desmoplakin |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of DSP mRNA] |
CTD |
PMID:21051528 |
|
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
|
|
G |
Dspp |
dentin sialophosphoprotein |
increases expression |
ISO |
Acetylcysteine results in increased expression of DSPP mRNA |
CTD |
PMID:20951298 |
|
NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DUSP1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of DUSP1 protein] |
CTD |
PMID:18573614 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
increases expression |
ISO |
Acetylcysteine results in increased expression of DUSP4 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dut |
deoxyuridine triphosphatase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [beta-hydroxyisovalerylshikonin results in decreased phosphorylation of and results in decreased activity of DUT protein] |
CTD |
PMID:18078828 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [5-nitroso-8-quinolinol results in decreased expression of E2F1 protein] |
CTD |
PMID:16497787 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein] Acetylcysteine inhibits the reaction [Paraquat results in increased expression of EDN1 mRNA] Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of EDN1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased secretion of EDN1 protein] |
CTD |
PMID:14623829 PMID:16261333 PMID:21765237 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Efcab3 |
EF-hand calcium binding domain 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:89,583,526...90,077,260
Ensembl chr10:89,644,522...90,077,259
|
|
G |
Efna1 |
ephrin A1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Efnb2 |
ephrin B2 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of EFNB2 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of HSPD1 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of EGF protein]; Acetylcysteine inhibits the reaction [cyadox results in increased expression of EGF]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA mRNA]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA protein] Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]; Acetylcysteine inhibits the reaction [EGF protein results in increased abundance of Peroxides] |
CTD |
PMID:11158190 PMID:11214823 PMID:26138014 PMID:30265530 PMID:32092105 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGFR mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EGFR protein]; Acetylcysteine inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of EGFR protein] Acetylcysteine inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of EGFR protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein] Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of EGFR protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of EGFR protein] |
CTD |
PMID:10640773 PMID:14660655 PMID:15520183 PMID:15849355 PMID:16261333 PMID:17942915 PMID:21220312 PMID:23948867 PMID:26368632 PMID:26514923 PMID:28123000 More...
|
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of EGLN1 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of EGR1 mRNA] Acetylcysteine inhibits the reaction [platycodin D results in increased expression of EGR1 mRNA] |
CTD |
PMID:10625299 PMID:18804340 PMID:19010381 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Egr2 |
early growth response 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of EGR2 mRNA] |
CTD |
PMID:19350554 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Ei24 |
EI24, autophagy associated transmembrane protein |
multiple interactions |
ISO |
Acetylcysteine promotes the reaction [Tobacco Smoke Pollution results in increased expression of EI24 mRNA] |
CTD |
PMID:16137721 |
|
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased phosphorylation of EIF2A protein]; Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased phosphorylation of EIF2A protein]] Acetylcysteine inhibits the reaction [Cadmium results in decreased phosphorylation of EIF2A protein] |
CTD |
PMID:21616140 PMID:25451595 PMID:27658547 PMID:29373603 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF2AK3 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [chrysophanic acid results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pendulone results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine results in increased phosphorylation of and results in increased activity of EIF2AK3 protein Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2AK3 protein modified form] Acetylcysteine results in decreased expression of EIF2AK3 protein modified form Acetylcysteine inhibits the reaction [chloroacetic acid results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:19722195 PMID:25341683 PMID:25451595 PMID:27484784 PMID:27784618 PMID:30300626 PMID:31330229 PMID:32506763 PMID:35288263 PMID:37300854 PMID:37300869 PMID:37692514 More...
|
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [chrysophanic acid results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased phosphorylation of EIF2S1 protein] Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2S1 protein modified form] Acetylcysteine inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [Indican results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2S1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of EIF2S1 protein] |
CTD |
PMID:15788408 PMID:16324875 PMID:21911445 PMID:24291486 PMID:25568320 PMID:27484784 PMID:27634458 PMID:27709270 PMID:27816613 PMID:29380555 PMID:30300626 PMID:31330229 PMID:32506763 More...
|
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of EIF4EBP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein] Acetylcysteine inhibits the reaction [frenolicin B results in decreased phosphorylation of EIF4EBP1 protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:21195169 PMID:24299490 PMID:26804764 PMID:30661989 PMID:36709824 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Emilin2 |
elastin microfibril interfacer 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:111,160,708...111,220,463
Ensembl chr 9:111,160,712...111,220,352
|
|
G |
Endog |
endonuclease G |
multiple interactions |
ISO |
[Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein; Acetylcysteine inhibits the reaction [perfosfamide results in increased localization of ENDOG protein] |
CTD |
PMID:17309078 PMID:18034189 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eng |
endoglin |
increases expression |
ISO |
Acetylcysteine results in increased expression of ENG mRNA; Acetylcysteine results in increased expression of ENG protein |
CTD |
PMID:32947957 |
|
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Toluene 2,4-Diisocyanate results in increased secretion of ENPP2 protein] |
CTD |
PMID:26072274 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENPP7 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:104,242,169...104,247,185
Ensembl chr10:104,242,223...104,246,589
|
|
G |
Entrep1 |
endosomal transmembrane epsin interactor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENTREP1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]] |
CTD |
PMID:19281832 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of EPAS1 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein] |
CTD |
PMID:23958427 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epb41 |
erythrocyte membrane protein band 4.1 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in decreased expression of EPB41 protein] |
CTD |
PMID:20946910 |
|
NCBI chr 5:144,110,010...144,264,037
Ensembl chr 5:144,111,906...144,237,821
|
|
G |
Ephb1 |
Eph receptor B1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPHB1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Eps8 |
EGFR pathway substrate 8, signaling adaptor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPS8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of ERCC1 mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc8 |
ERCC excision repair 8, CSA ubiquitin ligase complex subunit |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [dicrotophos results in decreased expression of ERCC8 protein] |
CTD |
PMID:28302478 |
|
NCBI chr 2:39,647,393...39,686,229
Ensembl chr 2:39,647,452...39,684,859
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions decreases phosphorylation |
EXP ISO |
Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ERN1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ERN1 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased phosphorylation of ERN1 protein] Acetylcysteine results in decreased phosphorylation of ERN1 protein Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of ERN1 protein modified form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein] Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of ERN1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]] |
CTD |
PMID:21198628 PMID:24394546 PMID:25451595 PMID:27784618 PMID:29373603 PMID:30633982 PMID:31330229 PMID:34687772 PMID:37692514 More...
|
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of ESR1 protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR1 mRNA] Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ESR1 protein] |
CTD |
PMID:18829485 PMID:26149760 PMID:32402895 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR2 mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esrra |
estrogen related receptor, alpha |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein] |
CTD |
PMID:30104959 |
|
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of ETS1 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of ETS1 mRNA]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETS1 mRNA] |
CTD |
PMID:21635667 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [EZH2 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of EZH2 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of EZH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of EZH2 protein] |
CTD |
PMID:24582688 PMID:31551408 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Norepinephrine results in increased expression of F3 mRNA] |
CTD |
PMID:23114885 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of FABP4 protein] |
CTD |
PMID:27117918 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fadd |
Fas associated via death domain |
multiple interactions |
EXP ISO |
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite results in increased expression of FADD protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of FADD mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in decreased expression of FADD protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of FADD mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in decreased expression of FADD protein]] |
CTD |
PMID:20946910 PMID:35833596 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads2 |
fatty acid desaturase 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam114a2 |
family with sequence similarity 114, member A2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:41,661,787...41,696,790
Ensembl chr10:41,661,787...41,696,741
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM13A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
|
|
G |
Fam186a |
family with sequence similarity 186 member A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM186A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:131,043,586...131,102,312
|
|
G |
Far1 |
fatty acyl CoA reductase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAR1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases expression |
EXP ISO |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of FAS mRNA] Acetylcysteine results in increased expression of FAS mRNA Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of FAS protein]; Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased expression of FAS protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of FAS protein] |
CTD |
PMID:9227460 PMID:15382040 PMID:16169029 PMID:19014919 PMID:19477266 PMID:19720122 PMID:21741372 PMID:28219700 More...
|
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
ISO EXP |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of FASLG mRNA; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased expression of FASLG protein] Acetylcysteine results in increased expression of FASLG mRNA [Atorvastatin co-treated with Acetylcysteine] inhibits the reaction [sodium arsenite results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG protein] Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of FASLG protein]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] |
CTD |
PMID:11864783 PMID:17574045 PMID:19644561 PMID:19720122 PMID:19760616 PMID:20431929 PMID:20946910 PMID:22429591 PMID:26332274 PMID:28219700 More...
|
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein] |
CTD |
PMID:30849338 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of FEN1 mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fer1l5 |
fer-1-like family member 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FER1L5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF12 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of FGF2 mRNA Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate results in increased secretion of FGF2 protein] |
CTD |
PMID:16084531 PMID:19176594 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF21 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF21 mRNA] Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of FGF21 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased secretion of FGF21 protein] |
CTD |
PMID:22129741 PMID:22917661 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgf6 |
fibroblast growth factor 6 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF6 protein] |
CTD |
PMID:26138014 |
|
NCBI chr 4:159,854,913...159,863,447
Ensembl chr 4:159,854,913...159,863,447
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein] |
CTD |
PMID:26138014 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of FHIT protein] |
CTD |
PMID:16585223 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Filip1l |
filamin A interacting protein 1-like |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of FILIP1L mRNA |
CTD |
PMID:16084531 |
|
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
|
|
G |
Fis1 |
fission, mitochondrial 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of FIS1 protein] Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of FIS1 protein] |
CTD |
PMID:37084995 PMID:37499777 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of FKBP5 mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flg |
filaggrin |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FLG mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Flna |
filamin A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenic trichloride results in increased phosphorylation of FLNA protein] |
CTD |
PMID:25944616 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
increases expression multiple interactions |
ISO |
Acetylcysteine results in increased expression of FLT1 protein Acetylcysteine inhibits the reaction [Cadmium results in increased expression of FLT1 mRNA]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of FLT1 mRNA] |
CTD |
PMID:17992120 PMID:29408318 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Flt3lg |
Fms related receptor tyrosine kinase 3 ligand |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FLT3LG protein] |
CTD |
PMID:26138014 |
|
NCBI chr 1:95,615,056...95,620,463
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
ISO |
Acetylcysteine promotes the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] |
CTD |
PMID:27385396 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Glucose results in increased expression of FN1 protein] Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP10 protein]; Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP3 protein]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of FN1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of FN1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of FN1 mRNA] |
CTD |
PMID:16632126 PMID:17395008 PMID:22245600 PMID:22648416 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of FOS]; Acetylcysteine inhibits the reaction [Etoposide results in increased expression of FOS]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased activity of FOS protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of FOS]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of FOS protein]; Acetylcysteine inhibits the reaction [xanthatin results in increased expression of FOS] Acetylcysteine results in decreased activity of FOS protein Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in decreased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [Carbon Tetrachloride results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of and results in increased phosphorylation of FOS protein]; Acetylcysteine promotes the reaction [bis(maltolato)oxovanadium(IV) results in decreased activity of [FOS protein binds to JUN protein]] Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOS mRNA]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of FOS protein]; Acetylcysteine inhibits the reaction [oxaliplatin results in increased expression of FOS protein]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of FOS mRNA] |
CTD |
PMID:7743507 PMID:8825185 PMID:8853906 PMID:9043100 PMID:9525474 PMID:10692565 PMID:14623829 PMID:15520183 PMID:16137721 PMID:17696279 PMID:19654923 PMID:20654705 PMID:22129741 PMID:23824011 PMID:24908156 PMID:36813253 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOSL1 mRNA] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of FOSL1 mRNA] |
CTD |
PMID:15520183 PMID:19010381 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxd2 |
forkhead box D2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
|
|
G |
Foxd4 |
forkhead box D4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:222,557,494...222,559,189
Ensembl chr 1:222,557,360...222,559,159
|
|
G |
Foxm1 |
forkhead box M1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Thiostrepton results in decreased expression of FOXM1 protein] |
CTD |
PMID:22761781 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cyclosporine results in increased expression of and affects the localization of FOXO1 protein modified form]; Acetylcysteine inhibits the reaction [Glucose affects the localization of FOXO1 protein] |
CTD |
PMID:23765110 PMID:33450223 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Simvastatin results in increased phosphorylation of FOXO3 protein] Acetylcysteine inhibits the reaction [tomentosin results in increased expression of FOXO3 protein] Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of FOXO3 protein] |
CTD |
PMID:20883752 PMID:23159718 PMID:25471227 PMID:30104959 PMID:30917517 PMID:34358621 More...
|
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp3 |
forkhead box P3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of FOXP3 protein] |
CTD |
PMID:31900833 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of FSHB protein] |
CTD |
PMID:30633982 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Rotenone results in increased expression of FTH1 mRNA] Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of FTH1 protein] |
CTD |
PMID:18325346 PMID:32687844 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [arsenite results in increased expression of FTL1 protein] |
CTD |
PMID:15175009 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of FTO mRNA] Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of FTO mRNA] |
CTD |
PMID:31004932 PMID:34425375 |
|
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Fxn |
frataxin |
affects response to substance multiple interactions |
ISO |
Acetylcysteine affects the susceptibility to FXN protein mutant form Acetylcysteine affects the reaction [Ethanol affects the expression of FXN protein] |
CTD |
PMID:16120311 PMID:33017621 |
|
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of FYN protein] Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of FYN protein] |
CTD |
PMID:12902192 PMID:20850416 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions increases activity |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of G6PD mRNA]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA] Acetylcysteine results in increased activity of G6PD protein |
CTD |
PMID:3099627 PMID:12717738 PMID:15225644 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions decreases expression increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Formaldehyde results in increased expression of GADD45A mRNA]; Acetylcysteine inhibits the reaction [raspberry ketone results in increased expression of GADD45A mRNA]; Acetylcysteine inhibits the reaction [rhododendrol results in increased expression of GADD45A mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of GADD45A mRNA] Acetylcysteine results in decreased expression of GADD45A mRNA Acetylcysteine results in increased expression of GADD45A mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45A mRNA; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GADD45A mRNA] |
CTD |
PMID:18849615 PMID:22129741 PMID:24291486 PMID:26332274 PMID:26867644 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA Acetylcysteine inhibits the reaction [[xanthatin results in increased expression of GADD45G mRNA] which results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G mRNA]; Acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G protein] |
CTD |
PMID:22129741 PMID:23313378 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Galntl5 |
polypeptide N-acetylgalactosaminyltransferase-like 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GALNTL5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:9,873,426...9,923,297
Ensembl chr 4:9,873,428...9,923,136
|
|
G |
Gap43 |
growth associated protein 43 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] |
CTD |
PMID:18375950 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
decreases expression multiple interactions |
EXP |
Acetylcysteine results in decreased expression of GAPDH mRNA Acetylcysteine inhibits the reaction [arsenite results in decreased expression of GAPDH protein] |
CTD |
PMID:11108245 PMID:15175009 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gata1 |
GATA binding protein 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] |
CTD |
PMID:10656287 |
|
NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of GBP1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein]; Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC protein]; Acetylcysteine inhibits the reaction [Hydrocarbons, Chlorinated analog results in increased expression of GCLC protein]; Acetylcysteine inhibits the reaction [Indomethacin results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of GCLC protein]; Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of GCLC mRNA] Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC protein] Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of GCLC mRNA]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA] |
CTD |
PMID:11820781 PMID:11909699 PMID:16631525 PMID:17540521 PMID:17980396 PMID:19328227 PMID:20851755 PMID:21728338 PMID:24355586 PMID:25263748 PMID:30951941 PMID:31029725 PMID:34036678 PMID:35123994 More...
|
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions affects response to substance |
ISO |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of GCLM mRNA]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of GCLM mRNA] GCLM protein affects the susceptibility to Acetylcysteine Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLM mRNA] |
CTD |
PMID:17584759 PMID:18723479 PMID:19328227 PMID:19350554 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf1 |
growth differentiation factor 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein] Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDF1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein] |
CTD |
PMID:33360347 |
|
NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,097,314...19,112,519
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of GDF15 mRNA] |
CTD |
PMID:35123994 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GDNF mRNA Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of GDNF protein] |
CTD |
PMID:22129741 PMID:26138014 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein] |
CTD |
PMID:28499986 PMID:31173782 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GGT1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased secretion of GGT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GGT1 protein]; Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of GGT1 protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]] |
CTD |
PMID:12030384 PMID:22129741 PMID:24485406 PMID:24634002 PMID:27387968 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of GJA1 protein] |
CTD |
PMID:34906888 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of GJA4 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of GJB1 mRNA] |
CTD |
PMID:32142722 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gk |
glycerol kinase |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased activity of GK protein] |
CTD |
PMID:25449180 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Gkn2 |
gastrokine 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GKN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:119,778,326...119,824,366
Ensembl chr 4:119,818,280...119,824,363
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased activity of GLB1 protein]; Acetylcysteine inhibits the reaction [lopinavir-ritonavir drug combination results in increased activity of GLB1 protein]; Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] |
CTD |
PMID:20884875 PMID:31551408 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Glcci1 |
glucocorticoid induced 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GLCCI1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Oleic Acid results in increased degradation of and results in decreased expression of GLP1R protein] |
CTD |
PMID:22925809 |
|
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
|
|
G |
Glrx |
glutaredoxin |
affects response to substance |
ISO |
GLRX protein affects the susceptibility to Acetylcysteine |
CTD |
PMID:17468103 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [epigallocatechin gallate results in decreased expression of GLUD1 mRNA] |
CTD |
PMID:31857147 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
multiple interactions |
ISO EXP |
Acetylcysteine affects the reaction [IER3 protein affects the expression of GNAI2 mRNA] Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GNAI2 protein] |
CTD |
PMID:18441196 PMID:20713914 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GNAI3 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GOT1 protein] |
CTD |
PMID:27387968 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gp1ba |
glycoprotein Ib platelet subunit alpha |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [THPO protein results in increased expression of GP1BA protein] |
CTD |
PMID:20523355 |
|
NCBI chr10:55,352,938...55,355,804
Ensembl chr10:55,352,899...55,356,774
|
|
G |
Gp2 |
glycoprotein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GP2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619
|
|
G |
Gpbar1 |
G protein-coupled bile acid receptor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPBAR1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:75,860,758...75,863,260
Ensembl chr 9:75,860,677...75,863,168
|
|
G |
Gpc5 |
glypican 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPC5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPC5 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
|
|
G |
Gpr153 |
G protein-coupled receptor 153 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR153 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
|
|
G |
Gpr20 |
G protein-coupled receptor 20 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR20 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430
|
|
G |
Gpr55 |
G protein-coupled receptor 55 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR55 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPR55 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GPT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of GPT protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [PTEN gene mutant form results in increased secretion of GPT protein]]; IL22 protein promotes the reaction [Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of GPT protein]] [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Acetaminophen affects the activity of GPT protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of GPT protein]; Acetylcysteine inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Glyphosate results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GPT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]] |
CTD |
PMID:17461432 PMID:20688495 PMID:20804811 PMID:23375450 PMID:24485406 PMID:27022031 PMID:27387968 PMID:27720869 PMID:28435131 PMID:28887131 PMID:29704510 PMID:30423402 PMID:30641872 PMID:32402895 PMID:33797725 PMID:37458150 PMID:38042273 More...
|
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA] Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GPX1 protein] Acetylcysteine results in increased expression of GPX1 protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of GPX1 protein]; Acetylcysteine inhibits the reaction [mancozeb results in decreased expression of GPX1 mRNA]; Acetylcysteine inhibits the reaction [raspberry ketone results in decreased expression of GPX1 protein]; Acetylcysteine inhibits the reaction [rhododendrol results in decreased expression of GPX1 protein] |
CTD |
PMID:25341683 PMID:26867644 PMID:30037311 PMID:30104959 PMID:35112789 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GPX4 mRNA] |
CTD |
PMID:12208374 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Pilocarpine results in increased expression of GRIN2B protein] |
CTD |
PMID:22824136 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
increases activity |
ISO |
Acetylcysteine results in increased activity of GRM2 protein |
CTD |
PMID:19136971 |
|
NCBI chr 8:107,280,099...107,293,159
Ensembl chr 8:107,280,099...107,293,146
|
|
G |
Grm3 |
glutamate metabotropic receptor 3 |
increases activity |
ISO |
Acetylcysteine results in increased activity of GRM3 protein |
CTD |
PMID:19136971 |
|
NCBI chr 4:24,364,854...24,643,972
Ensembl chr 4:24,365,115...24,609,804
|
|
G |
Grm5 |
glutamate metabotropic receptor 5 |
increases activity |
ISO |
Acetylcysteine results in increased activity of GRM5 protein |
CTD |
PMID:19136971 |
|
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased cleavage of GSDMD protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased cleavage of GSDMD protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of GSDMD protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased cleavage of GSDMD protein]] Acetylcysteine results in increased expression of GSDMD protein Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of GSDMD protein] Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of GSDMD mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of GSDMD protein] |
CTD |
PMID:30378427 PMID:34791735 PMID:36347317 PMID:36354081 PMID:36646296 PMID:37393521 More...
|
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of GSK3B protein] [Acetylcysteine co-treated with Chlorpyrifos] results in increased activity of GSK3B protein; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [GSK3B protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to GSK3B protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:18569013 PMID:19126599 PMID:24968063 PMID:25246272 PMID:27658547 PMID:33131013 PMID:33930485 More...
|
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GSR mRNA]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in decreased expression of GSR mRNA] Acetylcysteine inhibits the reaction [Acetaminophen results in decreased activity of GSR protein] [Acetylcysteine co-treated with Paraquat co-treated with Maneb] results in increased activity of GSR protein; [Acetylcysteine co-treated with Paraquat] results in increased activity of GSR protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide inhibits the reaction [GSR protein results in increased oxidation of NADP]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of GSR mRNA]; Acetylcysteine inhibits the reaction [Dimethylnitrosamine results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [Paraquat results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of GSR protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in decreased activity of GSR protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in decreased activity of GSR protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in decreased activity of GSR protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in decreased activity of GSR protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in decreased activity of GSR protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in decreased activity of GSR protein]]; Acetylcysteine promotes the reaction [Zinc Sulfate inhibits the reaction [EUK-134 results in decreased activity of GSR protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in decreased activity of GSR protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in decreased activity of GSR protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in decreased activity of GSR protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in decreased activity of GSR protein]] |
CTD |
PMID:16631525 PMID:19840221 PMID:21114986 PMID:23159886 PMID:24634002 PMID:25724285 PMID:26079211 PMID:30951941 PMID:37458150 More...
|
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of GSTA1 mRNA] |
CTD |
PMID:9152014 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with EUK-134] promotes the reaction [[Zinc Sulfate co-treated with Paraquat] results in increased activity of GSTA4 protein]; [EUK-134 co-treated with Acetylcysteine] promotes the reaction [Paraquat results in increased activity of GSTA4 protein]; [EUK-134 co-treated with Acetylcysteine] promotes the reaction [Zinc Sulfate results in increased activity of GSTA4 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of GSTA4 mRNA]; Acetylcysteine promotes the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of GSTA4 protein]; Acetylcysteine promotes the reaction [[Paraquat co-treated with Maneb] results in increased expression of GSTA4 mRNA]; Acetylcysteine promotes the reaction [Maneb results in increased expression of and results in increased activity of GSTA4 protein]; Acetylcysteine promotes the reaction [Maneb results in increased expression of GSTA4 mRNA]; Acetylcysteine promotes the reaction [Paraquat results in increased expression of and results in increased activity of GSTA4 protein]; Acetylcysteine promotes the reaction [Paraquat results in increased expression of GSTA4 mRNA] |
CTD |
PMID:23159886 PMID:25724285 PMID:30639957 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTA5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [alpha-methylepinine results in increased expression of GSTM1 mRNA] [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA |
CTD |
PMID:21871945 PMID:22129741 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of GULP1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
Gypa |
glycophorin A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of GYPA protein] |
CTD |
PMID:20523355 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [4-biphenylamine results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl)imidazole results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [alpha-terthienylmethanol results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [captax results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [chloropicrin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AX protein]]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [Crizotinib results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [eprenetapopt results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [gingerenone A results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [LAQ824 results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [manumycin results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AX protein]]; Acetylcysteine inhibits the reaction [nickel chloride results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [PCB 180 metabolite results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [phenanthridone results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [Plant Extracts results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [tomentosin results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [usnic acid results in increased expression of H2AX protein] Acetylcysteine results in increased expression of H2AX protein Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of H2AX protein]; Acetylcysteine inhibits the reaction [aristolochic acid I results in increased expression of H2AX protein]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [yttrium chloride results in increased phosphorylation of H2AX protein] Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [diepoxybutane results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of H2AX protein modified form]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased activity of H2AX protein] |
CTD |
PMID:15173094 PMID:15489221 PMID:18852132 PMID:19409983 PMID:21135414 PMID:22172632 PMID:23274516 PMID:24614525 PMID:25633853 PMID:26079211 PMID:26148434 PMID:28300663 PMID:28506552 PMID:28993908 PMID:29128613 PMID:29416738 PMID:30408460 PMID:30917517 PMID:31157515 PMID:31168028 PMID:31639374 PMID:31682804 PMID:31715134 PMID:31884112 PMID:32433928 PMID:33031904 PMID:33961949 PMID:33971260 PMID:35088107 PMID:35123993 PMID:35279910 PMID:35326237 PMID:36863539 PMID:37072049 More...
|
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Has2 |
hyaluronan synthase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA] |
CTD |
PMID:21220312 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of HAVCR1 protein] |
CTD |
PMID:35020164 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hax1 |
HCLS1 associated protein X-1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of HAX1 protein] |
CTD |
PMID:19679660 |
|
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [vanadium pentoxide results in increased expression of HBEGF mRNA] |
CTD |
PMID:12676768 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Ethanol results in increased expression of HECTD4 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of HECTD4 mRNA] |
CTD |
PMID:31004932 PMID:35713687 |
|
NCBI chr12:35,182,165...35,330,935
Ensembl chr12:35,182,154...35,330,987
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression multiple interactions |
ISO |
Acetylcysteine results in increased expression of HERPUD1 mRNA Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HERPUD1 mRNA] |
CTD |
PMID:16084531 PMID:18723479 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of HGF protein] |
CTD |
PMID:16757516 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hhip |
Hedgehog-interacting protein |
multiple interactions |
EXP |
[Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of HHIP mRNA |
CTD |
PMID:21051528 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of HIF1A protein] Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Nickel analog results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of HIF1A protein]] 1-(2-chloroethyl)-1-nitrosourea inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [Cisplatin affects the localization of HIF1A protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Fluorouracil affects the localization of HIF1A protein]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of HIF1A mRNA]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]] |
CTD |
PMID:10866824 PMID:11641398 PMID:11886167 PMID:13679210 PMID:16530163 PMID:17015263 PMID:17066447 PMID:17658243 PMID:19374849 PMID:19410601 PMID:21036805 PMID:22648416 PMID:22700867 PMID:25406100 PMID:27297870 PMID:29408318 PMID:31850806 PMID:35430258 PMID:36709824 PMID:36739042 More...
|
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hk2 |
hexokinase 2 |
increases expression multiple interactions |
ISO |
Acetylcysteine results in increased expression of HK2 mRNA Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of HK2 protein]] |
CTD |
PMID:16084531 PMID:36762617 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of HMBS mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA] |
CTD |
PMID:10656287 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMGA2 protein] |
CTD |
PMID:27071802 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of HMGB1 protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of HMGB1 protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein] |
CTD |
PMID:26079697 PMID:30977640 PMID:36055550 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgb2 |
high mobility group box 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA] |
CTD |
PMID:19931295 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions affects activity |
ISO EXP |
Acetylcysteine results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [2,2'-dihydroxychalcone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide results in increased abundance of Peroxides] which results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[chromium trioxide co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[Curcumin co-treated with piperine] results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid results in increased abundance of Peroxides] which results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [carnosol results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [chromium trioxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal results in increased expression of HMOX1]; Acetylcysteine inhibits the reaction [Hemin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of HMOX1 mRNA]]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of HMOX1 protein]]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Quercetin analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Urea results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 protein]; Polymyxin B inhibits the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of HMOX1 mRNA]] [Acetylcysteine results in increased abundance of Glutathione] inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of HMOX1 protein]; Acetylcysteine affects the reaction [Pyruvaldehyde affects the expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [2-butenal results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [2-xylene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[[[15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of and results in increased activity of HMOX1 protein] which results in increased abundance of Iron] which results in increased abundance of Reactive Oxygen Species] which results in increased expression of MMP1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[tin protoporphyrin IX results in decreased activity of HMOX1 protein] which results in increased chemical synthesis of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Ammonium Chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [camphorquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [chloropicrin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [gallium nitrate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Mercury results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [lipopolysaccharide A results in increased expression of HMOX1 protein]]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Silicon analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Silver analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [tetrathiomolybdate analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Toluene results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 mRNA]; Acetylcysteine promotes the reaction [Omeprazole results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Oxygen results in increased expression of HMOX1 mRNA] [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of HMOX1 protein]; Acetylcysteine affects the reaction [Glucose affects the expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [oxophenylarsine results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 protein] Acetylcysteine affects the activity of HMOX1 protein Acetylcysteine results in increased expression of HMOX1 mRNA; Acetylcysteine results in increased expression of HMOX1 protein |
CTD |
PMID:7538129 PMID:9152014 PMID:9545559 PMID:9747510 PMID:10975858 PMID:11103787 PMID:11592956 PMID:12420312 PMID:12690112 PMID:12699905 PMID:12763371 PMID:14687664 PMID:15175009 PMID:15368090 PMID:15541757 PMID:16137721 PMID:16171798 PMID:16274885 PMID:16631525 PMID:16806455 PMID:16890772 PMID:16959797 PMID:17540521 PMID:17979524 PMID:18077580 PMID:18156441 PMID:18332044 PMID:18336854 PMID:18357586 PMID:18586083 PMID:18723479 PMID:18830972 PMID:19033392 PMID:19136476 PMID:19323979 PMID:19350554 PMID:19642688 PMID:19654923 PMID:20020861 PMID:20054154 PMID:20934533 PMID:20938987 PMID:21144877 PMID:21238556 PMID:21384399 PMID:21397656 PMID:21787718 PMID:22019695 PMID:22263782 PMID:22507881 PMID:22564156 PMID:22643931 PMID:22659318 PMID:22714038 PMID:22917016 PMID:23290930 PMID:23900960 PMID:23942037 PMID:24126012 PMID:24291486 PMID:24355171 PMID:24361488 PMID:24401988 PMID:24489685 PMID:25003661 PMID:25246272 PMID:26163453 PMID:26169828 PMID:26291278 PMID:26404762 PMID:26542248 PMID:26600472 PMID:26658076 PMID:26945724 PMID:26968795 PMID:27151894 PMID:27393915 PMID:27658547 PMID:27725188 PMID:27777014 PMID:27867098 PMID:28013216 PMID:28555929 PMID:29086419 PMID:29111403 PMID:29155359 PMID:29540228 PMID:30104959 PMID:30349652 PMID:30633982 PMID:30951941 PMID:30965051 PMID:31029725 PMID:31272005 PMID:31790703 PMID:31884112 PMID:32023790 PMID:32525552 PMID:32708634 PMID:33930485 PMID:34036678 PMID:35123994 PMID:36813253 PMID:37084995 PMID:37353053 PMID:37369159 PMID:37598416 PMID:37692514 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HNF4G mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] Acetylcysteine inhibits the reaction [HRAS protein mutant form results in increased susceptibility to sodium arsenite] |
CTD |
PMID:15945272 PMID:25199681 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsbp1 |
heat shock factor binding protein 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Thioacetamide results in increased expression of HSBP1 protein] |
CTD |
PMID:17103249 |
|
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD11B2 mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of HSD17B3 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:26769589 PMID:29567110 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD17B8 mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,822,026...4,828,742
|
|
G |
Hsd3b3 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of HSD3B3 mRNA] |
CTD |
PMID:26769589 |
|
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:186,138,044...186,144,033
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased activity of HSF1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter affects the localization of HSF1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HSF1 promoter]]; Acetylcysteine inhibits the reaction [Vehicle Emissions affects the localization of HSF1 protein] |
CTD |
PMID:10403520 PMID:17922515 PMID:30309986 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSP90B1 mRNA]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of HSP90B1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSP90B1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSP90B1 protein] Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of HSP90B1 protein] Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of HSP90B1 protein] |
CTD |
PMID:21145380 PMID:21533816 PMID:21911445 PMID:25451595 PMID:25950987 PMID:31330229 More...
|
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HSPA1A mRNA]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of HSPA1A protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of HSPA1A mRNA] Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSPA1A protein] |
CTD |
PMID:12231548 PMID:16324719 PMID:18723479 PMID:36813253 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HSPA1B mRNA] Acetylcysteine inhibits the reaction [arsenite results in increased expression of HSPA1B protein] |
CTD |
PMID:15175009 PMID:18723479 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions decreases expression |
ISO EXP |
Acetylcysteine results in increased expression of HSPA5 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of HSPA5 protein] Acetylcysteine results in decreased expression of HSPA5 protein 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [(4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Benomyl results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [discretamine results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Ethylmercury Compounds affects the expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [fangchinoline results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [plumbagin results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Resveratrol results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Ursolic Acid results in increased expression of HSPA5 protein]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]] Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Brefeldin A results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein] |
CTD |
PMID:19722195 PMID:20493918 PMID:21145380 PMID:21198628 PMID:21533816 PMID:21911445 PMID:24157283 PMID:24291486 PMID:24802810 PMID:25341683 PMID:25451595 PMID:25950987 PMID:26772155 PMID:27484784 PMID:27511942 PMID:27784618 PMID:27816613 PMID:28296042 PMID:28754437 PMID:30502353 PMID:30633982 PMID:31276663 PMID:31330229 PMID:32506763 PMID:32590070 PMID:34687772 PMID:37148176 PMID:37487865 More...
|
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [arsenite results in increased expression of HSPB1 protein] |
CTD |
PMID:15175009 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of HSPD1 mRNA]; Acetylcysteine inhibits the reaction [Chlorine results in increased expression of HSPD1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of HSPD1 mRNA] |
CTD |
PMID:32092105 PMID:35065218 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of HTATIP2 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
affects expression multiple interactions decreases expression |
ISO EXP |
Acetylcysteine affects the expression of ICAM1 Acetylcysteine affects the reaction [Dinitrochlorobenzene affects the expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Tin Fluorides results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 protein] Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of ICAM1 mRNA] Acetylcysteine results in decreased expression of ICAM1 mRNA Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of ICAM1 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased secretion of ICAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
CTD |
PMID:10495789 PMID:10792388 PMID:11736926 PMID:17416599 PMID:17666914 PMID:19642688 PMID:20885979 PMID:22093110 PMID:23114885 PMID:25876056 PMID:26683377 PMID:26901245 PMID:29329563 PMID:30842373 PMID:35349355 More...
|
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of ID2 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein] |
CTD |
PMID:30104959 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions affects response to substance |
ISO |
Acetylcysteine affects the reaction [IER3 protein affects the expression of GNAI2 mRNA] IER3 protein affects the susceptibility to Acetylcysteine |
CTD |
PMID:20713914 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ier5 |
immediate early response 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of IER5 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Dieldrin inhibits the reaction [Poly I-C results in increased expression of IFIT2 mRNA]] |
CTD |
PMID:34051100 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IFNG protein]; Acetylcysteine inhibits the reaction [Eosine I Bluish results in increased expression of IFNG mRNA]; Acetylcysteine inhibits the reaction [Formaldehyde results in decreased expression of IFNG mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IFNG protein] Acetylcysteine inhibits the reaction [Malathion results in increased expression of IFNG mRNA] Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]]; Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IFNG protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:12847270 PMID:15004186 PMID:18849615 PMID:20431929 PMID:22440610 PMID:24810974 PMID:26138014 PMID:32620109 More...
|
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of IFRD1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of IRS1 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGF1 protein] |
CTD |
PMID:17458902 PMID:26138014 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of IGF1R protein] |
CTD |
PMID:21195169 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IGFBP1 protein] |
CTD |
PMID:22129741 PMID:26138014 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of IGFBP2 protein] |
CTD |
PMID:26138014 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of IGFBP4 protein] |
CTD |
PMID:26138014 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases activity multiple interactions |
ISO |
Acetylcysteine results in decreased activity of IKBKB protein Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IKBKB mRNA] Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:17395010 PMID:34310962 PMID:37458150 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO EXP |
[Eugenol co-treated with Acetylcysteine] inhibits the reaction [Nicotine results in decreased secretion of IL10 protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Nicotine results in decreased expression of IL10 mRNA] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL10 protein] Acetylcysteine inhibits the reaction [Methotrexate results in decreased secretion of IL10 protein]; Acetylcysteine promotes the reaction [Doxorubicin results in increased expression of IL10 mRNA] |
CTD |
PMID:11124598 PMID:20431929 PMID:20885979 PMID:21237301 PMID:21424515 PMID:26138014 PMID:32620109 PMID:37598416 More...
|
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10rb |
interleukin 10 receptor subunit beta |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of IL10RB mRNA |
CTD |
PMID:16084531 |
|
NCBI chr11:30,646,494...30,668,081
Ensembl chr11:30,652,096...30,668,074
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] |
CTD |
PMID:21237301 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Nicotine results in increased expression of IL12B mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] |
CTD |
PMID:21237301 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL13 protein] |
CTD |
PMID:26138014 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il15 |
interleukin 15 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL15 protein] |
CTD |
PMID:26138014 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il16 |
interleukin 16 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL16 protein] |
CTD |
PMID:26138014 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IL17A protein]; Acetylcysteine inhibits the reaction [Trichloroethylene results in increased expression of IL17A mRNA] |
CTD |
PMID:20431929 PMID:23993974 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17d |
interleukin 17D |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IL17D mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:31,671,337...31,688,833
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Adenosine Triphosphate results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide analog results in increased secretion of IL18 protein] Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL18 protein] Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL18 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL18 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL18 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL18 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased secretion of IL18 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL18 protein]] |
CTD |
PMID:27311643 PMID:30205151 PMID:34510229 PMID:34791735 PMID:35020164 PMID:35285579 PMID:35777681 PMID:36055550 PMID:36646296 PMID:37300869 PMID:37393521 More...
|
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
[Acetylcysteine co-treated with IL1A protein] results in increased expression of SOD2 protein; Acetylcysteine inhibits the reaction [butylphen results in increased expression of IL1A protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1A protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of IL1A protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of IL1A mRNA]; Acetylcysteine promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]] |
CTD |
PMID:7476933 PMID:24570342 PMID:26138014 PMID:28836394 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression affects expression |
EXP ISO |
Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of IL1B protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Malathion results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL1B protein] Acetylcysteine results in increased expression of IL1B protein [Acetylcysteine co-treated with Cobalt] results in decreased expression of IL1B protein; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein modified form]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [2,4-decadienal results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[Oligomycins co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of and results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Cobalt results in increased expression of IL1B protein modified form]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]]; Acetylcysteine inhibits the reaction [IL1B protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased secretion of IL1B protein modified form]; Acetylcysteine inhibits the reaction [TNF protein results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [xanthohumol results in increased expression of IL1B protein]; Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of IL1B mRNA]; Acetylcysteine promotes the reaction [titanium dioxide results in increased secretion of IL1B protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Adenosine Triphosphate results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Silicon Dioxide analog results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased secretion of IL1B protein] Acetylcysteine results in decreased expression of IL1B mRNA Acetylcysteine affects the expression of IL1B protein |
CTD |
PMID:10541287 PMID:11970852 PMID:16014734 PMID:16214328 PMID:18257742 PMID:18403674 PMID:19281832 PMID:21424515 PMID:21703343 PMID:21779360 PMID:22385246 PMID:22549761 PMID:22867088 PMID:23159886 PMID:23900960 PMID:23940760 PMID:23948867 PMID:24570342 PMID:24609059 PMID:24810974 PMID:25406100 PMID:26086368 PMID:26138014 PMID:26332274 PMID:26435000 PMID:26801986 PMID:26809137 PMID:26901245 PMID:27311643 PMID:27393034 PMID:27783111 PMID:28004443 PMID:28814068 PMID:30205151 PMID:30320338 PMID:30639957 PMID:30878009 PMID:30977640 PMID:31629901 PMID:32620109 PMID:32687961 PMID:32805375 PMID:34238121 PMID:34510229 PMID:34791735 PMID:34863858 PMID:35190838 PMID:35285579 PMID:35349355 PMID:35833596 PMID:36055550 PMID:36347317 PMID:36354081 PMID:36493885 PMID:36646296 PMID:36762617 PMID:36880428 PMID:37300869 PMID:37369159 PMID:37393521 PMID:37458150 PMID:37598416 PMID:37692514 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO EXP |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of IL2 mRNA; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of IL2 protein] Acetylcysteine inhibits the reaction [Fenitrothion results in increased secretion of IL2 protein] |
CTD |
PMID:22429591 PMID:22910795 PMID:31173782 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il24 |
interleukin 24 |
decreases activity |
ISO |
Acetylcysteine results in decreased activity of IL24 protein |
CTD |
PMID:14678967 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of IL27RA mRNA |
CTD |
PMID:16084531 |
|
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RA protein]] |
CTD |
PMID:23134680 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il3 |
interleukin 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL3 protein] |
CTD |
PMID:26138014 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il33 |
interleukin 33 |
multiple interactions |
ISO |
Acetylcysteine promotes the reaction [Soot results in increased expression of IL33 mRNA] |
CTD |
PMID:35776887 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL4 protein] |
CTD |
PMID:26138014 PMID:27634759 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il4r |
interleukin 4 receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL4R mRNA] |
CTD |
PMID:29753051 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of IL5 protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL5 protein] |
CTD |
PMID:20431929 PMID:26138014 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
EXP ISO |
Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of IL6 protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Malathion results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in increased expression of IL6 protein] Acetylcysteine results in decreased expression of IL6 mRNA [Acetylcysteine co-treated with Ascorbic Acid] inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [calcium silicate results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL6 mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [zinc chloride results in increased secretion of IL6 protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL6 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL6 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL6 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of and results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]] |
CTD |
PMID:9378980 PMID:10022265 PMID:11970852 PMID:16757516 PMID:17922515 PMID:18257742 PMID:20801209 PMID:21131394 PMID:21424515 PMID:21533553 PMID:21762757 PMID:21779360 PMID:21912612 PMID:22472292 PMID:23624824 PMID:24570342 PMID:24810974 PMID:26160521 PMID:27427241 PMID:27917510 PMID:28555929 PMID:28739487 PMID:29329563 PMID:29753051 PMID:30259999 PMID:32687961 PMID:32810504 PMID:32947957 PMID:33146789 PMID:35065218 PMID:35122928 PMID:35285579 PMID:35349355 PMID:35833596 PMID:36055550 PMID:36493885 PMID:36762617 PMID:36880428 PMID:37458150 PMID:37598416 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7r |
interleukin 7 receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of IL7R mRNA alternative form]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN1A mRNA]]; IL7R mRNA alternative form promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of CDKN2A mRNA]] |
CTD |
PMID:35303175 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [Fructose results in increased expression of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]] Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of FABP4 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in decreased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Acetylcysteine inhibits the reaction [tributyltin results in increased secretion of INS1 protein] |
CTD |
PMID:15680273 PMID:16918248 PMID:20006636 PMID:21145380 PMID:23405080 PMID:27117918 PMID:28180948 More...
|
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Glucose results in increased expression of INS protein]; Acetylcysteine inhibits the reaction [tributyltin promotes the reaction [Glucose results in increased secretion of INS protein]] Acetylcysteine inhibits the reaction [Dexamethasone inhibits the reaction [Glucose results in increased secretion of INS protein]] |
CTD |
PMID:16505238 PMID:21888768 PMID:28180948 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Insig1 |
insulin induced gene 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Insr |
insulin receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of INSR protein] Acetylcysteine inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of INSR protein] |
CTD |
PMID:18569013 PMID:22917016 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Zinc deficiency results in increased expression of IREB2 protein] |
CTD |
PMID:18073202 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of IRF1 protein] [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA |
CTD |
PMID:20525893 PMID:22129741 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:17458902 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Irs2 |
insulin receptor substrate 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Itga2 |
integrin subunit alpha 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of ITGA2 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of ITGA2 mRNA]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ITGA2 mRNA] |
CTD |
PMID:21635667 |
|
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
|
|
G |
Itga2b |
integrin subunit alpha 2b |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGA2B protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGA2B protein] |
CTD |
PMID:20523355 |
|
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA]] |
CTD |
PMID:29945211 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgav |
integrin subunit alpha V |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of ITGAV mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [DDT results in increased expression of ITGB1 mRNA] |
CTD |
PMID:24820114 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb3 |
integrin subunit beta 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB3 protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGB3 protein] |
CTD |
PMID:20523355 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of JAG1 mRNA Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of JAG1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of JAG1 mRNA] |
CTD |
PMID:16084531 PMID:20974985 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jak1 |
Janus kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of JAK1 protein] |
CTD |
PMID:24820114 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein] N-acetyl-L-cysteine inhibits the reaction [hispidulin decreases phoshphorylation of JAK2 protein in colon and colorectum] N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid decreases phosphorylation of JAK2 protein in stomach] N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases phosphorylation of JAK2 protein in the stomach) Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of JAK2 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of JAK2 protein] |
CTD RGD |
PMID:12847270 PMID:29894800 PMID:34627931 PMID:29575334 PMID:32106377 PMID:29408335 More...
|
RGD:149735333, RGD:127284886, RGD:127284846 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases activity multiple interactions |
ISO EXP |
Acetylcysteine results in decreased activity of JUN protein Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of and results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [8-bromo-7-methoxychrysin results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with Disulfiram] results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [afimoxifene results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of JUN]; Acetylcysteine inhibits the reaction [darinaparsin results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [Niclosamide results in increased phosphorylation of JUN protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Morphine results in increased phosphorylation of and results in increased activity of JUN protein]; Acetylcysteine inhibits the reaction [Niclosamide results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of JUN protein] Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with Cobalt] results in increased localization of and results in increased activity of JUN protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Chromium results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Oxidopamine promotes the reaction [MAPK8 protein binds to and results in increased phosphorylation of JUN protein]]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]]; Acetylcysteine inhibits the reaction [zinc chloride results in increased expression of JUN mRNA] Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Carbon Tetrachloride results in increased expression of JUN mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of JUN protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of and results in increased phosphorylation of JUN protein]; Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of JUN mRNA]; Acetylcysteine promotes the reaction [bis(maltolato)oxovanadium(IV) results in decreased activity of [FOS protein binds to JUN protein]] |
CTD |
PMID:7743507 PMID:8797811 PMID:8825185 PMID:8853906 PMID:9043100 PMID:9890986 PMID:10397638 PMID:10692565 PMID:11306679 PMID:15252869 PMID:15520183 PMID:15945272 PMID:17458902 PMID:17696279 PMID:18569013 PMID:18633430 PMID:19038359 PMID:19292871 PMID:19654923 PMID:19747498 PMID:19935718 PMID:20632440 PMID:20654705 PMID:21635667 PMID:22260869 PMID:22288910 PMID:23033007 PMID:24750999 PMID:30796935 PMID:31229567 PMID:32540572 PMID:35689653 PMID:36813253 More...
|
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of JUNB mRNA] |
CTD |
PMID:15520183 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Ka11 |
type I keratin KA11 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KA11 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:85,161,424...85,164,737
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Kcnh5 |
potassium voltage-gated channel subfamily H member 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNH5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
|
|
G |
Kcnq5 |
potassium voltage-gated channel subfamily Q member 5 |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNQ5 mRNA Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of KCNQ5 mRNA] |
CTD |
PMID:22129741 PMID:31004932 |
|
NCBI chr 9:23,830,185...24,395,984
Ensembl chr 9:23,833,087...24,394,704
|
|
G |
Kctd4 |
potassium channel tetramerization domain containing 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCTD4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:51,263,664...51,278,030
Ensembl chr15:51,274,295...51,277,499
|
|
G |
Kdm2a |
lysine demethylase 2A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of KDM2A protein] Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [KDM2A protein binds to CDKN2A promoter]] |
CTD |
PMID:31551408 |
|
NCBI chr 1:201,612,427...201,682,359
Ensembl chr 1:201,612,453...201,680,787
|
|
G |
Kdr |
kinase insert domain receptor |
increases expression |
ISO |
Acetylcysteine results in increased expression of KDR protein |
CTD |
PMID:17992120 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of KEAP1 protein]; Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] Acetylcysteine inhibits the reaction [Copper Sulfate results in decreased expression of KEAP1 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in decreased expression of KEAP1 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of KEAP1 protein] Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 protein] |
CTD |
PMID:11909699 PMID:19033392 PMID:30104959 PMID:37353053 PMID:37369159 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif2c |
kinesin family member 2C |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of KIF2C protein] |
CTD |
PMID:28343997 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Kitlg |
KIT ligand |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of KITLG protein] |
CTD |
PMID:26138014 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Kl |
Klotho |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Cyclosporine results in decreased expression of KL protein] Acetylcysteine results in increased expression of KL protein Acetylcysteine inhibits the reaction [Indican results in decreased expression of KL mRNA]; Acetylcysteine inhibits the reaction [Indican results in decreased expression of KL protein] |
CTD |
PMID:21389697 PMID:23183129 PMID:23765110 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of KLF4 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of KLK3 mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of KMT2A protein] |
CTD |
PMID:31551408 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] |
CTD |
PMID:19409983 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Kremen2 |
kringle containing transmembrane protein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KREMEN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:12,763,345...12,767,622
Ensembl chr10:12,763,397...12,767,854
|
|
G |
Krt10 |
keratin 10 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of KRT10 protein] |
CTD |
PMID:31551408 |
|
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
|
|
G |
Krt8 |
keratin 8 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased phosphorylation of KRT8 protein] |
CTD |
PMID:15939799 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] Acetylcysteine affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]; Acetylcysteine affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein] Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMP1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA] |
CTD |
PMID:28347754 PMID:29307831 PMID:31319114 PMID:33462182 PMID:35550146 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased secretion of LDHA protein]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of LDHA protein] Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of LDHA mRNA]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of LDHA mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LDHA mRNA]; Acetylcysteine inhibits the reaction [DDT results in increased expression of LDHA mRNA] |
CTD |
PMID:21671307 PMID:30821169 PMID:31251971 PMID:31724279 PMID:36000575 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldhb |
lactate dehydrogenase B |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of LDHB protein] |
CTD |
PMID:21671307 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Lgalsl |
galectin-like |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of HAS2 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PGR mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of TNFAIP6 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] Acetylcysteine results in increased expression of LHB protein Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of LHB protein] |
CTD |
PMID:21220312 PMID:30633982 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhx8 |
LIM homeobox 8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LHX8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:243,244,958...243,269,624
Ensembl chr 2:243,244,961...243,269,416
|
|
G |
Lipe |
lipase E, hormone sensitive type |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of LIPE protein] |
CTD |
PMID:30648648 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of LONP1 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lpin1 |
lipin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LPIN1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased phosphorylation of LRRK2 protein] Acetylcysteine inhibits the reaction [Cadmium results in increased expression of LRRK2 mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of LRRK2 mRNA] |
CTD |
PMID:34816377 PMID:34897981 |
|
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
|
|
G |
Ly9 |
lymphocyte antigen 9 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LY9 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:84,079,345...84,100,783
Ensembl chr13:84,079,458...84,100,823
|
|
G |
Lyplal1 |
lysophospholipase-like 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYPLAL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:97,626,568...97,657,901
Ensembl chr13:97,626,451...97,657,867
|
|
G |
Lyzl4 |
lysozyme-like 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYZL4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:121,248,129...121,255,366
Ensembl chr 8:121,248,168...121,255,353
|
|
G |
Madcam1 |
mucosal vascular addressin cell adhesion molecule 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein] |
CTD |
PMID:12388057 |
|
NCBI chr 7:10,036,301...10,039,703
Ensembl chr 7:10,036,301...10,039,703
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased metabolism of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B mRNA]; Acetylcysteine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [dimethyl alpha-ketoglutarate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [ovatodiolide results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Vorinostat results in increased cleavage of MAP1LC3B protein]; Acetylcysteine promotes the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein]; Cadmium Chloride promotes the reaction [Acetylcysteine results in increased expression of MAP1LC3B protein modified form]; Cadmium Chloride promotes the reaction [Acetylcysteine results in increased expression of MAP1LC3B protein] Acetylcysteine results in increased expression of MAP1LC3B protein; Acetylcysteine results in increased expression of MAP1LC3B protein modified form Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion affects the expression of and results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of MAP1LC3B protein modified form]; Acetylcysteine inhibits the reaction [Indican results in increased expression of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate affects the localization of MAP1LC3B protein] Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]]; Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]]; Acetylcysteine inhibits the reaction [nonylphenol results in increased expression of MAP1LC3B protein] |
CTD |
PMID:20543569 PMID:25301941 PMID:27832966 PMID:28347754 PMID:28600121 PMID:29247770 PMID:29307831 PMID:30849338 PMID:31319114 PMID:31368586 PMID:32512069 PMID:32687844 PMID:33002460 PMID:34238121 PMID:34547296 PMID:34580807 PMID:34861471 PMID:35130734 PMID:36111830 PMID:36739042 PMID:37148176 PMID:37678662 PMID:38000454 More...
|
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2 |
microtubule-associated protein 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MAP2 mRNA] Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] |
CTD |
PMID:28153600 PMID:28499986 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K1 protein] |
CTD |
PMID:18703135 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K2 protein] |
CTD |
PMID:18703135 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein] |
CTD |
PMID:18703135 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K4 protein] N-acetyl-L-cysteine inhibits the reaction [Curcumin increases phosphorylation of MAP2K4 protein in uterine cervix] Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAP2K4 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K4 protein] |
CTD RGD |
PMID:18703135 PMID:22085843 PMID:25198898 |
RGD:150429751 |
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] |
CTD |
PMID:18703135 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] N-acetyl-L-cysteine co-treated with Curcumin increases phosphorylation of MAP3K5 protein in uterine cervix Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein] |
CTD RGD |
PMID:16449798 PMID:18703135 PMID:20083342 PMID:22784044 PMID:33039870 PMID:25198898 More...
|
RGD:150429751 |
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions decreases phosphorylation |
EXP ISO |
Acetylcysteine results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [acacetin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of and results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Daunorubicin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [dihydromyricetin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Etoposide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [morusin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [shikonin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Thiostrepton results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased phosphorylation of MAPK1 protein]; Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK1 protein; Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK1 protein Acetylcysteine affects the reaction [Cadmium results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[cobaltous chloride results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of and results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [raiser results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Acetylcysteine results in increased phosphorylation of MAPK1 protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK1 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine affects the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with Cobalt] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Indican results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]; Acetylcysteine promotes the reaction [Polymyxin B inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]] Acetylcysteine results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:8616849 PMID:10658192 PMID:12065697 PMID:12690112 PMID:12717738 PMID:14516795 PMID:14623829 PMID:15228596 PMID:15252869 PMID:15978937 PMID:16014620 PMID:16024921 PMID:16251475 PMID:16261333 PMID:16445087 PMID:16603213 PMID:16632126 PMID:16983658 PMID:17458902 PMID:17596522 PMID:17645304 PMID:17828457 PMID:18357586 PMID:18375950 PMID:18495191 PMID:18629305 PMID:18703135 PMID:19038359 PMID:19747498 PMID:20951154 PMID:21055460 PMID:21135414 PMID:21145380 PMID:21220312 PMID:21391979 PMID:21533816 PMID:21549813 PMID:21843585 PMID:21998720 PMID:22085843 PMID:22134701 PMID:22288910 PMID:22700867 PMID:22761781 PMID:22767315 PMID:22867088 PMID:22910795 PMID:23370007 PMID:23405080 PMID:23416263 PMID:23577223 PMID:23774252 PMID:23836369 PMID:23876460 PMID:24019090 PMID:24401988 PMID:24463199 PMID:24582688 PMID:25199686 PMID:25246272 PMID:25531190 PMID:25724548 PMID:25876056 PMID:26514923 PMID:27539140 PMID:28555929 PMID:28600122 PMID:28867437 PMID:29087013 PMID:29155359 PMID:29248572 PMID:29248592 PMID:29486182 PMID:30055241 PMID:30766661 PMID:30849338 PMID:30871965 PMID:30917517 PMID:31068539 PMID:31313457 PMID:31724279 PMID:31790703 PMID:31837377 PMID:31860779 PMID:31900833 PMID:32305283 PMID:32683294 PMID:32745510 PMID:33030807 PMID:33035517 PMID:33421718 PMID:34439521 PMID:34510229 PMID:34520753 PMID:34580807 PMID:34890707 PMID:34963561 PMID:35122928 PMID:35833596 PMID:36740148 PMID:36813253 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in increased phosphorylation of and results in increased activity of MAPK10 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with vorinostat] results in increased phosphorylation of and results in increased activity of MAPK10 protein] |
CTD |
PMID:15173093 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk13 |
mitogen activated protein kinase 13 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK13 protein] |
CTD |
PMID:28087840 |
|
NCBI chr20:6,835,277...6,845,500
Ensembl chr20:6,835,320...6,844,222
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Emodin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK14 protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK14 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]] |
CTD |
PMID:12684028 PMID:14729614 PMID:15650392 PMID:17237268 PMID:18703135 PMID:19767766 PMID:21635667 PMID:28087840 PMID:35833596 More...
|
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions decreases phosphorylation |
EXP ISO |
Acetylcysteine results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [acacetin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [antimony trichloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of and results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Daunorubicin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [dihydromyricetin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Etoposide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [morusin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [shikonin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Thiostrepton results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [tomentosin results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [withaferin A results in increased phosphorylation of MAPK3 protein]; Acetylcysteine results in increased activity of and results in increased phosphorylation of MAPK3 protein; Acetylcysteine results in increased phosphorylation of and results in increased activity of MAPK3 protein Acetylcysteine affects the reaction [Cadmium results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[cobaltous chloride results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Ditiocarb results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein modified form]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of and results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [raiser results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Acetylcysteine results in increased phosphorylation of MAPK3 protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK3 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine affects the reaction [Phytol promotes the reaction [alpha-MSH results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [[tungsten carbide co-treated with Cobalt] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Endosulfan results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK3 protein modified form]; Acetylcysteine inhibits the reaction [Indican results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [LHB protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]; Acetylcysteine promotes the reaction [Polymyxin B inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]] Acetylcysteine results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:8616849 PMID:12065697 PMID:12690112 PMID:12717738 PMID:14516795 PMID:14623829 PMID:15228596 PMID:15252869 PMID:15978937 PMID:16014620 PMID:16024921 PMID:16251475 PMID:16261333 PMID:16445087 PMID:16603213 PMID:16632126 PMID:16983658 PMID:17458902 PMID:17596522 PMID:17645304 PMID:17828457 PMID:18357586 PMID:18375950 PMID:18495191 PMID:18629305 PMID:18703135 PMID:19038359 PMID:19747498 PMID:20951154 PMID:21055460 PMID:21135414 PMID:21145380 PMID:21220312 PMID:21391979 PMID:21533816 PMID:21549813 PMID:21843585 PMID:21998720 PMID:22085843 PMID:22134701 PMID:22288910 PMID:22700867 PMID:22761781 PMID:22767315 PMID:22867088 PMID:22910795 PMID:23405080 PMID:23416263 PMID:23577223 PMID:23774252 PMID:23836369 PMID:23876460 PMID:24019090 PMID:24401988 PMID:24463199 PMID:24582688 PMID:25199686 PMID:25246272 PMID:25531190 PMID:25724548 PMID:25876056 PMID:26514923 PMID:27539140 PMID:28555929 PMID:28600122 PMID:28867437 PMID:29087013 PMID:29155359 PMID:29248572 PMID:29248592 PMID:29486182 PMID:30055241 PMID:30766661 PMID:30849338 PMID:30871965 PMID:30917517 PMID:31068539 PMID:31313457 PMID:31724279 PMID:31790703 PMID:31837377 PMID:31860779 PMID:31900833 PMID:32305283 PMID:32683294 PMID:32745510 PMID:33030807 PMID:33035517 PMID:33421718 PMID:34439521 PMID:34510229 PMID:34520753 PMID:34580807 PMID:34890707 PMID:34963561 PMID:35122928 PMID:35833596 PMID:36740148 PMID:36813253 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions decreases phosphorylation |
EXP ISO |
Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [aureusidin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of MAPK8 mRNA]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of MAPK8 mRNA] N-acetyl-L-cysteine inhibits the reaction [Curcumin increases phosphorylation of MAPK8 protein in uterine cervix] Acetylcysteine results in decreased phosphorylation of MAPK8 protein Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [8-bromo-7-methoxychrysin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Vorinostat] results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [butein results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cholix toxin, Vibrio cholerae results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [efavirenz metabolite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [efavirenz results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [eriocitrin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [isoliensinine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [longikaurin A results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Spermine results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK8 protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK8 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Oxidopamine promotes the reaction [MAPK8 protein binds to and results in increased phosphorylation of JUN protein]]; Acetylcysteine inhibits the reaction [zinc chloride results in increased activity of MAPK8 protein] |
CTD RGD |
PMID:10397638 PMID:11306679 PMID:12684028 PMID:12902192 PMID:14687664 PMID:15173093 PMID:17041759 PMID:17481858 PMID:18412143 PMID:18728404 PMID:19654923 PMID:19760616 PMID:20121705 PMID:20632440 PMID:21135414 PMID:21145380 PMID:21391979 PMID:21958719 PMID:22085843 PMID:22767315 PMID:23836369 PMID:24386346 PMID:24735948 PMID:25531190 PMID:26219228 PMID:26514923 PMID:28087840 PMID:28600122 PMID:28801140 PMID:29248572 PMID:29458170 PMID:30259999 PMID:30550853 PMID:30633982 PMID:30766661 PMID:30796935 PMID:31229567 PMID:31313457 PMID:31790703 PMID:33039870 PMID:34510229 PMID:34520753 PMID:34724282 PMID:34861471 PMID:35122928 PMID:35130734 PMID:35512476 PMID:35689653 PMID:35833596 PMID:36070022 PMID:36813253 PMID:25198898 More...
|
RGD:150429751 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions decreases phosphorylation |
ISO EXP |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MAPK9 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased phosphorylation of MAPK9 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MAPK9 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]]; Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Biological Products results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [maduramicin results in increased phosphorylation of MAPK9 protein] Acetylcysteine results in decreased phosphorylation of MAPK9 protein Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of and results in increased activity of MAPK9 protein]; Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [longikaurin A results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein] Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:14687664 PMID:18412143 PMID:19654923 PMID:19760616 PMID:21135414 PMID:21145380 PMID:21391979 PMID:22085843 PMID:22767315 PMID:23836369 PMID:24386346 PMID:24735948 PMID:25531190 PMID:26514923 PMID:28801140 PMID:29248572 PMID:29458170 PMID:30766661 PMID:31229567 PMID:35122928 PMID:35689653 PMID:35833596 More...
|
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of MAPKAPK2 protein] |
CTD |
PMID:21911445 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [cyanoginosin LR results in increased phosphorylation of MAPT protein] Acetylcysteine inhibits the reaction [1,2-diacetylbenzene results in increased phosphorylation of MAPT protein] |
CTD |
PMID:24142891 PMID:28734998 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in decreased expression of MCL1 protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Vorinostat] results in decreased expression of MCL1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of MCL1 protein]; Acetylcysteine inhibits the reaction [sepantronium results in decreased expression of MCL1 protein] Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MCL1 mRNA] |
CTD |
PMID:15173093 PMID:21533816 PMID:23082001 PMID:31837377 PMID:31900833 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mcm8 |
minichromosome maintenance 8 homologous recombination repair factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein] |
CTD |
PMID:32433928 |
|
NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008
|
|
G |
Me1 |
malic enzyme 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ME1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL14 protein] Acetylcysteine inhibits the reaction [Paraquat results in increased expression of METTL14 mRNA] |
CTD |
PMID:31004932 PMID:34425375 |
|
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mettl3 |
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of METTL3 mRNA] Acetylcysteine inhibits the reaction [Paraquat results in increased expression of METTL3 mRNA] |
CTD |
PMID:31004932 PMID:34425375 |
|
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
|
|
G |
Mfn1 |
mitofusin 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MFN1 protein] Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of MFN1 protein] Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of MFN1 protein] |
CTD |
PMID:31408635 PMID:37084995 PMID:37499777 |
|
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
G |
Mfn2 |
mitofusin 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [ALB protein modified form results in decreased expression of MFN2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of MFN2 protein] Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of MFN2 protein] Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of MFN2 protein] |
CTD |
PMID:27997345 PMID:31408635 PMID:37084995 PMID:37499777 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
multiple interactions increases expression decreases activity |
ISO |
Acetylcysteine results in increased expression of and results in increased activity of MGMT protein Acetylcysteine results in increased expression of MGMT mRNA Acetylcysteine results in decreased activity of MGMT protein |
CTD |
PMID:16950796 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir144 |
microRNA 144 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of MIR144 mRNA] |
CTD |
PMID:23584289 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir21 |
microRNA 21 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of MIR21 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions affects the expression of MIR21 mRNA] |
CTD |
PMID:23584289 PMID:27323401 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir23b |
microRNA 23b |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MIR23B mRNA] |
CTD |
PMID:25092309 |
|
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir28 |
microRNA 28 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MIR28 mRNA] |
CTD |
PMID:25092309 |
|
NCBI chr11:75,975,523...75,975,608
Ensembl chr11:75,975,523...75,975,608
|
|
G |
Mir761 |
microRNA 761 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of MIR761 mRNA] |
CTD |
PMID:23867156 |
|
NCBI chr 5:123,776,534...123,776,609
Ensembl chr 5:123,776,534...123,776,609
|
|
G |
Mitf |
melanocyte inducing transcription factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Phytol inhibits the reaction [alpha-MSH results in increased expression of MITF protein]] |
CTD |
PMID:29486182 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of MKI67 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MKI67 protein] |
CTD |
PMID:31518672 PMID:32745510 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlc1 |
modulator of VRAC current 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MLC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:120,046,705...120,067,049
Ensembl chr 7:120,046,705...120,067,049
|
|
G |
Mlh1 |
mutL homolog 1 |
multiple interactions |
ISO |
[Acetylcysteine co-treated with Hydrogen Peroxide] results in increased expression of MLH1 mRNA; Acetylcysteine inhibits the reaction [sodium arsenite affects the expression of MLH1 protein] |
CTD |
PMID:28690196 PMID:29854080 |
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mlkl |
mixed lineage kinase domain like pseudokinase |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of MLKL protein] Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of MLKL protein] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MLKL mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of MLKL protein]]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased phosphorylation of MLKL protein] |
CTD |
PMID:30378427 PMID:35833596 PMID:36000575 PMID:37678662 |
|
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[[[15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of and results in increased activity of HMOX1 protein] which results in increased abundance of Iron] which results in increased abundance of Reactive Oxygen Species] which results in increased expression of MMP1 protein]; Acetylcysteine inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of MMP1 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of MMP1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of MMP1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of MMP1 mRNA] |
CTD |
PMID:17449795 PMID:19136476 PMID:21635667 PMID:29731195 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP10 protein] |
CTD |
PMID:17395008 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Ethanol results in increased expression of MMP12 mRNA] |
CTD |
PMID:23978445 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP13 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP13 protein]] |
CTD |
PMID:17395008 PMID:34791735 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases activity |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP2 mRNA] Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP2 protein]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [tomentosin results in decreased activity of MMP2 protein] Acetylcysteine results in decreased activity of MMP2 protein |
CTD |
PMID:15451797 PMID:15962302 PMID:16213474 PMID:21540248 PMID:21635667 PMID:30917517 PMID:36493885 More...
|
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp25 |
matrix metallopeptidase 25 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of MMP25 mRNA] |
CTD |
PMID:21635667 |
|
NCBI chr10:12,661,297...12,676,119
Ensembl chr10:12,661,208...12,675,871
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP3 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP3 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP3 protein]] |
CTD |
PMID:17395008 PMID:34791735 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of MMP7 protein]; Acetylcysteine inhibits the reaction [Tretinoin results in increased expression of MMP7 mRNA] |
CTD |
PMID:17928719 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Chlorine results in decreased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of MMP9 mRNA] Acetylcysteine results in decreased activity of MMP9 protein [Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [RELA protein binds to MMP9 promoter]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] |
CTD |
PMID:15451797 PMID:15557194 PMID:15962302 PMID:16213474 PMID:16251475 PMID:17015178 PMID:17603938 PMID:18930813 PMID:19350554 PMID:19371603 PMID:19962414 PMID:21051528 PMID:23774252 PMID:26514923 PMID:30766661 PMID:33437163 PMID:35065218 More...
|
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Moap1 |
modulator of apoptosis 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of MOAP1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 6:121,882,565...121,884,500
Ensembl chr 6:121,882,366...121,898,643
|
|
G |
Mov10l1 |
Mov10 like RNA helicase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MOV10L1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:120,070,171...120,135,406
Ensembl chr 7:120,070,135...120,134,765
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO EXP |
[MPO protein co-treated with XDH protein co-treated with Acetaldehyde] promotes the reaction [Serotonin binds to Acetylcysteine]; Acetylcysteine promotes the reaction [[MPO protein results in increased oxidation of dibromoacetonitrile] which results in increased chemical synthesis of Cyanides]; Acetylcysteine promotes the reaction [MPO protein results in increased oxidation of dibromoacetonitrile] Acetylcysteine inhibits the reaction [arachidonyl-2-chloroethylamide results in increased activity of MPO protein] Acetylcysteine inhibits the reaction [Ethanol results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Gentamicins results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Malathion results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of MPO protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased activity of MPO protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Smoke results in increased activity of MPO protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased activity of MPO protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased activity of MPO protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased activity of MPO protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased activity of MPO protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased activity of MPO protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased activity of MPO protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased activity of MPO protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased activity of MPO protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased activity of MPO protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased activity of MPO protein]] |
CTD |
PMID:11470263 PMID:17216608 PMID:17603938 PMID:20885979 PMID:22664789 PMID:23009681 PMID:24810974 PMID:25614581 PMID:25724285 PMID:32033504 More...
|
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrap |
melanocortin 2 receptor accessory protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MRAP mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
multiple interactions |
ISO |
[Paraquat co-treated with Acetylcysteine] results in decreased expression of MRC1 mRNA; [Paraquat co-treated with Acetylcysteine] results in decreased expression of MRC1 protein |
CTD |
PMID:34863858 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Ms4a8 |
membrane spanning 4-domains A8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MS4A8A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:207,730,665...207,744,260
Ensembl chr 1:207,730,665...207,744,324
|
|
G |
Msgn1 |
mesogenin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MSGN1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:33,912,787...33,913,427
Ensembl chr 6:33,912,787...33,913,427
|
|
G |
Msh2 |
mutS homolog 2 |
multiple interactions |
ISO |
Acetylcysteine affects the reaction [Cadmium Chloride results in decreased expression of MSH2 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of MSH2 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite affects the expression of MSH2 protein] |
CTD |
PMID:28690196 PMID:33971260 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of MSH6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of MSH6 protein] |
CTD |
PMID:28690196 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Msrb1 |
methionine sulfoxide reductase B1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MSRB1 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
|
|
G |
Mstn |
myostatin |
decreases expression |
EXP |
Acetylcysteine results in decreased expression of MSTN mRNA; Acetylcysteine results in decreased expression of MSTN protein |
CTD |
PMID:16968467 |
|
NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP6 mRNA] |
CTD |
PMID:30104959 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of ATP8 mRNA] |
CTD |
PMID:26980303 |
|
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX1 mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of COX1 mRNA] |
CTD |
PMID:26980303 PMID:30104959 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CYTB mRNA] Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of CYTB mRNA] |
CTD |
PMID:30104959 PMID:30998386 |
|
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND1 mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ND2 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND2 mRNA] Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND2 mRNA] |
CTD |
PMID:30104959 PMID:30998386 PMID:35403558 |
|
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ND5 mRNA] Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND5 mRNA] |
CTD |
PMID:30104959 PMID:30998386 |
|
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MT1A mRNA]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT1A mRNA]]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT1A protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT1A mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT1A protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT1A mRNA]]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT1A protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT1A mRNA]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT1A protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT1A mRNA]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT1A protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased expression of MT1A mRNA]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased expression of MT1A protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT1A mRNA]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT1A protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased expression of MT1A mRNA]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased expression of MT1A protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT1A mRNA]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT1A protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT1A mRNA]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT1A protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT1A mRNA]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT1A protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT1A mRNA]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT1A protein]] |
CTD |
PMID:9152014 PMID:25724285 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of MT1E mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [gallium nitrate results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Nickel results in increased expression of MT2A mRNA] Acetylcysteine results in decreased expression of MT2A mRNA Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A protein]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A protein]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]]; Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A protein]]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A protein]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased expression of MT2A mRNA]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Paraquat results in increased expression of MT2A protein]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A protein]]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]; Acetylcysteine promotes the reaction [EUK-134 inhibits the reaction [Zinc Sulfate results in increased expression of MT2A protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A mRNA]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MT2A protein]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A protein]]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]]; EUK-134 promotes the reaction [Acetylcysteine inhibits the reaction [Zinc Sulfate results in increased expression of MT2A protein]] [MT1 protein co-treated with MT2 protein] affects the reaction [Acetylcysteine affects the susceptibility to Doxorubicin] |
CTD |
PMID:9545559 PMID:18586083 PMID:19097988 PMID:20600803 PMID:25724285 PMID:33188856 More...
|
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] Acetylcysteine inhibits the reaction [Paraquat results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Zearalenone results in decreased phosphorylation of MTOR protein] Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of MTOR mRNA]; Acetylcysteine inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Biological Products results in decreased expression of MTOR protein modified form]; Acetylcysteine inhibits the reaction [butein results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Butyric Acid results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Cannabidiol results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Estradiol results in increased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [ginsenoside Rk1 results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Patulin results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:21195169 PMID:23000059 PMID:26804764 PMID:27106530 PMID:28025121 PMID:28219700 PMID:28600122 PMID:29604266 PMID:30797898 PMID:31368586 PMID:31982503 PMID:33002460 PMID:35130734 PMID:35430258 PMID:36709824 PMID:36810933 PMID:37148176 More...
|
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MTR mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MUC5AC mRNA]; Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MUC5AC protein]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC mRNA]; Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MUC5AC protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of MUC5AC mRNA] |
CTD |
PMID:10640773 PMID:20709182 PMID:25177032 PMID:31622892 PMID:33421718 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in increased expression of MUC5B mRNA]; Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in increased expression of MUC5B protein] |
CTD |
PMID:31622892 |
|
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
|
|
G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MUC6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Dieldrin inhibits the reaction [Poly I-C results in increased expression of MX1 mRNA]] |
CTD |
PMID:34051100 |
|
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [5-nitroso-8-quinolinol results in decreased expression of MYC protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with Cisplatin] results in decreased expression of MYC protein]; Acetylcysteine inhibits the reaction [Hydrocarbons, Chlorinated analog results in increased expression of MYC protein]; Acetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of MYC protein] Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYC mRNA]; Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of MYC mRNA]; Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of MYC mRNA] |
CTD |
PMID:15945272 PMID:16497787 PMID:21600978 PMID:22129741 PMID:24355586 PMID:29944906 PMID:33797725 More...
|
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mycbpap |
Mycbp associated protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MYCBPAP mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYCBPAP mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
ISO |
[Particulate Matter co-treated with Acetylcysteine co-treated with Polymyxin B] results in increased secretion of MYD88 protein; [Particulate Matter co-treated with Acetylcysteine] results in increased secretion of MYD88 protein; Acetylcysteine inhibits the reaction [benzanthrone results in increased expression of MYD88 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of MYD88 mRNA]; MYD88 protein affects the reaction [[Acetylcysteine co-treated with Particulate Matter] results in increased secretion of CCL3 protein]; MYD88 protein affects the reaction [[Particulate Matter co-treated with Acetylcysteine co-treated with Polymyxin B] results in increased secretion of MYD88 protein]; MYD88 protein affects the reaction [[Particulate Matter co-treated with Acetylcysteine] results in increased secretion of MYD88 protein]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CXCL1 protein]]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of IL6 protein]]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]] Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of MYD88 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MYD88 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of MYD88 protein]] |
CTD |
PMID:28495615 PMID:28555929 PMID:36055550 PMID:37369159 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Myh3 |
myosin heavy chain 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Indican results in decreased expression of MYH3 protein] |
CTD |
PMID:29380555 |
|
NCBI chr10:51,770,177...51,793,994
Ensembl chr10:51,770,177...51,793,992
|
|
G |
Myog |
myogenin |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MYOG mRNA Acetylcysteine inhibits the reaction [Indican results in decreased expression of MYOG protein] |
CTD |
PMID:22129741 PMID:29380555 |
|
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
|
|
G |
Nanog |
Nanog homeobox |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NANOG protein] |
CTD |
PMID:32745510 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Nbn |
nibrin |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein]] |
CTD |
PMID:15489221 |
|
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
|
|
G |
Ncam2 |
neural cell adhesion molecule 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NCAM2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
decreases expression multiple interactions |
EXP ISO |
Acetylcysteine results in decreased expression of NCF1 protein Acetylcysteine inhibits the reaction [Aldrin results in increased expression of NCF1 mRNA]; Acetylcysteine inhibits the reaction [alpha-hexachlorocyclohexane results in increased expression of NCF1 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NCF1 mRNA]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of NCF1 mRNA] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF1 protein] |
CTD |
PMID:21195169 PMID:28273962 PMID:29087013 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
decreases expression multiple interactions |
EXP |
Acetylcysteine results in decreased expression of NCF2 protein Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF2 protein] |
CTD |
PMID:21195169 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ncf4 |
neutrophil cytosolic factor 4 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein] Acetylcysteine results in decreased expression of NCF4 protein |
CTD |
PMID:21195169 |
|
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of NCOA4 protein] |
CTD |
PMID:32687844 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Galactosamine results in decreased expression of NDUFB6 mRNA] Acetylcysteine results in increased expression of NDUFB6 protein |
CTD |
PMID:19523936 |
|
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
increases expression |
ISO |
Acetylcysteine results in increased expression of NDUFS7 protein |
CTD |
PMID:19523936 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of NEDD9 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Nefh |
neurofilament heavy chain |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of NEFH protein] |
CTD |
PMID:26079211 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nefl |
neurofilament light chain |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] |
CTD |
PMID:31969611 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nek4 |
NIMA-related kinase 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:6,144,900...6,185,376
Ensembl chr16:6,144,959...6,188,932
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
Acetylcysteine affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]]; Acetylcysteine affects the reaction [sodium arsenite affects the expression of NFATC1 protein] |
CTD |
PMID:30742845 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nfatc3 |
nuclear factor of activated T-cells 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Arsenic affects the localization of NFATC3 protein] |
CTD |
PMID:31822296 |
|
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of NFE2 mRNA]; Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA] |
CTD |
PMID:10656287 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression increases expression affects localization |
ISO EXP |
[6-formylindolo(3,2-b)carbazole co-treated with Acetylcysteine] results in decreased expression of NFE2L2 mRNA; [Acetylcysteine co-treated with Particulate Matter] results in decreased expression of NFE2L2 mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NFE2L2 mRNA]]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NFE2L2 protein]]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter analog affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog affects the localization of NFE2L2 protein] Acetylcysteine results in decreased expression of NFE2L2 mRNA Acetylcysteine results in increased expression of NFE2L2 mRNA; Acetylcysteine results in increased expression of NFE2L2 protein Acetylcysteine affects the localization of NFE2L2 protein Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [[Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Ammonium Chloride results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [dimethoxyethyl phthalate results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of and affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of NFE2L2 promoter]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]]; Acetylcysteine inhibits the reaction [Indomethacin results in increased localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine inhibits the reaction [NFE2L2 protein affects the susceptibility to Silver]; Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Silver analog results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HSF1 promoter]]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to NQO1 promoter]]; Acetylcysteine inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased phosphorylation of and results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NFE2L2 protein] [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein]; [Particulate Matter co-treated with Acetylcysteine] results in increased expression of NFE2L2 protein; Acetylcysteine affects the reaction [yttrium chloride affects the expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [aureusidin affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [decamethrin affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased activity of NFE2L2 protein]; Acetylcysteine inhibits the reaction [decamethrin results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [ferrous sulfate affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in decreased expression of NFE2L2 mRNA]; Acetylcysteine inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [triptolide affects the expression of NFE2L2 protein]; Acetylcysteine promotes the reaction [Acrylamide results in increased expression of and affects the localization of NFE2L2 protein]; Acetylcysteine promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]; Sodium Fluoride promotes the reaction [Acetylcysteine affects the localization of NFE2L2 protein] |
CTD |
PMID:11909699 PMID:15322212 PMID:16631525 PMID:16806455 PMID:16959797 PMID:17540521 PMID:17959236 PMID:17979524 PMID:17980396 PMID:18156441 PMID:19033392 PMID:19234301 PMID:19350554 PMID:20851755 PMID:21384399 PMID:21643505 PMID:21728338 PMID:21787718 PMID:22019695 PMID:22129741 PMID:22546375 PMID:22564156 PMID:24126012 PMID:24157283 PMID:24355171 PMID:24361488 PMID:24489685 PMID:24634002 PMID:25003661 PMID:25169008 PMID:25263748 PMID:25341683 PMID:25568320 PMID:26079211 PMID:26163453 PMID:26291278 PMID:27867098 PMID:27917510 PMID:28583816 PMID:28807874 PMID:29061315 PMID:29155359 PMID:29426002 PMID:29792947 PMID:29966676 PMID:30104959 PMID:30309986 PMID:30633982 PMID:30742845 PMID:30965051 PMID:31790703 PMID:33797725 PMID:33930485 PMID:34036678 PMID:34214916 PMID:34358621 PMID:35088107 PMID:35123993 PMID:35285579 PMID:35430258 PMID:36786954 PMID:36813253 PMID:37257343 PMID:37353053 PMID:37369159 PMID:37598416 PMID:37692514 More...
|
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NFIL3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of NFKB1 protein]] Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKB1 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NFKB1 mRNA] Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [Norepinephrine affects the localization of NFKB1 protein]; Acetylcysteine inhibits the reaction [phosphoaspirin results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [Sulindac analog results in decreased activity of NFKB1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of NFKB1 protein]; Acetylcysteine inhibits the reaction [Zinc deficiency affects the localization of NFKB1 protein] |
CTD |
PMID:11970852 PMID:18922898 PMID:19642688 PMID:21600978 PMID:21741372 PMID:23114885 PMID:24394546 PMID:25845326 PMID:30259999 PMID:31068539 PMID:32402895 More...
|
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFKB2 protein]] |
CTD |
PMID:19642688 |
|
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions affects expression decreases degradation |
ISO EXP |
Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein] Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased degradation of NFKBIA protein]; Acetylcysteine inhibits the reaction [ferrous sulfate results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of NFKBIA protein] Acetylcysteine affects the expression of NFKBIA protein Acetylcysteine results in decreased degradation of NFKBIA protein Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in increased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of NFKBIA protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [cryptotanshinone results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [piperlongumine analog inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]]; NFKBIA protein affects the reaction [Acetylcysteine results in decreased susceptibility to hydroxyethyl methacrylate] |
CTD |
PMID:10636889 PMID:10921504 PMID:15949477 PMID:16214328 PMID:18404532 PMID:19176594 PMID:21741372 PMID:25845326 PMID:28583816 PMID:28600121 PMID:31518571 PMID:33030807 PMID:35122928 PMID:35285579 PMID:37369159 More...
|
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [oenothein B results in decreased phosphorylation of NFKBIB protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in decreased phosphorylation of NFKBIB protein] |
CTD |
PMID:10381628 PMID:30452899 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [NGF protein results in increased localization of and results in increased activity of PRKCE protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [NGF protein results in increased phosphorylation of MAPK3 protein] Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of NGF mRNA] |
CTD |
PMID:16603213 PMID:18375950 PMID:23472850 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlgn3 |
neuroligin 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NLGN3 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NLGN3 promoter]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased methylation of NLGN3 promoter] |
CTD |
PMID:27624276 |
|
NCBI chr X:66,427,926...66,457,378
Ensembl chr X:66,429,458...66,451,876
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of NLRP3 mRNA]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [APP protein results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of NLRP3 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of and results in decreased ubiquitination of NLRP3 protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]] Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 mRNA] Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of NLRP3 mRNA]; Acetylcysteine inhibits the reaction [Aluminum Chloride results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NLRP3 protein] Acetylcysteine results in increased expression of NLRP3 mRNA; Acetylcysteine results in increased expression of NLRP3 protein |
CTD |
PMID:24885895 PMID:26086368 PMID:26435000 PMID:26901245 PMID:28004443 PMID:28814068 PMID:30205151 PMID:30259999 PMID:30878009 PMID:30977640 PMID:34217685 PMID:34238121 PMID:34510229 PMID:34791735 PMID:35190838 PMID:36055550 PMID:36347317 PMID:36354081 PMID:36646296 PMID:37300869 PMID:37393521 PMID:37692514 More...
|
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [[ferric ammonium citrate co-treated with Buthionine Sulfoximine] results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [nickel chloride results in decreased expression of NOS2 mRNA] Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [mancozeb results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [orazipone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of NOS2 protein] Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 protein] |
CTD |
PMID:7532384 PMID:9826428 PMID:9918918 PMID:16140881 PMID:18039960 PMID:18830972 PMID:19642688 PMID:21237301 PMID:21741372 PMID:22227475 PMID:23159886 PMID:23268108 PMID:23624824 PMID:23900960 PMID:24239652 PMID:25406100 PMID:30037311 PMID:30259999 PMID:34863858 PMID:37369159 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases expression |
EXP ISO |
Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS3 protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]] Acetylcysteine inhibits the reaction [Aldrin results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [alpha-hexachlorocyclohexane results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA]; Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [TNF results in decreased expression of NOS3 protein] Acetylcysteine results in increased expression of NOS3 protein |
CTD |
PMID:16140881 PMID:17026986 PMID:17321519 PMID:19837105 PMID:21912612 PMID:26906511 PMID:28273962 More...
|
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of NOX1 mRNA] |
CTD |
PMID:16213474 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [mancozeb results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of AIF1 protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of CS protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of HK2 protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL6 protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of PKM protein]]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [salubrinal results in increased expression of [Cisplatin results in increased expression of NOX4 protein]] Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NOX4 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NOX4 protein] |
CTD |
PMID:21131394 PMID:21616140 PMID:24224404 PMID:30037311 PMID:36762617 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NPAS2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Npff |
neuropeptide FF-amide peptide precursor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NPFF mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NPFF mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 7:133,654,530...133,655,319
|
|
G |
Npm1 |
nucleophosmin 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to arsenic trioxide]; Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Bortezomib] |
CTD |
PMID:23877794 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO EXP |
[Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] which results in decreased expression of NQO1 mRNA; Acetylcysteine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Aspirin analog results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [NQO1 protein results in increased susceptibility to 9,10-phenanthrenequinone]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter analog results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to NQO1 promoter]]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of NQO1 mRNA]; NQO1 protein promotes the reaction [Acetylcysteine results in decreased susceptibility to 9,10-phenanthrenequinone] Acetylcysteine results in increased expression of NQO1 mRNA; Acetylcysteine results in increased expression of NQO1 protein [Acetylcysteine co-treated with Sodium Fluoride] results in increased expression of NQO1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 protein]; Acetylcysteine promotes the reaction [Sodium Fluoride results in increased expression of NQO1 protein] [Acetylcysteine co-treated with chromium trioxide] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NQO1 protein]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NQO1 mRNA]]; Acetylcysteine inhibits the reaction [Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of NQO1 protein]]; Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased activity of NQO1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of NQO1 mRNA]; Acetylcysteine promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 protein] |
CTD |
PMID:12730081 PMID:15044633 PMID:16274885 PMID:16920990 PMID:19033392 PMID:21533816 PMID:21569840 PMID:22129741 PMID:22925602 PMID:23035985 PMID:24489685 PMID:24646717 PMID:25003661 PMID:25341683 PMID:25980575 PMID:26600472 PMID:29108775 PMID:30104959 PMID:30309986 PMID:30633982 PMID:30951941 PMID:31029725 PMID:32525552 PMID:35430258 PMID:37353053 PMID:37598416 More...
|
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr2e3 |
nuclear receptor subfamily 2, group E, member 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Benzo(a)pyrene results in decreased expression of NR2E3 protein] |
CTD |
PMID:26149760 |
|
NCBI chr 8:60,365,581...60,373,383
Ensembl chr 8:60,366,124...60,373,163
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of NR3C1 mRNA Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of NR3C1 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of NR3C1 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of NR3C1 mRNA] |
CTD |
PMID:16084531 PMID:25617244 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of NR3C2 mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of NR3C2 mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of NR3C2 mRNA] |
CTD |
PMID:25617244 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA] |
CTD |
PMID:21775390 PMID:26980303 PMID:35403558 PMID:36493885 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Nrxn1 |
neurexin 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRXN1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NRXN1 promoter]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased methylation of NRXN1 promoter] |
CTD |
PMID:27624276 |
|
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
|
|
G |
Ntf3 |
neurotrophin 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NTF3 protein] |
CTD |
PMID:26138014 |
|
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
|
|
G |
Nthl1 |
nth-like DNA glycosylase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of NTHL1 mRNA] |
CTD |
PMID:16137721 |
|
NCBI chr10:13,655,791...13,661,958
Ensembl chr10:13,655,785...13,661,957
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of NTRK1 protein]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased phosphorylation of and results in increased activity of NTRK1 protein] |
CTD |
PMID:23472850 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NTRK2 protein] |
CTD |
PMID:28499986 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nuak2 |
NUAK family kinase 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUAK2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
multiple interactions |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUPR1 mRNA Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NUPR1 mRNA] |
CTD |
PMID:22129741 PMID:31319114 |
|
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
|
|
G |
Ocln |
occludin |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of OCLN protein] Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of OCLN protein] Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OCLN mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OCLN protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of OCLN mRNA] |
CTD |
PMID:29235125 PMID:32683294 PMID:32687961 PMID:33485121 PMID:34906888 PMID:37598416 More...
|
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Oga |
O-GlcNAcase |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of OGA mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of OLR1 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of OLR1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of OLR1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of OLR1 protein] Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of OLR1 protein] |
CTD |
PMID:16055083 PMID:24145059 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Olr1093 |
olfactory receptor 1093 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR1093 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:12,575,398...12,576,354
Ensembl chr 7:12,574,956...12,587,973
|
|
G |
Olr1451 |
olfactory receptor 1451 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR1451 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:43,429,140...43,430,069
Ensembl chr10:43,424,036...43,432,210
|
|
G |
Olr1481 |
olfactory receptor 1481 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR1481 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:58,237,886...58,238,830
Ensembl chr10:58,235,688...58,239,281
|
|
G |
Olr59 |
olfactory receptor 59 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR59 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Omg |
oligodendrocyte-myelin glycoprotein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OMG mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:64,461,350...64,464,084
Ensembl chr10:64,461,350...64,464,084
|
|
G |
Opa1 |
OPA1, mitochondrial dynamin like GTPase |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form]; Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 results in increased ubiquitination of OPA1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein] Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of OPA1 protein] |
CTD |
PMID:20678484 PMID:37084995 PMID:37499777 |
|
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
|
|
G |
Or10al5b |
olfactory receptor family 10 subfamily AL member 5B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR10AL5B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr20:798,038...810,925
Ensembl chr20:734,965...811,125
|
|
G |
Or1f30 |
olfactory receptor family 1 subfamily F member 30 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR1F30 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:12,483,032...12,483,973
Ensembl chr10:12,481,906...12,484,513
|
|
G |
Or2ak5f |
olfactory receptor family 2 subfamily AK member 5F |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR2AK6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:43,269,046...43,269,960
Ensembl chr10:43,289,142...43,290,062
|
|
G |
Or2t48e |
olfactory receptor family 2 subfamily T member 48E |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR2T48E mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:42,690,368...42,691,297
Ensembl chr10:42,689,609...42,701,405
|
|
G |
Or4a77d |
olfactory receptor family 4 subfamily A member 77D |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4A77D mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:75,796,815...75,797,765
Ensembl chr 3:75,796,364...75,801,803
|
|
G |
Or4c105b |
olfactory receptor family 4 subfamily C member 105B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4C105B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:74,458,280...74,459,209
Ensembl chr 3:74,455,596...74,467,433
|
|
G |
Or4f4b |
olfactory receptor family 4 subfamily F member 4B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4F4B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:98,058,061...98,061,955
|
|
G |
Or4p20b |
olfactory receptor family 4 subfamily P member 20B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4P20B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:74,022,169...74,023,089
Ensembl chr 3:74,022,169...74,023,089
|
|
G |
Or4s2 |
olfactory receptor family 4 subfamily S member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4S2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:74,377,492...74,378,427
Ensembl chr 3:74,375,165...74,381,097
|
|
G |
Or51i2 |
olfactory receptor family 51 subfamily I member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR51I2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:158,513,673...158,514,611
Ensembl chr 1:158,513,673...158,514,611
|
|
G |
Or5as1 |
olfactory receptor family 5 subfamily AS member 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR5AS1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:72,324,043...72,324,981
Ensembl chr 3:72,323,706...72,326,585
|
|
G |
Or6d13c |
olfactory receptor family 6 subfamily D member 13C |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR6D13C mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:149,752,294...149,753,277
Ensembl chr 4:149,750,101...149,754,458
|
|
G |
Or8g2c |
olfactory receptor family 8 subfamily G member 2C |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR8G2C mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:40,226,318...40,227,241
Ensembl chr 8:40,223,812...40,227,610
|
|
G |
Ormdl3 |
ORMDL sphingolipid biosynthesis regulator 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Benomyl results in increased expression of ORMDL3 protein] |
CTD |
PMID:27784618 |
|
NCBI chr10:83,590,052...83,596,035
Ensembl chr10:83,590,071...83,598,620
|
|
G |
Oser1 |
oxidative stress responsive serine-rich 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of OSER1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr 3:152,066,975...152,085,180
Ensembl chr 3:152,066,975...152,085,149
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of OSGIN1 protein] |
CTD |
PMID:28807874 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Otoa |
otoancorin |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OTOA mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:175,642,978...175,710,528
Ensembl chr 1:175,642,975...175,710,435
|
|
G |
P2rx2 |
purinergic receptor P2X 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]]; Acetylcysteine inhibits the reaction [Rotenone promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]] |
CTD |
PMID:19793987 |
|
NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
|
|
G |
P2rx5 |
purinergic receptor P2X 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of P2RX5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
|
|
G |
Pak6 |
p21 (RAC1) activated kinase 6 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAK6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:105,638,248...105,674,399
Ensembl chr 3:105,638,653...105,672,975
|
|
G |
Paqr9 |
progestin and adipoQ receptor family member 9 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAQR9 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:96,114,249...96,116,546
|
|
G |
Park7 |
Parkinsonism associated deglycase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased oxidation of PARK7 protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased oxidation of PARK7 protein]; Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Quinones binds to PARK7 protein]]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of PARK7 protein] |
CTD |
PMID:18377993 PMID:20851755 PMID:32540572 PMID:34897981 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage decreases expression multiple interactions |
ISO EXP |
Acetylcysteine results in increased cleavage of PARP1 protein Acetylcysteine results in decreased expression of PARP1 protein modified form Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Gentamicins results in increased activity of PARP1 protein] [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]; [Acetylcysteine results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] which results in increased cleavage of PARP1 protein; [Glucose deficiency co-treated with Acetylcysteine] results in increased cleavage of PARP1 protein; Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [4-chromone analog results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [[Berberine co-treated with Cisplatin] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [ABBV-744 results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of PARP1 mRNA]; Acetylcysteine inhibits the reaction [Acrylamide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [chloropicrin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [divinyl sulfone analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [frenolicin B results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [isoliensinine results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [manumycin results in increased cleavage of PARP1]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Morpholines analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [N-methylisoindigotin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Oligopeptides analog results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [pendulone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Plant Extracts results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [salvin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [scutebarbatine A results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [shikonin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [tomentosin results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of PARP1 protein]; Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased cleavage of PARP1 protein] Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of PARP1 protein]; Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of PARP1 protein] |
CTD |
PMID:11470263 PMID:14660655 PMID:14687664 PMID:15375156 PMID:15496615 PMID:17237268 PMID:17309078 PMID:18281123 PMID:18384088 PMID:18703135 PMID:19409983 PMID:19536524 PMID:19679660 PMID:20674558 PMID:20981856 PMID:21031461 PMID:21565247 PMID:22002103 PMID:22172632 PMID:22578287 PMID:22714038 PMID:22733624 PMID:22909951 PMID:22922937 PMID:23082001 PMID:23405080 PMID:23711929 PMID:24036456 PMID:24100277 PMID:24157283 PMID:24373880 PMID:24463199 PMID:24614525 PMID:24634002 PMID:24875536 PMID:25034532 PMID:25246272 PMID:25619640 PMID:25824409 PMID:25845326 PMID:25939952 PMID:25940438 PMID:25972196 PMID:26203587 PMID:26219228 PMID:26887594 PMID:27106530 PMID:27539140 PMID:27634458 PMID:27658547 PMID:28087840 PMID:28237877 PMID:28548367 PMID:28918123 PMID:29111403 PMID:29111459 PMID:29248572 PMID:29479036 PMID:29774349 PMID:29800641 PMID:29944906 PMID:30256521 PMID:30408460 PMID:30661989 PMID:30796935 PMID:30871965 PMID:30917517 PMID:31157515 PMID:31313457 PMID:31330229 PMID:31408635 PMID:31433961 PMID:31884112 PMID:32662599 PMID:33002460 PMID:33971260 PMID:34599545 PMID:34627931 PMID:35288263 PMID:35396826 PMID:36070022 PMID:37072049 PMID:37769529 PMID:38042493 More...
|
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased expression of PCK1 mRNA] |
CTD |
PMID:25449180 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Dopamine results in decreased expression of PCMT1 mRNA]; Acetylcysteine inhibits the reaction [Dopamine results in decreased expression of PCMT1 protein] |
CTD |
PMID:24631677 |
|
NCBI chr 1:2,111,756...2,160,354
Ensembl chr 1:2,111,763...2,159,201
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of PCNA protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased activity of PCNA protein] Acetylcysteine inhibits the reaction [Glyphosate results in increased expression of PCNA protein] |
CTD |
PMID:31551408 PMID:33485121 PMID:33797725 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd4 |
programmed cell death 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[tungsten carbide analog co-treated with Cobalt analog] results in decreased expression of PDCD4 protein] Acetylcysteine inhibits the reaction [chromium hexavalent ion results in decreased expression of PDCD4 mRNA] |
CTD |
PMID:23758151 PMID:27323401 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdcd6ip |
programmed cell death 6 interacting protein |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [hesperetin results in decreased expression of PDCD6IP protein] |
CTD |
PMID:37487865 |
|
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
|
|
G |
Pde6b |
phosphodiesterase 6B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PDE6B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:1,323,310...1,366,450
Ensembl chr14:1,323,310...1,366,450
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Nickel analog promotes the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]]; Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of HIF1A protein]] Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PDGFB protein] |
CTD |
PMID:22700867 PMID:26138014 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of PDGFRB mRNA] Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA]; Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB mRNA]]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of PDGFRB protein]] |
CTD |
PMID:21134390 PMID:23392711 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pdha1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [epigallocatechin gallate results in decreased expression of PDHA1 mRNA]; Acetylcysteine inhibits the reaction [epigallocatechin gallate results in decreased expression of PDHA1 protein] |
CTD |
PMID:31857147 |
|
NCBI chr X:34,700,481...34,714,309
Ensembl chr X:34,700,409...34,714,311
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PDK1 mRNA]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PDK1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PDK1 mRNA]; Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of PDK1 protein]; Acetylcysteine inhibits the reaction [DDT results in increased expression of PDK1 mRNA] |
CTD |
PMID:17171638 PMID:30821169 PMID:31251971 PMID:31724279 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PDK4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdlim5 |
PDZ and LIM domain 5 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of PDLIM5 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PEX11A mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PEX11A mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases activity |
EXP |
Acetylcysteine results in increased activity of PGD protein |
CTD |
PMID:3099627 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pgr |
progesterone receptor |
multiple interactions decreases secretion |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of PGR mRNA] Acetylcysteine results in decreased secretion of PGR protein Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PGR mRNA]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of PGR protein] |
CTD |
PMID:18829485 PMID:21220312 PMID:30648648 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
increases expression |
ISO |
Acetylcysteine results in increased expression of PIGA mRNA |
CTD |
PMID:16084531 |
|
NCBI chr X:30,043,033...30,055,861
Ensembl chr X:30,042,343...30,055,804
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
ISO |
Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]] |
CTD |
PMID:28836394 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIM1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
|
|
G |
Pim2 |
Pim-2 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
Acetylcysteine results in increased expression of PIM2 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr X:14,617,582...14,622,851
Ensembl chr X:14,617,582...14,622,851
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased expression of PINK1 protein] Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of PINK1 mRNA] Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein] |
CTD |
PMID:25464205 PMID:29567065 PMID:34547296 PMID:34816377 PMID:37678662 PMID:37692514 More...
|
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pip |
prolactin induced protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIP mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:70,787,627...70,791,921
Ensembl chr 4:70,787,627...70,791,921
|
|
G |
Pirb |
paired Ig-like receptor B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LILRB3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:65,499,195...65,506,666
Ensembl chr 1:65,499,195...65,506,666
|
|
G |
Piwil4 |
piwi-like RNA-mediated gene silencing 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIWIL4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:11,536,520...11,579,883
Ensembl chr 8:11,536,520...11,579,761
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of PKM protein]]; Acetylcysteine inhibits the reaction [quinone results in increased degradation of PKM protein] Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM mRNA]; Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM protein]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PKM protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]; Acetylcysteine inhibits the reaction [DDT results in increased expression of and affects the localization of PKM protein alternative form]; Acetylcysteine inhibits the reaction [DDT results in increased expression of PKM mRNA alternative form] |
CTD |
PMID:25437431 PMID:28284859 PMID:30821169 PMID:31251971 PMID:31724279 PMID:36762617 More...
|
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PLA2G4A mRNA] |
CTD |
PMID:15683734 PMID:16603213 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of PLAU mRNA Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased secretion of PLAU protein] |
CTD |
PMID:15962302 PMID:16084531 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Nicotine results in increased expression of PLAUR mRNA] |
CTD |
PMID:22261521 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Pld1 |
phospholipase D1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] |
CTD |
PMID:17640750 |
|
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] |
CTD |
PMID:17640750 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Plin2 |
perilipin 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLIN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plppr1 |
phospholipid phosphatase related 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLPPR1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:63,437,457...63,725,286
Ensembl chr 5:63,437,816...63,763,835
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2-xylene results in increased expression of PMAIP1 mRNA]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of PMAIP1 mRNA]; Acetylcysteine inhibits the reaction [elesclomol results in increased expression of PMAIP1 mRNA]; Acetylcysteine inhibits the reaction [Toluene results in increased expression of PMAIP1 mRNA] |
CTD |
PMID:18723479 PMID:21144877 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of PNPLA3 mRNA] |
CTD |
PMID:21051528 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Pnpla5 |
patatin-like phospholipase domain containing 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PNPLA5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:115,246,050...115,257,039
Ensembl chr 7:115,246,050...115,257,039
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PNRC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Polr1c |
RNA polymerase I and III subunit C |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Paraquat results in decreased methylation of POLR1C mRNA] |
CTD |
PMID:34425375 |
|
NCBI chr 9:14,735,740...14,739,852
Ensembl chr 9:14,735,714...14,739,852
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [POMC protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein]] |
CTD |
PMID:24412703 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
EXP |
Acetylcysteine affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of PON1 protein] |
CTD |
PMID:23644946 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pon2 |
paraoxonase 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [iron(II)-ascorbic acid complex results in increased expression of PON2 protein] |
CTD |
PMID:17916643 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Postn |
periostin |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of POSTN mRNA |
CTD |
PMID:32947957 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [decabromobiphenyl ether results in decreased expression of POU5F1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of POU5F1 protein] |
CTD |
PMID:26206603 PMID:32745510 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
EXP ISO |
Acetylcysteine results in increased expression of PPARG mRNA; Acetylcysteine results in increased expression of PPARG protein Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]; Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein] Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] Acetylcysteine inhibits the reaction [yttrium chloride results in decreased expression of PPARG protein]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein] |
CTD |
PMID:16945329 PMID:17602960 PMID:22046279 PMID:23964924 PMID:27117918 PMID:35088107 More...
|
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Flavonoids results in increased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of PPARGC1A protein] Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of PPARGC1A mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1A mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARGC1A protein]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of PPARGC1A mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of PPARGC1A mRNA] |
CTD |
PMID:21775390 PMID:23063593 PMID:26980303 PMID:30104959 PMID:30641872 PMID:35403558 PMID:36493885 PMID:37084995 More...
|
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppargc1b |
PPARG coactivator 1 beta |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1B mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPARGC1B protein] |
CTD |
PMID:36493885 |
|
NCBI chr18:54,758,891...54,861,103
Ensembl chr18:54,758,902...54,861,194
|
|
G |
Ppbp |
pro-platelet basic protein |
multiple interactions |
ISO |
Acetylcysteine promotes the reaction [Cadmium Chloride results in decreased secretion of PPBP protein] |
CTD |
PMID:26138014 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA] Acetylcysteine inhibits the reaction [arsenite promotes the reaction [TARDBP protein binds to PPP1R15A protein]] |
CTD |
PMID:24291486 PMID:29109149 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased methylation of and results in increased phosphorylation of PPP2CA protein] |
CTD |
PMID:18703135 |
|
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein] |
CTD |
PMID:18703135 |
|
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
|
|
G |
Ppp5c |
protein phosphatase 5, catalytic subunit |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP5C protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPP5C protein] |
CTD |
PMID:18703135 PMID:19038359 |
|
NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:77,690,208...77,714,456
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[frenolicin B results in decreased activity of PRDX1 protein] which results in increased abundance of Reactive Oxygen Species] |
CTD |
PMID:30661989 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx3 |
peroxiredoxin 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Thiostrepton affects the expression of PRDX3 protein modified form] |
CTD |
PMID:22761781 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of PRDX5 protein]] |
CTD |
PMID:29753072 |
|
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Prh1 |
proline rich protein HaeIII subfamily 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PRH1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:166,543,755...166,547,614
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of PRKAA1 protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of PRKAA1 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of PRKAA1 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of PRKAA1 mRNA]; Acetylcysteine inhibits the reaction [Quercetin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; Acetylcysteine inhibits the reaction [Quercetin results in increased phosphorylation of PRKAA1 protein]; Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased phosphorylation of PRKAA1 protein] |
CTD |
PMID:19293639 PMID:20083342 PMID:21195169 PMID:24386346 PMID:24535669 PMID:31900833 PMID:36534932 More...
|
|
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[PRKAA2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of PRDX5 protein]]; Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]] |
CTD |
PMID:29753072 |
|
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Curcumin results in increased phosphorylation of PRKCD protein]; Acetylcysteine inhibits the reaction [Ursodeoxycholic Acid results in increased localization of PRKCD protein] Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased cleavage of and results in increased phosphorylation of PRKCD protein] Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of PRKCD protein] |
CTD |
PMID:17171638 PMID:21362627 PMID:27658547 PMID:37308051 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [NGF protein results in increased localization of and results in increased activity of PRKCE protein] |
CTD |
PMID:18375950 |
|
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [usnic acid results in increased expression of PRKDC protein] Acetylcysteine results in increased expression of PRKDC protein |
CTD |
PMID:31715134 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PRKN mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PRKN]; Acetylcysteine inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of PRKN mRNA] Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PRKN mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of PRKN mRNA] Acetylcysteine inhibits the reaction [quinone results in increased expression of PRKN protein] |
CTD |
PMID:22872702 PMID:25464205 PMID:29567065 PMID:31368586 PMID:34547296 PMID:34816377 More...
|
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Prl |
prolactin |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased secretion of PRL protein] |
CTD |
PMID:27151894 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Prlr |
prolactin receptor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PRLR mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PRLR mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSAT1 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Psmd1 |
proteasome 26S subunit, non-ATPase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Paraquat results in decreased methylation of PSMD1 mRNA] |
CTD |
PMID:34425375 |
|
NCBI chr 9:86,709,714...86,785,213
Ensembl chr 9:86,709,947...86,785,211
|
|
G |
Psme4 |
proteasome activator subunit 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of PSME4 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of PTEN mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PTEN protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased degradation of and results in decreased expression of PTEN protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased degradation of and results in decreased expression of PTEN protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [PTEN gene mutant form results in increased secretion of GPT protein]] |
CTD |
PMID:21195169 PMID:24449419 PMID:27022031 PMID:35430258 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
ISO EXP |
Acetylcysteine results in decreased expression of PTGS2 mRNA Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone]; Acetylcysteine inhibits the reaction [benzanthrone results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2]; Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Endosulfan results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Humic Substances results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein]; Acetylcysteine promotes the reaction [3-methylquercetin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]] Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol] results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [[Formaldehyde co-treated with eugenol, zinc oxide dental cavity lining] results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [[IL1B protein co-treated with Oligomycins] results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [acenaphthenequinone results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Benzene results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride affects the localization of PTGS2 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [dentinol results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol] results in increased expression of PTGS2 mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]; Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Styrene results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Toluene results in increased expression of PTGS2 protein]; Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2 protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of PTGS2 protein] |
CTD |
PMID:14687664 PMID:15576159 PMID:15934011 PMID:16024921 PMID:16084531 PMID:16777358 PMID:17082565 PMID:17255567 PMID:17640750 PMID:18068289 PMID:18480072 PMID:19084589 PMID:19095747 PMID:19642688 PMID:21220312 PMID:21533553 PMID:21540248 PMID:21703343 PMID:21779360 PMID:21801798 PMID:22288910 PMID:22767315 PMID:23268108 PMID:24239652 PMID:24337631 PMID:24609059 PMID:24793810 PMID:24961358 PMID:24967690 PMID:25199686 PMID:28495310 PMID:28495615 PMID:28555929 PMID:29248572 PMID:29753051 PMID:29894800 PMID:31068539 PMID:32525552 PMID:33437163 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein] |
CTD |
PMID:17888894 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [TNF protein results in decreased phosphorylation of PTK2B protein] |
CTD |
PMID:23774252 |
|
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
|
|
G |
Ptk6 |
protein tyrosine kinase 6 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PTK6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:168,307,073...168,315,664
Ensembl chr 3:168,307,073...168,315,664
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]; Acetylcysteine inhibits the reaction [Pamidronate promotes the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]; Acetylcysteine inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein] |
CTD |
PMID:22917016 PMID:32337366 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of PYCARD protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Ethanol results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PYCARD protein]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PYCARD protein]] Acetylcysteine results in increased expression of PYCARD protein |
CTD |
PMID:26079697 PMID:26435000 PMID:30977640 PMID:34791735 PMID:36055550 PMID:36646296 More...
|
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Pygl |
glycogen phosphorylase L |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased expression of PYGL mRNA] |
CTD |
PMID:25449180 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
Rab24 |
RAB24, member RAS oncogene family |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of RAB24 protein] |
CTD |
PMID:16137721 |
|
NCBI chr17:9,308,471...9,310,553
Ensembl chr17:9,308,525...9,310,553
|
|
G |
Rab30 |
RAB30, member RAS oncogene family |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RAB30 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RAB30 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
|
|
G |
Rab7a |
RAB7A, member RAS oncogene family |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [RAB7A protein co-treated with MAP1LC3B protein]] |
CTD |
PMID:28347754 |
|
NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of RAC1 protein] Acetylcysteine results in decreased expression of RAC1 protein |
CTD |
PMID:21195169 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rac2 |
Rac family small GTPase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Resveratrol affects the localization of RAC2 protein] |
CTD |
PMID:37482209 |
|
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
|
|
G |
Rack1 |
receptor for activated C kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of RACK1 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
|
|
G |
Rad1 |
RAD1 checkpoint DNA exonuclease |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of RAD1 mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
|
|
G |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of RAD18 protein] |
CTD |
PMID:32433928 |
|
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
|
|
G |
Rad51b |
RAD51 paralog B |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of RAD51B mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
|
|
G |
Rad54l |
RAD54 like |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of RAD54L mRNA] |
CTD |
PMID:35430258 |
|
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
|
|
G |
Rad9a |
RAD9 checkpoint clamp component A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in decreased expression of RAD9A mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 1:201,488,511...201,553,582
Ensembl chr 1:201,487,136...201,553,608
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [NSC 680410 results in decreased expression of RAF1 protein] Acetylcysteine inhibits the reaction [tubocapsenolide A results in increased degradation of RAF1 protein] [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of RAF1 mRNA |
CTD |
PMID:16481037 PMID:18442981 PMID:22129741 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [5-nitroso-8-quinolinol results in decreased expression of RB1 protein modified form]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased phosphorylation of RB1 protein]; Acetylcysteine inhibits the reaction [Levamisole results in decreased expression of RB1 protein] Acetylcysteine inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of RB1 mRNA]; Acetylcysteine inhibits the reaction [Maneb results in increased expression of RB1 mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of RB1 mRNA] |
CTD |
PMID:11139434 PMID:16497787 PMID:22927544 PMID:29859004 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of REL protein] Acetylcysteine inhibits the reaction [Norepinephrine affects the localization of REL protein] |
CTD |
PMID:11970852 PMID:23114885 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases phosphorylation decreases phosphorylation increases activity increases glutathionylation |
ISO EXP |
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RELA mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [[PRKAA2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [endotoxin, Escherichia coli affects the localization of and results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELA mRNA]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; Acetylcysteine promotes the reaction [Particulate Matter results in decreased phosphorylation of RELA protein] Acetylcysteine results in increased phosphorylation of RELA protein Acetylcysteine results in decreased phosphorylation of RELA protein Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of and results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of and affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [ferrous sulfate affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [RELA protein binds to MMP9 promoter]; Acetylcysteine inhibits the reaction [Smoke affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein affects the localization of RELA protein] [Acetylcysteine co-treated with oenothein B] results in decreased phosphorylation of RELA protein; [Acetylcysteine co-treated with TNF protein] results in decreased activity of RELA protein; Acetylcysteine affects the localization of and results in increased activity of RELA protein; Acetylcysteine affects the reaction [[manganese chloride results in increased abundance of Manganese] which affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of RELA protein]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [acenaphthenequinone results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [APP protein affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Chloroquine results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [chrysin results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [cryptotanshinone affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Fenbendazole analog results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Fenbendazole results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate affects the localization of and results in decreased activity of RELA protein]; Acetylcysteine inhibits the reaction [IL1B promotes the reaction [EP300 protein binds to RELA protein]]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [Imatinib Mesylate results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased phosphorylation of RELA protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [mancozeb affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Norepinephrine affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [saikosaponin D results in increased acetylation of RELA protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of RELA protein modified form]; Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of RELA protein]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased activity of RELA protein] Acetylcysteine results in increased activity of RELA protein Acetylcysteine results in increased glutathionylation of RELA protein |
CTD |
PMID:7491977 PMID:8760145 PMID:11970852 PMID:15139008 PMID:17925309 PMID:18457675 PMID:19095747 PMID:19176594 PMID:19281832 PMID:19608869 PMID:19760616 PMID:20116392 PMID:20351055 PMID:21533553 PMID:21741372 PMID:22664789 PMID:22704995 PMID:23114885 PMID:23755222 PMID:23774252 PMID:24961358 PMID:25845326 PMID:25876056 PMID:25972196 PMID:27235710 PMID:27393034 PMID:28004443 PMID:28115242 PMID:28495310 PMID:28583816 PMID:28600121 PMID:29087013 PMID:29329563 PMID:29426002 PMID:29753072 PMID:30452899 PMID:31068539 PMID:32687961 PMID:34171359 PMID:34310962 PMID:34510229 PMID:34890707 PMID:35122928 PMID:35190838 PMID:35285579 PMID:35349355 PMID:35569513 PMID:36055550 PMID:36343683 PMID:36646296 PMID:36786954 PMID:36880428 PMID:37369159 PMID:37393521 PMID:37598416 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Relb |
RELB proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Lipopolysaccharides affects the localization of RELB protein] Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of RELB protein]] |
CTD |
PMID:11970852 PMID:19642688 |
|
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
|
|
G |
Ren |
renin |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [ioxitalamic acid results in increased expression of REN protein] |
CTD |
PMID:19945959 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGS16 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rgsl2h |
regulator of G-protein signaling like 2 homolog (mouse) |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGSL2H mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:65,973,695...65,974,702
|
|
G |
Rhobtb1 |
Rho-related BTB domain containing 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of RHOBTB1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
ISO |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK1 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK1 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK1 protein]]; Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased phosphorylation of RIPK1 protein] |
CTD |
PMID:35777681 PMID:35833596 PMID:37678662 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] |
CTD |
PMID:19477266 |
|
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
ISO EXP |
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK3 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of RIPK3 protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK3 mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of RIPK3 protein]]; Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK3 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased phosphorylation of RIPK3 protein] Acetylcysteine inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of RIPK3 protein] |
CTD |
PMID:35777681 PMID:35833596 PMID:36000575 PMID:37678662 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rnase2 |
ribonuclease A family member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNASE2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479
|
|
G |
Rnf125 |
ring finger protein 125 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNF125 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983
|
|
G |
Rora |
RAR-related orphan receptor A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RORA mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Zearalenone results in decreased phosphorylation of RPS6KB1 protein] Acetylcysteine inhibits the reaction [4-nonylphenol results in decreased phosphorylation of RPS6KB1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:14516795 PMID:18569013 PMID:21195169 PMID:24299490 PMID:26804764 PMID:31982503 More...
|
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rtp1 |
receptor (chemosensory) transporter protein 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RTP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RTP1 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr11:77,422,982...77,425,498
Ensembl chr11:77,422,982...77,425,498
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of RUNX2 mRNA] Acetylcysteine inhibits the reaction [Dexamethasone affects the expression of RUNX2 mRNA] |
CTD |
PMID:19017541 PMID:24239970 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of RXRA mRNA] |
CTD |
PMID:18829485 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
S100a11 |
S100 calcium binding protein A11 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein]; Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein] |
CTD |
PMID:25940438 |
|
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of S100A4 mRNA] |
CTD |
PMID:21051528 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of S100A9 protein] |
CTD |
PMID:32924446 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SAT1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SCD1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sec31a |
SEC31 homolog A, COPII coat complex component |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of SEC31A mRNA] |
CTD |
PMID:34425375 |
|
NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273
|
|
G |
Sele |
selectin E |
decreases expression multiple interactions |
ISO |
Acetylcysteine results in decreased expression of SELE mRNA Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of SELE protein] Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of SELE protein]] |
CTD |
PMID:16084531 PMID:19642688 PMID:26901245 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Selenoi |
selenoprotein I |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SELENOI mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:26,073,127...26,111,326
Ensembl chr 6:26,072,648...26,111,314
|
|
G |
Serpinh1 |
serpin family H member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SERPINH1 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SERPINH1 protein] |
CTD |
PMID:13679210 |
|
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of SESN2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of SESN2 protein]; Acetylcysteine inhibits the reaction [erastin results in increased expression of SESN2 protein]; Acetylcysteine inhibits the reaction [Hemin results in increased expression of SESN2 protein]; Acetylcysteine inhibits the reaction [Quercetin results in increased expression of SESN2 protein] |
CTD |
PMID:24535669 PMID:29662624 PMID:31054940 PMID:31323261 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SFRP2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
|
|
G |
Sftpa1 |
surfactant protein A1 |
multiple interactions |
ISO |
Acetylcysteine affects the reaction [Particulate Matter affects the expression of SFTPA1 protein] Acetylcysteine inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPA1 protein] |
CTD |
PMID:31449845 PMID:35689653 |
|
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPB protein] Acetylcysteine results in increased expression of SFTPB protein Acetylcysteine inhibits the reaction [[Air Pollutants, Occupational results in increased abundance of Particulate Matter] which results in decreased expression of SFTPB protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SFTPB protein] |
CTD |
PMID:27208422 PMID:35689653 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpc |
surfactant protein C |
increases expression multiple interactions |
ISO |
Acetylcysteine results in increased expression of SFTPC protein Acetylcysteine inhibits the reaction [[Air Pollutants, Occupational results in increased abundance of Particulate Matter] which results in decreased expression of SFTPC protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SFTPC protein] |
CTD |
PMID:27208422 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Shc1 |
SHC adaptor protein 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [SHC1 protein results in decreased expression of CDH1 protein]; Acetylcysteine inhibits the reaction [SHC1 protein results in increased expression of VIM protein] Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of SHC1 protein] Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased phosphorylation of SHC1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of SHC1 protein] |
CTD |
PMID:32659284 PMID:33360347 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Shisa2 |
shisa family member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SHISA2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:33,806,715...33,811,013
Ensembl chr15:33,805,958...33,811,013
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 mRNA]; Acetylcysteine inhibits the reaction [antimony trichloride results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SIRT1 protein] Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of SIRT1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SIRT1 protein] |
CTD |
PMID:21031461 PMID:30055241 PMID:33360347 PMID:36493885 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt3 |
sirtuin 3 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of SIRT3 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT3 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT3 protein] Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of SIRT3 mRNA] |
CTD |
PMID:30104959 PMID:30641872 PMID:35430258 |
|
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Sla2 |
Src-like-adaptor 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLA2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:145,367,070...145,383,586
Ensembl chr 3:145,368,598...145,382,480
|
|
G |
Slc12a1 |
solute carrier family 12 member 1 |
increases expression |
EXP |
Acetylcysteine results in increased expression of SLC12A1 protein |
CTD |
PMID:23183129 |
|
NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
|
|
G |
Slc12a3 |
solute carrier family 12 member 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC12A3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
|
|
G |
Slc14a2 |
solute carrier family 14 member 2 |
multiple interactions increases expression |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC14A2 mRNA Acetylcysteine results in increased expression of SLC14A2 protein |
CTD |
PMID:22129741 PMID:23183129 |
|
NCBI chr18:71,612,460...72,039,462
Ensembl chr18:71,612,460...71,792,968
|
|
G |
Slc19a2 |
solute carrier family 19 member 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC19A2 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
|
|
G |
Slc1a1 |
solute carrier family 1 member 1 |
multiple interactions |
ISO |
Acetylcysteine affects the reaction [SLC1A1 protein affects the transport of Zinc]; Acetylcysteine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the localization of SLC1A1 protein]; Acetylcysteine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the metabolism of SLC1A1 protein] |
CTD |
PMID:18093171 PMID:22575539 |
|
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SLC1A2 protein]; Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein] Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 mRNA]; Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 protein] |
CTD |
PMID:19717140 PMID:22895544 PMID:34310962 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc22a17 |
solute carrier family 22, member 17 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SLC22A17 mRNA] |
CTD |
PMID:31004932 |
|
NCBI chr15:28,382,285...28,389,435
Ensembl chr15:28,382,292...28,388,799
|
|
G |
Slc22a24 |
solute carrier family 22, member 24 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of SLC22A24 protein] |
CTD |
PMID:26230185 |
|
NCBI chr 1:204,910,450...204,965,538
Ensembl chr 1:204,910,455...204,965,538
|
|
G |
Slc22a4 |
solute carrier family 22 member 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Mercury results in decreased activity of SLC22A4 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased activity of SLC22A4 protein] |
CTD |
PMID:25490951 |
|
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
multiple interactions |
EXP |
Acetylcysteine affects the reaction [Methylmercury Compounds results in decreased transport of SLC22A5 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] |
CTD |
PMID:22900493 |
|
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
adipic acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; Glutarates inhibits the reaction [SLC22A6 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine]]; Ketoglutaric Acids inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; p-Aminohippuric Acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]]; Probenecid inhibits the reaction [SLC22A6 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine]]; SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]; SLC22A6 protein results in increased transport of [Acetylcysteine co-treated with Mercury]; SLC22A6 protein results in increased transport of [Acetylcysteine co-treated with Methylmercury Compounds]; SLC22A6 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine] |
CTD |
PMID:12606766 PMID:15908511 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
EXP |
SLC22A8 protein results in increased uptake of [mercuric oxide co-treated with Acetylcysteine] |
CTD |
PMID:12606766 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc24a2 |
solute carrier family 24 member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC24A2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:101,497,916...101,741,840
Ensembl chr 5:101,502,278...101,739,337
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SLC25A20 protein] Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of SLC25A20 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased activity of SLC25A20 protein] |
CTD |
PMID:23402788 PMID:25849418 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc25a47 |
solute carrier family 25, member 47 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC25A47 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:127,767,365...127,773,000
Ensembl chr 6:127,767,305...127,773,005
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Dietary Fats] results in increased expression of SLC27A2 mRNA |
CTD |
PMID:21051528 |
|
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC2A1 mRNA]; Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SLC2A1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SLC2A1 mRNA]; Acetylcysteine inhibits the reaction [DDT results in increased expression of SLC2A1 mRNA] |
CTD |
PMID:30821169 PMID:31251971 PMID:31724279 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Pyruvaldehyde affects the localization of SLC2A2 protein] |
CTD |
PMID:22917016 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 mRNA]; Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 protein] |
CTD |
PMID:31857147 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein] |
CTD |
PMID:27117918 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC30A1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc35d2 |
solute carrier family 35 member D2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of SLC35D2 mRNA] |
CTD |
PMID:33146789 |
|
NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] |
CTD |
PMID:22215663 |
|
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
|
|
G |
Slc39a14 |
solute carrier family 39 member 14 |
increases expression |
ISO |
Acetylcysteine results in increased expression of SLC39A14 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SLC40A1 mRNA] |
CTD |
PMID:20090884 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Slc4a1 |
solute carrier family 4 member 1 (Diego blood group) |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Atorvastatin] inhibits the reaction [sodium arsenite affects the localization of SLC4A1 protein] |
CTD |
PMID:20946910 |
|
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of SLC5A5 mRNA] |
CTD |
PMID:30352396 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Slc6a6 |
solute carrier family 6 member 6 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC7A11 mRNA] |
CTD |
PMID:18723479 PMID:19717140 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a14 |
solute carrier family 7, member 14 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC7A14 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:112,065,286...112,171,319
Ensembl chr 2:112,065,286...112,171,313
|
|
G |
Smad1 |
SMAD family member 1 |
decreases phosphorylation |
ISO |
Acetylcysteine results in decreased phosphorylation of SMAD1 protein |
CTD |
PMID:32947957 |
|
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of SMAD2 mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of SMAD2 mRNA] Acetylcysteine results in decreased phosphorylation of SMAD2 protein |
CTD |
PMID:29408318 PMID:30317545 PMID:32947957 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions decreases phosphorylation |
ISO |
[Acetylcysteine co-treated with Cadmium Chloride co-treated with sodium arsenite] results in decreased expression of SMAD3 mRNA; [Acetylcysteine co-treated with Cadmium] results in decreased expression of SMAD3 mRNA; [Acetylcysteine co-treated with Water Pollutants, Chemical] results in decreased expression of SMAD3 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of SMAD3 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] Acetylcysteine results in decreased phosphorylation of SMAD3 protein |
CTD |
PMID:21131394 PMID:29408318 PMID:30317545 PMID:34687772 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein]]; Acetylcysteine inhibits the reaction [resveratrol results in increased phosphorylation of SMC1A protein] |
CTD |
PMID:15489221 PMID:24933654 |
|
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNAI1 protein]; Acetylcysteine inhibits the reaction [Aldosterone results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [benz(a)anthracene results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [benzo(k)fluoranthene results in increased expression of SNAI1 mRNA]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of SNAI1 protein]; Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of SNAI1 mRNA] Acetylcysteine results in decreased expression of SNAI1 protein |
CTD |
PMID:17596522 PMID:21635667 PMID:28284859 PMID:32687844 PMID:34687772 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of SNAI2 protein] |
CTD |
PMID:32687844 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline results in increased expression of SNCA protein] Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SNCA mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of SNCA mRNA]; Acetylcysteine inhibits the reaction [Silicon Dioxide analog results in increased expression of SNCA protein] |
CTD |
PMID:15114628 PMID:27613482 PMID:34816377 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sntg1 |
syntrophin, gamma 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SNTG1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:9,980,550...10,794,666
Ensembl chr 5:9,981,115...10,791,181
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions decreases expression increases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in decreased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of SOD1]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD1 protein]; Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA] Acetylcysteine inhibits the reaction [Cadmium results in decreased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [Lead results in decreased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of SOD1 protein] [Acetylcysteine co-treated with Thapsigargin] results in decreased expression of SOD1 mRNA; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SOD1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 protein]; Acetylcysteine inhibits the reaction [perfluorooctanoic acid results in increased expression of SOD1 mRNA] Acetylcysteine results in decreased expression of SOD1 mRNA Acetylcysteine results in increased activity of SOD1 protein |
CTD |
PMID:16101137 PMID:17309078 PMID:19264484 PMID:19409983 PMID:20674559 PMID:21888768 PMID:22155089 PMID:22714038 PMID:24299490 PMID:28013216 PMID:28535741 PMID:29111403 PMID:32023790 PMID:32092105 PMID:32578922 PMID:34816377 PMID:35112789 PMID:35810264 PMID:36813253 PMID:37084995 PMID:37692514 More...
|
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO EXP |
[Acetylcysteine results in increased expression of SOD2 protein] which results in decreased abundance of Reactive Oxygen Species; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Cyclosporine results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; Acetylcysteine promotes the reaction [Oxygen results in increased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [Oxygen results in increased expression of SOD2 protein] Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased acetylation of SOD2 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased acetylation of SOD2 protein]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of SOD2 mRNA] Acetylcysteine results in increased expression of SOD2 mRNA; Acetylcysteine results in increased expression of SOD2 protein [Acetylcysteine co-treated with IL1A protein] results in increased expression of SOD2 protein; [Acetylcysteine co-treated with TNF protein] results in increased expression of SOD2 protein; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of SOD2 mRNA; Acetylcysteine affects the reaction [SOD2 protein affects the activity of CASP9 protein]; Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin]; Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel]; Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [[EGF co-treated with Colforsin co-treated with Rotenone] results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [linsidomine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Peroxynitrous Acid results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of SOD2 protein]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [Rotenone results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the activity of AR protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AKR1C3 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of AMACR mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR1 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of ESR2 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of FKBP5 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD11B2 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD17B8 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of KLK3 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of PGR mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of RXRA mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of TMPRSS2 mRNA]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2]; Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA]; Acetylcysteine promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Acetylcysteine results in increased expression of SOD2 mRNA] |
CTD |
PMID:7476933 PMID:8760145 PMID:9535218 PMID:9741582 PMID:11264281 PMID:12031898 PMID:15904944 PMID:16101137 PMID:17010595 PMID:17309078 PMID:18594523 PMID:18829485 PMID:20674559 PMID:21131394 PMID:21775390 PMID:22429591 PMID:22714038 PMID:22718889 PMID:23114885 PMID:23159718 PMID:23765110 PMID:23964924 PMID:28499986 PMID:29111403 PMID:30104959 PMID:30641872 PMID:32023790 PMID:32092105 PMID:35403558 PMID:35430258 More...
|
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SOD3 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of SOD3 protein] |
CTD |
PMID:21804221 PMID:34358621 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sord |
sorbitol dehydrogenase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Diclofenac results in increased secretion of SORD protein] |
CTD |
PMID:12763371 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
multiple interactions |
ISO |
N-acetyl-cysteine inhibits the reaction [angiotensin II decreases expression of SOX17 protein in retinal endothelial cells] |
RGD |
PMID:32078435 |
RGD:329853329 |
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of SP1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SP1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of SP1 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in decreased expression of SP1 protein] Acetylcysteine results in decreased expression of SP1 protein |
CTD |
PMID:16928829 PMID:18556457 PMID:30851366 PMID:33360347 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sphk1 |
sphingosine kinase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Glucose results in increased expression of and results in increased activity of SPHK1 protein] |
CTD |
PMID:21998146 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Spi1 |
Spi-1 proto-oncogene |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA]]; Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA]] |
CTD |
PMID:29945211 |
|
NCBI chr 3:77,059,744...77,093,730
Ensembl chr 3:77,073,012...77,092,393
|
|
G |
Spock2 |
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SPOCK2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr20:28,037,334...28,064,272
Ensembl chr20:28,033,475...28,064,272
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Allylamine results in increased expression of SPP1 mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of SPP1 protein] |
CTD |
PMID:15910882 PMID:19356721 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine affects the reaction [sodium arsenite affects the expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [brazilin results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased degradation of SQSTM1 protein]; Acetylcysteine inhibits the reaction [ovatodiolide results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Patulin results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Potassium Iodide results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [pyrovalerone analog results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [tri-o-cresyl phosphate results in increased expression of SQSTM1 protein] Acetylcysteine results in increased expression of SQSTM1 protein Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of SQSTM1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [chromium hexavalent ion results in decreased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in decreased expression of SQSTM1 protein] Acetylcysteine inhibits the reaction [decamethrin results in increased expression of SQSTM1 protein]; Acetylcysteine promotes the reaction [manganese chloride results in increased expression of SQSTM1 protein] |
CTD |
PMID:22927544 PMID:25301941 PMID:26588882 PMID:27106530 PMID:28063998 PMID:28578026 PMID:29222055 PMID:29604266 PMID:29923297 PMID:30205151 PMID:31563593 PMID:32512069 PMID:32525552 PMID:33462182 PMID:33617914 PMID:34547296 PMID:34861471 PMID:35550146 PMID:36739042 PMID:37678662 PMID:38000454 More...
|
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of SRC protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of SRC protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of SRC protein] N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases phosphorylation of SRC protein in the stomach) |
CTD RGD |
PMID:21777978 PMID:29894800 PMID:31433961 PMID:29408335 |
RGD:127284846 |
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srms |
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SRMS mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:168,318,511...168,324,915
Ensembl chr 3:168,318,512...168,324,915
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions |
ISO |
[Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA]; [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [sodium arsenite results in increased expression of SRXN1 mRNA] |
CTD |
PMID:22003191 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Dimethoate results in decreased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [nickel sulfate results in decreased expression of STAR protein] Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of STAR protein]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [Polystyrenes analog results in decreased expression of STAR protein] Acetylcysteine inhibits the reaction [anacetrapib results in increased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [dalcetrapib results in increased expression of STAR mRNA]; Acetylcysteine inhibits the reaction [torcetrapib results in increased expression of STAR mRNA] |
CTD |
PMID:25617244 PMID:26769589 PMID:29567110 PMID:30648648 PMID:36709824 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [nickel sulfate results in increased phosphorylation of STAT1 protein]; Acetylcysteine inhibits the reaction [Ozone results in increased phosphorylation of STAT1 protein] Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of STAT1 protein] Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:12847270 PMID:16896058 PMID:17607690 PMID:19061877 PMID:20525893 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions treatment decreases phosphorylation |
ISO EXP |
Acetylcysteine inhibits the reaction [1,2,5,8-tetrahydroxy anthraquinone results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [1,4-naphthoquinone analog results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of STAT3 protein modified form]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of STAT3 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of and results in increased expression of STAT3 protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased phosphorylation of and results in increased activity of STAT3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of STAT3 protein] N-acetyl-L-cysteine co-treated with Il-6 inhibits the reaction [apigenin-7-O-gentiobioside decreases phosphorylation of STAT3 protein in the stomach) Acetylcysteine results in decreased phosphorylation of STAT3 protein Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of STAT3 protein]; Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of STAT3 protein]] Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of STAT3 mRNA]; Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of STAT3 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased phosphorylation of STAT3 protein] |
CTD RGD |
PMID:16481037 PMID:16896058 PMID:17666914 PMID:19409983 PMID:21741372 PMID:21912612 PMID:23948867 PMID:24582688 PMID:24820114 PMID:27856279 PMID:28284859 PMID:28739487 PMID:29329563 PMID:29894800 PMID:30871965 PMID:31433961 PMID:33030807 PMID:34425375 PMID:34627931 PMID:29408335 More...
|
RGD:127284846 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Sumo1 |
small ubiquitin-like modifier 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of SUMO1 mRNA] |
CTD |
PMID:33971260 |
|
NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:61,077,435...61,108,761
|
|
G |
Syn1 |
synapsin I |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SYN1 mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of SYN1 protein] |
CTD |
PMID:27624276 PMID:28153600 |
|
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
|
|
G |
Syp |
synaptophysin |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of SYP protein] |
CTD |
PMID:28499986 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Syt7 |
synaptotagmin 7 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Dexamethasone] results in decreased expression of SYT7 mRNA |
CTD |
PMID:21888768 |
|
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
|
|
G |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
decreases binding |
EXP |
N-acetyl-cysteine inhibits binding of Traf6 protein to Tab2 in rat neonatal cardiomyocytes |
RGD |
PMID:27249171 |
RGD:155646134 |
NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756
|
|
G |
Taldo1 |
transaldolase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of Glutathione]; Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of NADP]; Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased abundance of Nitric Oxide]; Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] |
CTD |
PMID:19436114 |
|
NCBI chr 1:196,493,634...196,503,965
Ensembl chr 1:196,493,589...196,503,974
|
|
G |
Tank |
TRAF family member-associated NFKB activator |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of TANK mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
|
|
G |
Tardbp |
TAR DNA binding protein |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [arsenite promotes the reaction [TARDBP protein binds to PPP1R15A protein]] |
CTD |
PMID:29109149 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tas2r108 |
taste receptor, type 2, member 108 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TAS2R108 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:69,287,667...69,288,581
Ensembl chr 4:69,287,667...69,288,581
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TERT protein]; Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TERT protein] Acetylcysteine results in increased expression of TERT protein Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased activity of TERT protein]; Acetylcysteine inhibits the reaction [monomethylarsonous acid results in decreased activity of TERT protein] |
CTD |
PMID:18336854 PMID:19409983 PMID:30851366 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tet1 |
tet methylcytosine dioxygenase 1 |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [TET1 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of TET1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TET1 mRNA] [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with Acetylcysteine] results in decreased expression of TET1 mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TET1 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of TET1 mRNA] Acetylcysteine results in increased expression of TET1 mRNA |
CTD |
PMID:28153600 PMID:31551408 PMID:33188856 |
|
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
|
|
G |
Tet2 |
tet methylcytosine dioxygenase 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [dorsomorphin results in decreased expression of TET2 protein] |
CTD |
PMID:31900833 |
|
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of TFAM mRNA] Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of TFAM mRNA]; Acetylcysteine inhibits the reaction [dimethoxyethyl phthalate results in decreased expression of TFAM protein] |
CTD |
PMID:21775390 PMID:26980303 PMID:32142722 PMID:34214916 PMID:35403558 PMID:36493885 More...
|
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tfe3 |
transcription factor binding to IGHM enhancer 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of TFE3 mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased phosphorylation of and affects the localization of TFE3 protein] |
CTD |
PMID:29945972 PMID:32439580 |
|
NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571
|
|
G |
Tfeb |
transcription factor EB |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal affects the localization of TFEB protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of TFEB protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of TFEB mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased phosphorylation of TFEB protein] |
CTD |
PMID:29307831 PMID:29945972 PMID:33462182 PMID:35550146 |
|
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Zinc deficiency results in increased expression of TFRC protein] |
CTD |
PMID:18073202 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TGFA mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of TGFB1 mRNA] Acetylcysteine results in decreased expression of TGFB1 mRNA; Acetylcysteine results in decreased expression of TGFB1 protein modified form Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of TGFB1 protein] Acetylcysteine inhibits the reaction [4-cresol sulfate results in increased expression of and results in increased secretion of TGFB1 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of TGFB1 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in decreased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of HGF protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of IL6 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of NOX4 mRNA]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of VEGFA protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased secretion of IL6 protein] |
CTD |
PMID:16757516 PMID:21131394 PMID:21765237 PMID:23159718 PMID:23325087 PMID:25406100 PMID:26138014 PMID:30317545 PMID:30543783 PMID:32947957 PMID:36493885 More...
|
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased expression of TGFB1I1 mRNA] |
CTD |
PMID:27511942 |
|
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
multiple interactions |
ISO |
[Acetylcysteine co-treated with Cadmium] results in decreased expression of TGFB3 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of and results in increased secretion of TGFB3 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of TGFB3 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of and results in increased secretion of TGFB3 protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of and results in increased secretion of TGFB3 protein]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of TGFB3 mRNA] |
CTD |
PMID:29408318 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
decreases expression multiple interactions |
EXP ISO |
Acetylcysteine results in decreased expression of TGFBR1 mRNA; Acetylcysteine results in decreased expression of TGFBR1 protein [Acetylcysteine co-treated with Cadmium] results in decreased expression of TGFBR1 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite] results in increased expression of TGFBR1 mRNA]; Acetylcysteine inhibits the reaction [Water Pollutants, Chemical results in increased expression of TGFBR1 mRNA] Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR1 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR1 protein] |
CTD |
PMID:17602960 PMID:29408318 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
decreases expression multiple interactions |
EXP |
Acetylcysteine results in decreased expression of TGFBR2 mRNA; Acetylcysteine results in decreased expression of TGFBR2 protein Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR2 mRNA]; Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in decreased expression of TGFBR2 protein] |
CTD |
PMID:17602960 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tgm1 |
transglutaminase 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Particulate Matter analog results in decreased activity of TGM1 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in decreased activity of TGM1 protein] |
CTD |
PMID:15541757 |
|
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
|
|
G |
Tgm2 |
transglutaminase 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Particulate Matter analog results in decreased activity of TGM2 protein]; Acetylcysteine inhibits the reaction [Vehicle Emissions analog results in decreased activity of TGM2 protein] |
CTD |
PMID:15541757 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions decreases expression |
EXP |
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in decreased expression of TH protein; Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of TH protein] Acetylcysteine results in decreased expression of TH protein |
CTD |
PMID:22714038 PMID:25891525 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of TSP1 mRNA] |
CTD |
PMID:20524210 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thpo |
thrombopoietin |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [THPO protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of GP1BA protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGA2B protein]; Acetylcysteine inhibits the reaction [THPO protein results in increased expression of ITGB3 protein] |
CTD |
PMID:20523355 |
|
Ensembl chr11:80,182,820...80,188,167
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP2 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP2 mRNA] |
CTD |
PMID:33188856 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
increases expression multiple interactions |
EXP |
Acetylcysteine results in increased expression of TIMP3 mRNA Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP3 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIMP3 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of TIMP3 mRNA] |
CTD |
PMID:33188856 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of TJP1 protein] Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein] Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein] |
CTD |
PMID:26079211 PMID:27783111 PMID:29235125 PMID:32687961 PMID:33485121 PMID:34906888 PMID:37598416 More...
|
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tjp2 |
tight junction protein 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP2 protein] |
CTD |
PMID:27783111 |
|
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
|
|
G |
Tlr2 |
toll-like receptor 2 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of TLR2 mRNA |
CTD |
PMID:22385246 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]]; Acetylcysteine inhibits the reaction [benzanthrone results in increased expression of TLR4 protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TLR4 mRNA] Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TLR4 protein] Acetylcysteine results in decreased expression of TLR4 mRNA |
CTD |
PMID:19627980 PMID:22385246 PMID:28495615 PMID:36055550 PMID:37369159 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tmem140 |
transmembrane protein 140 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TMEM140 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455
|
|
G |
Tnc |
tenascin C |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of TNC mRNA |
CTD |
PMID:32947957 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions affects expression |
ISO EXP |
Acetylcysteine results in decreased expression of TNF mRNA; Acetylcysteine results in decreased expression of TNF protein [Acetylcysteine co-treated with TNF protein] results in decreased activity of RELA protein; [Acetylcysteine co-treated with TNF protein] results in increased expression of SOD2 protein; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [2,4-decadienal results in increased expression of and results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with TNF protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [butylphen results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of TNF mRNA]]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of TNF mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Mimosine results in decreased activity of TNF protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [piperlongumine analog inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [TNF protein results in decreased abundance of Glutathione]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Hydrogen Peroxide]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Superoxides]; Acetylcysteine inhibits the reaction [TNF protein results in increased activity of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of FN1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of FN1 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of STAT3 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [TNF results in decreased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [TNF results in increased abundance of Malondialdehyde]; Acetylcysteine inhibits the reaction [TNF results in increased abundance of Nitric Oxide]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNF protein]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [butylphen results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Acetylcysteine results in increased expression of SOD2 mRNA] [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of TNF mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of TNF protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [azoxystrobin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fungal Polysaccharides results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [iprodione inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [manganese chloride promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Mimosine results in decreased activity of TNF protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Nicotine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [PRKAA2 protein affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]]; Acetylcysteine inhibits the reaction [titanium dioxide results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; MYD88 protein affects the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]; MYD88 protein affects the reaction [Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]]]; Polymyxin B promotes the reaction [Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of TNF protein]] Acetylcysteine affects the expression of TNF protein Acetylcysteine analog inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of TNF protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Acrylamide results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [cupric chloride results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Nicotine results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Nitric Oxide deficiency results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [Palmitates results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Palmitates results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Silicon Dioxide results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Acetylcysteine inhibits the reaction [TNF protein affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [TNF protein results in decreased phosphorylation of PTK2B protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Acetylcysteine promotes the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; Acetylcysteine promotes the reaction [Doxorubicin results in increased expression of TNF mRNA] |
CTD |
PMID:7476933 PMID:7532384 PMID:8760145 PMID:9535218 PMID:9721806 PMID:10495789 PMID:10878378 PMID:10921504 PMID:11124598 PMID:11167962 PMID:11264281 PMID:11970852 PMID:12388057 PMID:12615669 PMID:15050407 PMID:15158148 PMID:15161907 PMID:15451797 PMID:15550384 PMID:15601679 PMID:15650392 PMID:15795323 PMID:15945272 PMID:16014734 PMID:16214328 PMID:16632126 PMID:17026986 PMID:17216608 PMID:17471172 PMID:17666914 PMID:18257742 PMID:18755394 PMID:19176594 PMID:19477266 PMID:19608869 PMID:21237301 PMID:21424515 PMID:21912612 PMID:22385246 PMID:22472292 PMID:23159886 PMID:23268108 PMID:23774252 PMID:23900960 PMID:23940760 PMID:23948867 PMID:24224404 PMID:24316229 PMID:24447977 PMID:24530511 PMID:24570342 PMID:24793810 PMID:24961358 PMID:25406100 PMID:26332274 PMID:26683377 PMID:26801986 PMID:27313093 PMID:28087840 PMID:28535741 PMID:28555929 PMID:28836394 PMID:29111459 PMID:29426002 PMID:29479036 PMID:29753051 PMID:29753072 PMID:30259999 PMID:30529211 PMID:30639957 PMID:31173782 PMID:31518571 PMID:32142722 PMID:32402895 PMID:32620109 PMID:32687961 PMID:33226166 PMID:33720480 PMID:34310962 PMID:35285579 PMID:35349355 PMID:35833596 PMID:36055550 PMID:36493885 PMID:36762617 PMID:36880428 PMID:37458150 PMID:37598416 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TNFAIP3 mRNA] |
CTD |
PMID:16137721 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of TNFAIP6 mRNA] |
CTD |
PMID:21220312 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of TNFRSF10A protein]; Acetylcysteine inhibits the reaction [ilimaquinone results in increased expression of TNFRSF10A mRNA]; Acetylcysteine inhibits the reaction [pendulone results in increased expression of TNFRSF10A protein] |
CTD |
PMID:21741372 PMID:24930757 PMID:35288263 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tnfrsf13c |
TNF receptor superfamily member 13C |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF13C mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of TNFRSF1A protein]; Acetylcysteine inhibits the reaction [Mimosine results in increased cleavage of TNFRSF1A protein] |
CTD |
PMID:15550384 PMID:21741372 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF1B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tnfrsf22 |
tumor necrosis factor receptor superfamily, member 22 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of TNFRSF10B mRNA]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of TNFRSF10B protein] |
CTD |
PMID:27484784 |
|
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression decreases response to substance multiple interactions |
ISO |
Acetylcysteine results in decreased expression of TNFSF10 mRNA Acetylcysteine results in decreased susceptibility to TNFSF10 protein Acetylcysteine inhibits the reaction [[CSC-3436 co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with tanshinone] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2L1 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BID protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased abundance of Reactive Nitrogen Species]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased chemical synthesis of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of PARP1 protein modified form]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of VDAC1 protein] |
CTD |
PMID:16084531 PMID:20971099 PMID:23711929 PMID:25034532 PMID:25619640 PMID:26203587 PMID:34599545 More...
|
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
[Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of ATP6V0D2 mRNA; [Acetylcysteine co-treated with CSF1R protein co-treated with TNFSF11 protein] results in decreased expression of CTSK mRNA; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]]; Acetylcysteine affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of CTSK mRNA]]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tnfsf4 |
TNF superfamily member 4 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNFSF4 mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNFSF4 mRNA] |
CTD |
PMID:20974985 |
|
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
|
|
G |
Tnpo1 |
transportin 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TNPO1] |
CTD |
PMID:19409983 |
|
NCBI chr 2:30,207,529...30,300,162
Ensembl chr 2:30,211,510...30,300,375
|
|
G |
Tomm20 |
translocase of outer mitochondrial membrane 20 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in decreased expression of TOMM20 protein] |
CTD |
PMID:36739042 |
|
NCBI chr19:54,925,197...54,935,188
Ensembl chr19:54,923,402...54,935,198
|
|
G |
Tor3a |
torsin family 3, member A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TOR3A mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TOR3A mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression increases phosphorylation decreases expression decreases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased phosphorylation of TRP53 protein]; Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of TRP53 protein modified form]; Acetylcysteine inhibits the reaction [2,4-dibromophenol metabolite results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased activity of TRP53 protein]; Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased expression of TRP53 mRNA]; Acetylcysteine inhibits the reaction [[Excitatory Amino Acid Agents results in increased abundance of Reactive Oxygen Species] which results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of TRP53 protein]; Acetylcysteine inhibits the reaction [dihydrolipoic acid results in increased expression of TRP53 mRNA]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of TRP53 mRNA]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein modified form]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of TRP53 protein]; Acetylcysteine inhibits the reaction [Zinc results in increased expression of TRP53 protein] Acetylcysteine results in increased expression of TP53 protein Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Aflatoxin B1 promotes the reaction [fumonisin B1 results in increased expression of TP53 protein]]; Acetylcysteine inhibits the reaction [Aflatoxin B1 results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Aflatoxin B1 results in increased expression of TP53 protein]]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased expression of and results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Quercetin analog results in decreased phosphorylation of TP53 protein] Acetylcysteine results in increased phosphorylation of TP53 protein Acetylcysteine results in decreased expression of TP53 protein Acetylcysteine results in decreased activity of TP53 protein [Acetylcysteine co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] results in decreased expression of TP53 protein]; Acetylcysteine affects the reaction [4-biphenylamine affects the expression of TP53 protein]; Acetylcysteine inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TP53 protein modified form]; Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [[Cisplatin co-treated with Arsenic Trioxide] results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [[Zinc Sulfate co-treated with prolinedithiocarbamate] results in decreased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Aristolochic Acids results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [ATM protein promotes the reaction [Doxorubicin results in increased activity of TP53 protein]]; Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TP53 protein modified form]; Acetylcysteine inhibits the reaction [Capsaicin results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of TP53]; Acetylcysteine inhibits the reaction [Cisplatin results in increased glutathionylation of TP53 protein]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of and results in increased activity of TP53 protein]; Acetylcysteine inhibits the reaction [cyadox results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [diallyl disulfide results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [dorsomorphin results in increased expression of and results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of TP53 protein]]; Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [hesperetin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [Methotrexate results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Oxaliplatin results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TP53 protein]; Acetylcysteine inhibits the reaction [perfosfamide results in increased expression of TP53]; Acetylcysteine inhibits the reaction [Phytochemicals results in increased phosphorylation of TP53 protein]; Acetylcysteine inhibits the reaction [Reactive Oxygen Species affects the localization of TP53 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of TP53 protein]; Acetylcysteine inhibits the reaction [TP53 protein results in increased abundance of Reactive Oxygen Species]; Acetylcysteine inhibits the reaction [usnic acid results in increased expression of TP53 protein]; Acetylcysteine promotes the reaction [Chlorine results in increased expression of TP53 protein modified form] |
CTD |
PMID:9535218 PMID:10951577 PMID:11864783 PMID:14871840 PMID:15059885 PMID:15489221 PMID:15496615 PMID:15904916 PMID:17555331 PMID:18034189 PMID:18563748 PMID:18951928 PMID:18996350 PMID:19202565 PMID:19728331 PMID:20530418 PMID:20955365 PMID:21462292 PMID:21549813 PMID:21565247 PMID:22183962 PMID:22260869 PMID:22927544 PMID:23183129 PMID:23274516 PMID:23711929 PMID:23907460 PMID:24792323 PMID:24967384 PMID:25305377 PMID:25845326 PMID:25939952 PMID:26451628 PMID:26884717 PMID:26942697 PMID:27634759 PMID:27658547 PMID:28181396 PMID:29944906 PMID:29945211 PMID:29962303 PMID:30265530 PMID:30408460 PMID:30555576 PMID:31173782 PMID:31433961 PMID:31715134 PMID:32017938 PMID:32402895 PMID:32540572 PMID:32905825 PMID:32924446 PMID:33031904 PMID:33961949 PMID:35065218 PMID:35123993 PMID:36493885 PMID:37487865 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpm1 |
tropomyosin 1 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Allylamine results in increased expression of TPM1 mRNA] |
CTD |
PMID:15910882 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tpo |
thyroid peroxidase |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of TPO mRNA] |
CTD |
PMID:30352396 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Traf2 |
Tnf receptor-associated factor 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]] |
CTD |
PMID:24394546 |
|
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
decreases binding multiple interactions |
EXP |
N-acetyl-cysteine inhibits binding of Traf6 protein to Tab2 in rat neonatal cardiomyocytes N-acetyl-L-cysteine inhibits the reaction [angiotensin II increases expression of Traf6 protein in rat neonatal cardiomyocytes] |
RGD |
PMID:27249171 PMID:27249171 |
RGD:155646134, RGD:155646134 |
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Trib1 |
tribbles pseudokinase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRIB1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
multiple interactions |
ISO EXP |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of TRIB3 mRNA] Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of TRIB3 mRNA] |
CTD |
PMID:18723479 PMID:24291486 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Trim28 |
tripartite motif-containing 28 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [resveratrol results in increased phosphorylation of TRIM28 protein] |
CTD |
PMID:24933654 |
|
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
|
|
G |
Troap |
trophinin associated protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TROAP mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[allyl isothiocyanate results in increased activity of TRPA1 protein] which results in increased uptake of Calcium]; Acetylcysteine inhibits the reaction [[Mustard Gas results in increased activity of TRPA1 protein] which results in increased uptake of Calcium] |
CTD |
PMID:27738742 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRPC7 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:7,708,911...7,833,435
Ensembl chr17:7,709,583...7,833,435
|
|
G |
Tsc2 |
TSC complex subunit 2 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of TSC2 protein] |
CTD |
PMID:21195169 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [TSHB protein results in increased abundance of Hydrogen Peroxide] |
CTD |
PMID:11108245 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TSLP mRNA]; Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TSLP mRNA] |
CTD |
PMID:18049884 PMID:29753051 |
|
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Tspan6 |
tetraspanin 6 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of TSPAN6 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr X:97,092,394...97,099,659
Ensembl chr X:97,092,388...97,099,309
|
|
G |
Ttc7b |
tetratricopeptide repeat domain 7B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC7B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:119,587,389...119,799,167
Ensembl chr 6:119,587,390...119,799,330
|
|
G |
Ttc9b |
tetratricopeptide repeat domain 9B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC9B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:82,953,434...82,955,659
Ensembl chr 1:82,953,434...82,955,616
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TUBB3 mRNA] |
CTD |
PMID:28153600 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of TXN protein]; Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] Acetylcysteine results in decreased expression of TXN protein Acetylcysteine inhibits the reaction [Acrolein results in increased oxidation of TXN protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]; Acetylcysteine inhibits the reaction [NCX 4040 results in increased oxidation of TXN1 protein] |
CTD |
PMID:16449798 PMID:17959236 PMID:18023956 PMID:18922898 PMID:24157283 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txn2 |
thioredoxin 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of TXN2 mRNA] |
CTD |
PMID:36315628 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txndc8 |
thioredoxin domain containing 8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TXNDC8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:72,749,708...72,785,858
Ensembl chr 5:72,749,725...72,785,931
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNIP mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNIP protein] |
CTD |
PMID:37300869 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnl1 |
thioredoxin-like 1 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of TXNL1 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA] |
CTD |
PMID:15652504 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tymp |
thymidine phosphorylase |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein] |
CTD |
PMID:11103787 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Tyr |
tyrosinase |
multiple interactions |
ISO |
[Acetylcysteine co-treated with 6-formylindolo(3,2-b)carbazole] results in increased activity of TYR protein; [Acetylcysteine co-treated with Benzo(a)pyrene] results in increased activity of TYR protein |
CTD |
PMID:34856342 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
increases expression multiple interactions |
ISO |
Acetylcysteine results in increased expression of UBA7 protein Acetylcysteine inhibits the reaction [Paraquat results in increased methylation of UBA7 mRNA] Curcumin affects the reaction [Acetylcysteine results in increased expression of UBA7 protein]; epigallocatechin gallate affects the reaction [Acetylcysteine results in increased expression of UBA7 protein]; Resveratrol affects the reaction [Acetylcysteine results in increased expression of UBA7 protein] |
CTD |
PMID:25649257 PMID:34425375 |
|
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of UCP2 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of UCP2 protein]; Acetylcysteine inhibits the reaction [pirinixic acid results in increased expression of UCP2 protein] Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of UCP2 mRNA]; Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of UCP2 protein] |
CTD |
PMID:18183618 PMID:29061315 PMID:30104959 PMID:36493885 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ufm1 |
ubiquitin-fold modifier 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of UFM1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr 2:137,969,476...137,977,620
Ensembl chr 2:137,966,678...137,978,089 Ensembl chr 2:137,966,678...137,978,089
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
increases expression |
ISO |
Acetylcysteine results in increased expression of UGDH mRNA |
CTD |
PMID:16084531 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions |
EXP |
Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA]; Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of UGT1A6 promoter] |
CTD |
PMID:15336321 PMID:22129741 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of UHRF1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Ulk1 |
unc-51 like autophagy activating kinase 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in decreased expression of and results in decreased phosphorylation of ULK1 protein] |
CTD |
PMID:27106530 PMID:33002460 |
|
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
|
|
G |
Uspl1 |
ubiquitin specific peptidase like 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of USPL1 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr12:5,823,460...5,850,470
Ensembl chr12:5,823,359...5,850,366
|
|
G |
Uvrag |
UV radiation resistance associated |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of UVRAG mRNA] |
CTD |
PMID:29307831 |
|
NCBI chr 1:153,185,356...153,442,200
Ensembl chr 1:153,185,395...153,442,136
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of VCAM1 protein]] Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 mRNA]; Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein]; Acetylcysteine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:12615669 PMID:19281832 PMID:19642688 PMID:25876056 PMID:26901245 PMID:35349355 More...
|
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased expression of VDAC1 mRNA]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [VDAC1 protein binds to VDAC1 protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of VDAC1 protein]; Acetylcysteine inhibits the reaction [quinocetone promotes the reaction [VDAC1 protein binds to VDAC1 protein]]; Acetylcysteine inhibits the reaction [quinocetone results in increased expression of VDAC1 protein]; Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased expression of VDAC1 protein] |
CTD |
PMID:22858589 PMID:23711929 PMID:28343033 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vdac2 |
voltage-dependent anion channel 2 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [quinocetone promotes the reaction [VDAC2 protein binds to VDAC2 protein]] |
CTD |
PMID:29229420 |
|
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases secretion multiple interactions decreases expression |
ISO EXP |
Acetylcysteine results in decreased secretion of VEGFA protein Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA] Acetylcysteine inhibits the reaction [cobaltous chloride results in increased secretion of VEGFA protein] Acetylcysteine results in decreased expression of VEGFA mRNA Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in decreased expression of VEGFA protein]; Acetylcysteine inhibits the reaction [[Peanut Oil results in increased abundance of Particulate Matter] which results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Hydrogen Peroxide] results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [[Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of VEGFA protein]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA mRNA]; Acetylcysteine inhibits the reaction [EGF protein results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate results in decreased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of VEGFA protein]; Acetylcysteine inhibits the reaction [TGFB1 protein results in increased expression of VEGFA protein] |
CTD |
PMID:11214823 PMID:11641398 PMID:11886167 PMID:13679210 PMID:15788408 PMID:16309584 PMID:16757516 PMID:17992120 PMID:18829485 PMID:18930813 PMID:19176594 PMID:19622383 PMID:19910455 PMID:20850416 PMID:21804221 PMID:27856279 PMID:30878009 PMID:35430258 More...
|
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfb |
vascular endothelial growth factor B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VEGFB mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
|
|
G |
Vim |
vimentin |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [27-hydroxycholesterol results in increased expression of VIM protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VIM mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VIM protein]; Acetylcysteine inhibits the reaction [di-n-propyldithiocarbamate results in decreased expression of VIM protein] Acetylcysteine results in decreased expression of VIM protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of VIM protein]; Acetylcysteine inhibits the reaction [SHC1 protein results in increased expression of VIM protein] |
CTD |
PMID:28284859 PMID:32659284 PMID:32687844 PMID:33131013 PMID:34687772 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vmo1 |
vitelline membrane outer layer 1 homolog |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VMO1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VMO1 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr10:55,227,944...55,234,794
Ensembl chr10:55,227,944...55,229,289
|
|
G |
Vnn1 |
vanin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of VNN1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
|
|
G |
Wnt1 |
Wnt family member 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [quinocetone results in decreased expression of WNT1 protein] |
CTD |
PMID:28343033 |
|
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
|
|
G |
Wtap |
WT1 associated protein |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of WTAP mRNA]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of WTAP protein] |
CTD |
PMID:31004932 |
|
NCBI chr 1:47,665,965...47,691,067
Ensembl chr 1:47,665,965...47,691,065
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases splicing multiple interactions |
ISO EXP |
Acetylcysteine results in increased splicing of XBP1 mRNA Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased splicing of XBP1 mRNA]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [arsenic trioxide results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine inhibits the reaction [XBP1 protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]] Acetylcysteine inhibits the reaction [chloroacetic acid results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of XBP1 protein alternative form] Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of XBP1 protein]; Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased splicing of XBP1 mRNA] |
CTD |
PMID:19722195 PMID:21138464 PMID:21145380 PMID:21911445 PMID:25451595 PMID:27511942 PMID:30633982 PMID:31330229 PMID:37692514 More...
|
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
[MPO protein co-treated with XDH protein co-treated with Acetaldehyde] promotes the reaction [Serotonin binds to Acetylcysteine] |
CTD |
PMID:23009681 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with vorinostat] results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of XIAP protein]; Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of XIAP protein] |
CTD |
PMID:15173093 PMID:19679660 PMID:21310227 PMID:22578287 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XRCC1 mRNA] Acetylcysteine inhibits the reaction [XRCC1 gene mutant form results in decreased abundance of Adenosine Triphosphate]; Acetylcysteine inhibits the reaction [XRCC1 gene mutant form results in increased abundance of Malondialdehyde]; Acetylcysteine promotes the reaction [XRCC1 protein results in decreased abundance of Malondialdehyde]; Acetylcysteine promotes the reaction [XRCC1 protein results in decreased oxidation of Glutathione]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased abundance of Adenosine Triphosphate]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased activity of CAT protein]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of CYTB mRNA]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND2 mRNA]; Acetylcysteine promotes the reaction [XRCC1 protein results in increased expression of ND5 mRNA] |
CTD |
PMID:18948301 PMID:30998386 |
|
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of XRCC3 mRNA] |
CTD |
PMID:18948301 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions |
EXP |
Acetylcysteine promotes the reaction [Acrylonitrile results in increased expression of XRCC6 mRNA] |
CTD |
PMID:26332274 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to CTNNB1 protein]]; Acetylcysteine inhibits the reaction [27-hydroxycholesterol inhibits the reaction [YWHAH protein binds to GSK3B protein]] |
CTD |
PMID:33131013 |
|
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
|
|
G |
Yy1 |
YY1 transcription factor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 mRNA]; Acetylcysteine inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 protein] |
CTD |
PMID:34310962 |
|
NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZBTB16 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
|
|
G |
Zdhhc19 |
zinc finger DHHC-type palmitoyltransferase 19 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZDHHC19 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:68,277,847...68,289,110
Ensembl chr11:68,277,848...68,288,954
|
|
G |
Zfand2a |
zinc finger AN1-type containing 2A |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of ZFAND2A mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
|
|
G |
Zfhx4 |
zinc finger homeobox 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFHX4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:96,224,763...96,408,245
Ensembl chr 2:96,224,767...96,408,228
|
|
G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
increases expression |
ISO |
Acetylcysteine results in increased expression of ZFP36L2 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
|
|
G |
Zfp394 |
zinc finger protein 394 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [elesclomol results in increased expression of ZNF394 mRNA] |
CTD |
PMID:18723479 |
|
NCBI chr12:9,409,047...9,417,228
Ensembl chr12:9,409,078...9,417,246
|
|
G |
Zfp395 |
zinc finger protein 395 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFP395 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
|
|
G |
Zmym2 |
zinc finger MYM-type containing 2 |
decreases expression |
ISO |
Acetylcysteine results in decreased expression of ZMYM2 mRNA |
CTD |
PMID:16084531 |
|
NCBI chr15:31,035,835...31,108,945
Ensembl chr15:31,035,838...31,109,357
|
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
decreases activity |
EXP |
N-acetylmethionine results in decreased activity of GLUD1 protein |
CTD |
PMID:37871522 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
N-acetyltryptophan inhibits the reaction [Aluminum Chloride results in decreased activity of ACHE protein] |
CTD |
PMID:29185389 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
affects abundance |
ISO |
CYP2D6 affects the abundance of S-phenyl-N-acetylcysteine |
CTD |
PMID:10780264 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[CYP2E1 protein affects the metabolism of Benzene] which affects the chemical synthesis of S-phenyl-N-acetylcysteine |
CTD |
PMID:15051535 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
affects abundance multiple interactions |
ISO |
GSTA1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine GSTA1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine] |
CTD |
PMID:20100551 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects abundance multiple interactions |
ISO |
GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine; GSTM1 polymorphism affects the abundance of S-phenyl-N-acetylcysteine [GSTM1 polymorphism co-treated with Smoke] affects the abundance of S-phenyl-N-acetylcysteine; GSTA1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine]; GSTT1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine] |
CTD |
PMID:17056211 PMID:20100551 PMID:21300142 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
multiple interactions affects abundance affects chemical synthesis |
ISO |
[GSTT1 gene SNP affects the metabolism of Benzene] which affects the abundance of S-phenyl-N-acetylcysteine; GSTT1 gene polymorphism affects the reaction [GSTM1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine] GSTT1 gene polymorphism affects the abundance of S-phenyl-N-acetylcysteine; GSTT1 polymorphism affects the abundance of S-phenyl-N-acetylcysteine GSTT1 protein polymorphism affects the chemical synthesis of S-phenyl-N-acetylcysteine |
CTD |
PMID:15533900 PMID:15935803 PMID:20100551 PMID:21300142 PMID:30086327 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
affects abundance |
ISO |
NQO1 affects the abundance of S-phenyl-N-acetylcysteine; NQO1 polymorphism affects the abundance of S-phenyl-N-acetylcysteine |
CTD |
PMID:10780264 PMID:12798093 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
AIFM1 protein inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased reduction of Glutathione]; AIFM1 protein promotes the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased reduction of Adenine Nucleotides] |
CTD |
PMID:15316071 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]]; Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]] |
CTD |
PMID:21138475 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of AQP3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases phosphorylation multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein] |
CTD |
PMID:21138475 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein] |
CTD |
PMID:21138475 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein] S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 mRNA; S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein |
CTD |
PMID:17135264 PMID:21138475 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions increases secretion |
EXP |
Carbon Dioxide inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased secretion of CALCA protein] |
CTD |
PMID:18052948 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased activity of and results in increased cleavage of CASP1 protein |
CTD |
PMID:10903723 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases activity increases activity |
ISO EXP |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of CASP3 protein] Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased activity of CASP3 protein] S-Nitroso-N-Acetylpenicillamine results in decreased activity of CASP3 protein |
CTD |
PMID:10811113 PMID:12006578 PMID:12220328 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased phosphorylation of CREB1 protein]; S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Quercetin results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:17135264 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of CSRP3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Drgx |
dorsal root ganglia homeobox |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of DRGX mRNA |
CTD |
PMID:12102619 |
|
NCBI chr16:7,854,849...7,884,404
Ensembl chr16:7,854,849...7,900,600
|
|
G |
Edn1 |
endothelin 1 |
increases secretion |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased secretion of EDN1 protein |
CTD |
PMID:15640287 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eln |
elastin |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of ELN mRNA |
CTD |
PMID:12102619 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Exoc6 |
exocyst complex component 6 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of SEC15 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:235,314,612...235,457,824
Ensembl chr 1:235,300,369...235,457,015
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] |
CTD |
PMID:10811113 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR2B mRNA |
CTD |
PMID:12102619 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] |
CTD |
PMID:16351512 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Ghrh |
growth hormone releasing hormone |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of GHRH mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
multiple interactions decreases expression |
EXP |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]; Uric Acid inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions decreases expression |
EXP |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]; Uric Acid inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of GOT1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein]]; GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; GPX1 protein affects the susceptibility to [Diquat co-treated with S-Nitroso-N-Acetylpenicillamine]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased expression of GPX1 protein] |
CTD |
PMID:11672444 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
multiple interactions |
EXP |
[S-Nitroso-N-Acetylpenicillamine co-treated with 2-tert-butylhydroquinone] results in increased expression of GSTA2 |
CTD |
PMID:15357004 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of HCK mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased expression of HMOX1 protein |
CTD |
PMID:16439612 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Streptozocin results in increased expression of IFNG protein] |
CTD |
PMID:15892581 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Itpka |
inositol-trisphosphate 3-kinase A |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of ITPKA mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases expression decreases phosphorylation increases phosphorylation multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK1 protein S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:15640287 PMID:19252090 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases expression multiple interactions increases phosphorylation decreases phosphorylation |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:15640287 PMID:19252090 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mme |
membrane metallo-endopeptidase |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MME mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mtf1 |
metal-regulatory transcription factor 1 |
affects localization |
ISO |
S-Nitroso-N-Acetylpenicillamine affects the localization of MTF1 protein |
CTD |
PMID:16423564 |
|
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of NFKB1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases activity decreases expression |
ISO EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased activity of NOS2 protein S-Nitroso-N-Acetylpenicillamine results in decreased expression of NOS2 promoter |
CTD |
PMID:11076874 PMID:15565661 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:11799084 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of NPR3 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
multiple interactions |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein] |
CTD |
PMID:18652891 PMID:21235400 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of PAM mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]] |
CTD |
PMID:10811113 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein] |
CTD |
PMID:18652891 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcg |
protein kinase C, gamma |
multiple interactions |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein] |
CTD |
PMID:18652891 PMID:21235400 |
|
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions increases activity |
EXP |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] S-Nitroso-N-Acetylpenicillamine results in increased activity of PRKG1 protein |
CTD |
PMID:11799084 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
increases activity |
EXP |
SNAP increases activity of Ptpn1 protein in aortic smooth muscle cells |
RGD |
PMID:10484424 |
RGD:401965470 |
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Rack1 |
receptor for activated C kinase 1 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of RACK1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein] |
CTD |
PMID:21235400 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rgs17 |
regulator of G-protein signaling 17 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein] |
CTD |
PMID:18652891 |
|
NCBI chr 1:42,222,248...42,324,625
Ensembl chr 1:42,227,070...42,324,609
|
|
G |
Rplp0 |
ribosomal protein lateral stalk subunit P0 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of RPLP0 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
|
|
G |
Sftpa1 |
surfactant protein A1 |
decreases expression multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
multiple interactions decreases expression |
EXP |
bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpc |
surfactant protein C |
multiple interactions decreases expression |
EXP |
bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions affects response to substance |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein] SOD1 protein affects the susceptibility to S-Nitroso-N-Acetylpenicillamine |
CTD |
PMID:10698074 PMID:11672444 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO EXP |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein] [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA |
CTD |
PMID:11672444 PMID:14996425 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of TRP53 mRNA S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] |
CTD |
PMID:7673702 PMID:16351512 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein] |
CTD |
PMID:20177073 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
increases phosphorylation |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of VASP protein |
CTD |
PMID:11799084 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression increases secretion |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased expression of VEGFA mRNA S-Nitroso-N-Acetylpenicillamine results in increased secretion of VEGFA protein |
CTD |
PMID:10613739 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|